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ABSTRACT
Products of the umuD gene in E. coli are involved in regulating the timing of error-free
DNA repair processes and mutagenic translesion DNA synthesis (TLS) during the SOS response
to DNA damage. Homodimeric UmuD2 is upregulated early during the SOS response, and a
slow post-translational autocleavage process removes the N-terminal 24 amino acids of each
UmuD monomer. The remaining C-terminal fragment, UmuD' 2, activates the catalytic subunit
of the Y family DNA polymerase V for mutagenic TLS. The small proteins UmuD2 and UmuD' 2
make a large number of specific protein-protein contacts for their roles in regulation. This report
chronicles experiments that indicate that umuD gene products share characteristics with
intrinsically disordered proteins, which lack a defined secondary or tertiary structure when
purified and many of which have important roles in regulation. Counterintuitively, UmuD 2 and
UmuD' 2 form stable homodimers in vitro at concentrations where little or no a helix or 13 sheet is
detectable. High protein concentrations and certain crowding agents can confer more typical
secondary structure on UmuD2 and UmuD'2. The binding affinities between UmuD2 and two of
its interaction partners are reported; interaction with either of these interaction partners also
confers secondary structure on UmuD2. Intrinsic disorder in umuD gene products helps explain
how they can make a vast number of specific protein-protein interactions despite their small size,
and previous single-cysteine studies of both UmuD 2 and UmuD' 2 provide insights into the actual
structures of intrinsically disordered proteins. A model is presented for how umuD gene
products and certain hub proteins, which form highly connected nodes in protein-protein
interactomes, can make sequential protein-protein interactions.
For Mike Simon
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CHAPTER 1
INTRODUCTION
Mechanisms of Mutagnesis
Cells of all organisms and in all environments encounter DNA damaging agents (for a
comprehensive review on mechanisms and cellular responses to DNA damage, see reference
[3]). In addition to environmental DNA damaging agents such as UV irradiation [4], ionizing
radiation [5], and certain chemical environmental factors [6], cells produce DNA damaging
agents through their own internal metabolic processes. Reactive oxygen species, alkylating
agents, and other free radicals are byproducts of normal metabolism and can react with and
damage cellular DNA [7]. Spontaneous DNA damage such as depurination also occurs at a
significant frequency in the cell [8].
Much of this DNA damage is repaired through specialized repair pathways such as base
excision repair [9], nucleotide excision repair [10, 11], or direct reversal of damage such as
through photolyases [12]. However, on occasions when DNA damage is extensive or when
damage is encountered during DNA replication, processes of DNA damage tolerance can occur.
Tolerance allows DNA replication to continue despite the presence of a lesion. Tolerance differs
from repair in that the lesion is still present in the parental DNA after tolerance mechanisms are
completed [3]. DNA damage tolerance pathways include homologous recombination [13, 14]
and translesion DNA synthesis (TLS). TLS involves the active use of specialized DNA
polymerases that can use damaged or noncanonical DNA bases as a template for synthesis [15,
16]. When the normal replicative DNA polymerase encounters a lesion, it is more likely to stall
or reprime downstream of the lesion than to success in replicating the damage DNA itself [ 17].
The current models of translesion DNA synthesis involve a polymerase switch from the
replicative to the translesion DNA polymerase and back again [18] or recruitment of the TLS
polymerase to fill in gaps left behind by the replicative DNA polymerase repriming downstream
of the lesion [ 19, 20].
There are currently 5 known classes of DNA polymerases [21-23]. The earliest ones
discovered are from the A family, represented by bacterial DNA polymerase I (Pol I) [24]. This
polymerase has a proofreading subunit and fills in gaps in the DNA left by excision repair
processes. In eukaryotes, the A family is present partially as mitochondrial DNA polymerases,
which are involved in the replication and repair of the mitochondrial genome [25]. Additionally,
the nuclear proteins DNA polymerase 0, which appears to be involved in somatic hypermutation,
and polymerase v, whose function is unknown, are also in the A family [25]. The B family of
DNA polymerases includes bacterial DNA polymerase II (Pol II) and eukaryotic polymerases a,
which acts as a primase [26, 27], and polymerases 6 and E, both of which are implicated in both
replication and DNA repair [28-31]. DNA Pol II is involved in early replication restart after
DNA damage [32]. The C family of DNA polymerases is only represented in bacteria and
includes DNA polymerase III (Pol III), the normal replicative DNA polymerase in gram negative
bacteria, and the homologous replicative DNA polymerase C (Pol C) in gram positive bacteria
[33]. Although there are no homologs of Pol III/Pol C in eukaryotes, these enzymes display
structural homology to both B family and A family DNA polymerases, suggesting that domain
rearrangements may have led to the separate replicative DNA polymerases for bacteria and
eukaryotes, rather than DNA synthesis activity having evolved twice [34]. The X family of DNA
polymerases, conversely, is only present in eukaryotes and is involved in base excision repair,
somatic hypermutation, and non-homologous end-joining, among other functions [35]. This
family of DNA polymerases is part of a larger superfamily of nucleotidyl transferases and has
less homology to the A, B, or C families than those have to each other [36].
It is the relatively newly-discovered Y family of DNA polymerases that is most
associated with translesion DNA synthesis [15], although other polymerases can also perform
TLS in vitro [37]. In fact, the eukaryotic B family DNA polymerase ý [38, 39] is often grouped
with the eukaryotic Y family DNA polymerases i [40, 41], t [42], and ri [43, 44] due to its TLS
activity, despite the lack of structural homology of polymerase ý to Y family polymerases.
What defines Y family DNA polymerases is not so much their ability to perform TLS, as
members of other polymerase families can do so both in vivo and in vitro, but rather their
structures, which feature a relatively open active site [45, 46] compared to other polymerases'
more closed structure [47]. Although Y family DNA polymerases share an overall "right-hand"
fold with the replicative DNA polymerases, Y family DNA polymerases lack the replicative
polymerases' O-helix, which is responsible for a conformational change that allows replicative
DNA polymerases to discriminate against non-Watson-Crick base pairs in their active site [48],
and some have extra domains, such as the Polymerase Associated Domain (PAD, or little finger
domain) [49, 50]. As a result of these structural differences, the area surrounding the DNA in Y
family DNA polymerases is more solvent-exposed, which allows them to accommodate bulky
adducts on the template strand [51]. Several lines of evidence suggest that even with their open
active site, an open-to closed conformational change is necessary for Y family DNA polymerases
to perform TLS, although this conformational change does not result in the high fidelity that
replicative polymerases' conformational change effects [52-54]. Y family DNA polymerases
generally also have lower processivity on undamaged DNA than replicative DNA polymerases,
even in the presence of a processivity factor [55, 56].
The Y family of DNA polymerases includes the almost universally conserved DinB
subfamily, the eukaryotic Revl and Rad30 subfamilies and the prokaryotic UmuC subfamily,
which like the C family of DNA polymerases, has separate Gram negative and Gram positive
counterparts [15]. Some Y family DNA polymerases recognize specific cognate lesions and can
bypass them accurately [43, 53, 57]; others are more error-prone [58]. However, Y family DNA
polymerases generally have lower fidelity on undamaged DNA templates than the normal
replicative DNA polymerases [58-60]. In addition to the lack of O-helix, another possible reason
for this is that Y family DNA polymerases do not have proofreading subunits, although it is
possible that Y family DNA polymerases may use extrinsic accessory subunits to increase their
fidelity on undamaged templates [61]. Because of their mutagenic potential, it is generally
assumed that the activity of Y-family DNA polymerases must be regulated to prevent their action
on undamaged DNA and target them only to the correct DNA lesions.
At best, translesion DNA synthesis preserves genome replication under conditions of
severe DNA damage [62]. At worst, it can cause point mutations or deletions [16]. The
activities of prokaryotic error-prone DNA polymerases can induce a transient mutator phenotype,
increasing the genetic variation of a subset of organisms and thereby increasing the species'
overall chances of survival [23, 63]. Multicellular organisms benefit less from a mutagenic
bypass system because deleterious mutations have the potential to cause malignant tumors or
genetic diseases that can affect the entire organism; unicellular organisms do not get tumors [64].
Eukaryotic cells have more subfamilies of Y family DNA polymerases than prokaryotic cells,
presumably to provide specialists for more cognate lesions, thereby causing fewer point
mutations [60].
The E. coli SOS response
When a bacterial cell encounters extensive DNA damage or other stressors [65] that
requires a more stringent response than allowed by normal growth conditions, the cell undergoes
what is termed the SOS response [66]. The SOS response is only a subset of the generalized
DNA damage response, which involves more than 1,000 genes (about 25% of the bacterial
genome) [67]. In E. coli, the SOS response involves more than 40 genes (about 1% of the
bacterial genome) that are under the control of the LexA repressor [68]. LexA is a dimeric
transcription factor that binds to a consensus SOS box sequence (5'-
TACTGTATATATATACAGTA-3') in the promoters of SOS response genes [69]. Among the
genes upregulated during the SOS response are DNA repair genes [70, 71], certain genes
involved in cell division [68], polB, which encodes DNA Pol II [71], and several other genes
whose functions are unknown or that are less obviously involved in a response to stress [68, 71,
72]. Also upregulated are TLS genes: dinB, encoding the relatively accurate DNA polymerase
IV (Pol IV) [71, 73]; umuC, encoding the catalytic subunit of DNA polymerase V (Pol V) [74-
76]; and umuD, which encodes an accessory to both of these Y family DNA polymerases [74-
77]. DNA Pol I is expressed constitutively rather than as part of the SOS response, and it has not
been implicated in mutagenesis [78].
During cellular growth in the absence of significant DNA damage, LexA binding to the
SOS boxes represses the expression of the SOS genes [79]. However, under conditions of
extensive DNA damage, stalling of the normal replicative DNA polymerase at sites of damage
produces long tracts of single stranded DNA (ssDNA) [67]. This extra ssDNA binds to cellular
RecA protein, which forms the RecA nucleoprotein filament (RecA* or RecA:ssDNA) [80].
RecA* binds to LexA and facilitates a conformational change in LexA that causes autocleavage
and inactivation of the repressor [81]. This process is similar to X cI repressor cleavage at the
start of lytic cycle of X phage (extensively reviewed in [82]). A serine-lysine dyad in the C-
terminus of these proteins acts as a protease to cleave an Ala-Gly bond between the N- and C-
terminal domains [83, 84]. Cleavage results in separation of the LexA and X N-terminal DNA
binding domains from the C-terminal dimerization domains, destroying cooperative DNA
binding and releasing repressor from the DNA [85, 86]. In the case of LexA, cleavage exposes
cryptic ClpXP proteolytic sites and results in rapid degradation of the two halves of the protein
[87].
A similar cleavage reaction is thought to occur in p-lactamases [88], bacterial signal
peptidases [89, 90], and UmuD [91], the subject of this work. No similar mechanism is known
in eukaryotes, although the extensively-used phosphorylation reaction may represent a similar
autoregulatory scheme with many different proteins undergoing a similar post-translational
regulator step [92]. Although processing of LexA and similar proteins is considered
"autocatalytic," it is not in fact catalytic, because the products of the reaction do not include the
reactant, intact LexA [92]. In the case of UmuD (discussed below), the post-translational
cleavage product UmuD' can act as a true enzyme to cleave intact UmuD [93]. An advantage of
autocatalysis is that the local concentration of substrate can be rather high, resulting in extremely
fast catalysis when the correct conditions are met [92], and it is therefore unsurprising that both
prokaryotes and eukaryotes use autocatalysis as a regulation scheme.
UmuD and similar proteins
Among the 40+ genes upregulated during the SOS response are the umuDC operon [68,
76]. This operon encodes DNA Pol V, the Y-family DNA polymerase required for most point
mutagenesis in E. coli [75]. Members of this operon were found in a screen for cells that were
nonmutable after UV irradiation [76]. The umuDC operon is functionally similar to the plasmid-
encoded mucAB operon that is responsible for Salmonella typhimurium mutagenesis as used in
the Ames test for mutagenic substances [94].
The SOS box for the umuDC operon (5'- CTGTATATAAAAACAG-3') is substantially
different from the consensus sequence above [95], with the result that the umuDC operon is
among the first set of genes upregulated after DNA damage [68]. During normal cellular
growth, UmuD is present in about 200 copies per cell, whereas UmuC is undetected [96]. One of
the reasons why translation of UmuC is underrepresented relative to that of UmuD, even though
they are on the same transcript, is that umuC uses rare codons [91]. Interestingly, the stop codon
of UmuD and the start codon of UmuC overlap by one nucleotide [91].
UmuC is the catalytic subunit of the Y family DNA polymerase Pol V [75]. The initial
product of the umuD gene is a 139 amino acid protein [91]. UmuD and UmuC together effect a
primitive DNA damage checkpoint-like function, in which UmuD, together with UmuC, induces
a temporary decrease in the rate of DNA synthesis [97]. Accurate DNA repair processes are
believed to be active during this time [97]. Overexpression of umuDC induces a cold-sensitive
phenotype that is thought to be an exacerbation of this DNA damage checkpoint [98]. This cold-
sensitive phenotype is partially relieved through mutations in either UmuC or the 0 processivity
subunit that appear to weaken the interaction between these two proteins [99, 100].
UmuD shares considerable homology with the C-terminal domains of LexA and the X cI
repressor, including one cleavage site residue and both of the catalytic serine-lysine dyad
residues [91] (Figure 1-1 p. 18), although the N-terminal DNA binding domains of LexA and X cI
repressor are missing in UmuD. Based on this homology, it had been correctly predicted that
UmuD may be able to undergo RecA*-facilitated autoproteolysis similar to that of LexA [101-
103]. In this reaction, the N-terminal 24 amino acids are removed from UmuD, leaving the C-
terminal portion, termed UmuD'. It is UmuD' that activates UmuC for its role in TLS [103];
DNA Pol V has been defined as the heterotrimeric complex UmuD'2C [75].
The mutagenic mechanism of DNA Pol V, in addition to replicating past DNA lesions,
also appears to involve untargeted mutations at sites without damage [104-106]. This was
experimentally demonstrated by showing that unirradiated phage injected into an irradiated host
bacterium incurs greater numbers of point mutations than the same phage introduced into
unirradiated bacteria [106]. Additionally, most point mutations caused by constitutive (rather
than damage-induced) SOS activation can be corrected by mismatch repair systems, implying
that they do not contain a non-coding DNA lesion [105]. Finally, during constitutive SOS
response activation, E. coli strains that are defective in excision repair are not significantly more
susceptible to point mutations than those that are proficient, again suggesting that these sites of
mutation do not contain lesions that are excision repair substrates, but rather are the results of
simple replication errors [104]. TLS by UmuD'2C is augmented in the presence of the a and P
subunits of DNA Pol III in addition to single-stranded DNA binding protein (SSBP) and RecA
[107-109]. The once enigmatic "third role" [103, 110] of RecA in TLS (aside from activating
the SOS response and the conversion of UmuD2 to UmuD' 2) has recently been discovered [111 ].
RecA acts in conjunction with trans ssDNA to augment TLS activity, perhaps acting as a signal
that extensive DNA damage is still present [111].
Cleavage of UmuD is slower than that of LexA or even functional homologs such as
MucA (discussed below). It is likely that some of the inefficiency is due to the cysteine in the
cleavage site, where proteins that undergo more efficient RecA cleavage have an alanine [91]. If
the Cys residue of the UmuD cleavage site is converted to Ala to make a LexA-like cleavage
site, RecA* cleavage proceeds more efficiently in vivo than for the wild-type protein [112].
Similarly, if the Ala of LexA or MucA is converted to the Cys of UmuD, their cleavage becomes
slower [113, 114]. The homologous phage 933W repressor, which also cleaves relatively
slowly, has a leucine at this position [115]. Another factor that may slow the cleavage of UmuD
to UmuD' is DinI, which appears to bind to RecA and inhibit UmuD cleavage [116-118]. A
similar protein is found on the plasmid-encoded mpCAB operon, in which impA encodes a
homolog of umuD, impB is similar to umuC, and impC appears to function as dinI [119].
Protein-protein interactions involving umuD gene products
In addition to the dimerization as part of the UmuD'2C complex, UmuD and UmuD' can
form homodimers on their own [120] and the thermodynamically most stable UmuD'D
heterodimer [121]. However, it was previously unknown how stable these dimers were.
Glutaraldehyde cross-linking resulted in both dimeric and monomeric species as visualized by
SDS-PAGE electrophoresis [121], and there is disagreement in the literature as to the level of
homodimerization of the homologous protein LexA [1, 122, 123]. Although it is now known
that the dissociation constant for the homodimer LexA2 is in the pM range [1], the homologous
phage X cI repressor is thought to have a Kd of 20 nM, suggesting that about 5% of the protein is
monomeric at physiological concentrations [124]. Evidence is presented in Chapter 4 that
indicate that all three umuD gene products are dimeric at a wide range of protein concentrations,
from nM to mM, although higher order oligomers of both UmuD' and UmuD have been trapped
by cross-linking [100, 125].
The UmuD'D heterodimer is important at the end of the SOS response for its role in
targeting the mutagenic UmuD' for cleavage by ClpXP protease [126]. The UmuD member of
the dimer acts as an adaptor protein to target the UmuD' member for proteolysis; UmuD can be
fed into ClpXP for degradation in the same manner if the dimeric complex is UmuD2 [127].
UmuD2 and UmuC are rapidly and continuously degraded by Lon protease [126]. Although both
UmuD 2 and UmuD' 2 can interact with UmuC in vitro, the interaction between the heterodimer
UmuD'D and UmuC results in an insoluble complex [128]. There is no known mechanism for
degradation of UmuD'2.
In addition to their interactions with UmuC, both UmuD2 and UmuD'2 can specifically
interact with a multitude of cellular proteins, many but not all of them components of DNA
polymerases. This is particularly surprising given the small size of UmuD2 and UmuD'2 (30 and
25 kDa, respectively), as there may not be enough distinct binding sites on umuD gene products
to account for all of the interactions. UmuD2 and UmuD' 2 have recently been shown to interact
with the other E. coli Y family DNA polymerase, DinB, and in contrast to the case with UmuC,
the UmuD'D heterodimer can also bind to DinB [77]. Overexpression of umuD rescues a -1
frameshift phenotype of dinB overexpression, suggesting that UmuD plays a role in regulating
the activity of DinB [77]. Interestingly, although there are no known homolgs of UmuD in
eukaryotes, overexpression of the eukaryotic DinB homolog, Pol K, also results in a -1 frameshift
phenotype [129, 130], suggesting that eukaryotes may also have a regulator of Pol K that
performs this role of UmuD.
Both UmuD2 and UmuD' 2 also interact with the a catalytic, P processivity, and c
proofreading subunits of the normal replicative DNA polymerase [131], and with RecA [ 101-
103, 111]. Interestingly, despite their nearly identical primary structure, UmuD2 and UmuD' 2
interact differently with different proteins, either to effect a different response (UmuD2 in
conjunction with UmuC is associated with a DNA damage checkpoint, whereas UmuD' 2C is a
mutageneic translesion DNA polymerase), or with different strengths of interaction. UmuD2
interacts more strongly with the 0 processivity subunit of DNA Pol III than does UmuD' 2, which
may cause the DNA damage checkpoint [131]. Conversely, UmuD' 2 interacts more strongly
with the a processivity subunit of DNA Pol III [131]. It was initially thought that UmuD' 2
enabled mutagenesis by modifying the a subunit to become proficient for mutagenic TLS [132];
however, it is now know that UmuD' 2C is a DNA polymerase in its own right [75, 108]. It is not
known what the functional consequences of the interaction between UmuD'2 and the Pol III a
subunit are, although the "tool belt" model of DNA polymerase switching suggests that many
DNA polymerases are kept in close proximity by interactions with P and can be switched as
necessary for TLS [18, 133]. In the case of the DinB interaction, UmuD2 interacts more strongly
with DinB than does UmuD'2 [77], and it is known that some of the amino acids involved in
DinB binding make up the homodimer interface for UmuD'2 but not for UmuD2 [134]. It seems
likely that subtle differences in the conformations between UmuD 2 and UmuD'2 may partially
explain their different affinities for interaction partners. These replication proteins are not
expressed at high levels, and the interactions are quite specific [77, 131]. For example, products
of the umuDC operon interact with each other, as do products of the homologous mucAB operon
[91]. However, although mucB and umuC are 55% identical, UmuD can interact with UmuC but
not MucB, and similarly, MucA can interact with MucB but not UmuC [91].
Less well characterized interaction partners for UmuD2 were found in a high-throughput
pull-down assay, although it is unknown whether these interactions have relevance in vivo [135].
Interaction partners found in this study include: PurE (involved in purine biosynthesis), Fur
(ferric uptake regulator), FldB (flavodoxin 2), RpsE (a ribosomal protein), InsM (transposase),
YjgM (a putative acetlytransferase), and the hypothetical proteins YbiA and YdfU [135].
Unpublished bacterial two-hybrid results by Charles Kuang suggest that UmuD may interact
with NifJ (a putative pyruvate flavodixin oxidoreductase), RseA (an anti-sigma factor), RpoE
(sigma factor), TilS (involved in tRNA-Ile production), and the proteins of unknown function
YhjG, YhjH, and YbfG. Using the same assay, UmuD' has been proposed to interact with PotF
(putrescine binding protein), PotG (involved in putrescine transport), Adk (has adenylate kinase
activity), FruK (fructose- l-phosphate kinase), FruB (diphosphoryl transfer protein), HofF
(general secretion), PyrH (uridylate kinase), BasR (transcriptional regulator), DgoT (transport of
D-galactonate), GlgP (glycogen phosphorylase), NifJ as for UmuD, the small molecule transport
proteins LivF, LivG, LivM, livH, and the hypothetical proteins YheG (putative export protein),
YjdB (putative membrane protein), YidS (putative oxidoreductase), YjeP (a putative periplasmic
binding protein), YtfE, YtfF (putatively involved in cationic amino acid transport). Experiments
are underway to determine the physiological relevance of some of these interaction partners.
The roles ofumuD gene products in regulating TLS
UmuD is present early during the SOS response, whereas UmuD' appears later [97].
UmuD2 is associated with a DNA damage checkpoint, during which error-free DNA repair
processes have a chance to repair damaged DNA before tolerance mechanisms are active [131].
Conversely, UmuD' 2 is associated with mutagenic TLS [103]. Conversion of UmuD2 to UmuD'2
may represent a temporal shift from error-free DNA repair to a more error-prone DNA damage
tolerance. In support of this hypothesis, it is the early UmuD2 protein that is associated with the
function of the more accurate Y family DNA polymerase DinB [77], and UmuD'2 that is a
component of the more error-prone Pol V [75]. DinB is specialized to bypass certain N2-dG
adducts that result from cellular respiration [53] and is present in relatively high copies in the cell
even without SOS induction [136]; Pol V is active relatively late during the SOS response [97].
This temporal division between error-free and error-prone TLS may also occur in eukaryotes by
partitioning TLS polymerases in a cell-cycle dependent manner [19].
The umuDC operon is well represented in bacteria, including the bacterium with the
smallest genome discovered to date, Pelagibacter ubique [137]. Its UmuD homolog had been
classified as MucA, which is functionally and similar and highly homolgous to UmuD (Figure 1-
1 p. 18), although the mucAB and umuDC operons have slightly different mutation spectra [138].
It appears that the umuDC operon may be important enough to be preserved in a minimalistic,
streamlined bacterial genome.
Certain aspects of umuDC operon function remain enigmatic. Both UmuD'2C and DinB
have some AP lyase activity in vitro, but the purpose of this activity in either polymerase is
unknown [139]. Additionally, the SOS response seems to oscillate in a temporal fashion, and the
oscillation requires the umuDC operon, although the functions of the umuDC operon in this
effect and the functions of the oscillations are unknown [140].
Structures of UmuD2 and UmuD'2
The NMR and crystal structures of UmuD' 2 have been solved, and both methods of
structure determination agree that UmuD'2 is a dimeric protein with a C2 axis of symmetry and a
mostly 3-sheet structure [141, 142]. The proteins have a P sheet structured C-terminal globular
domain with unstructured N-terminal arms (amino acids 25 through 39, numbering as in full-
length UmuD). The NMR structure shows the correct dimerization interface [142], one that is
consistent with chemical cross-linking and mutational data [143-145]. It was impossible to tell
by crystallography which of the two possible dimer interfaces was the correct one, and it had
been proposed that UmuD' may form filaments of dimers [141]. Although UmuD' has been
shown to cross-link as multimeric species [125], no evidence of filament formation was found by
NMR [125, 142].
Despite their overall similarities, the NMR and crystal structures show several substantial
differences in structure [142] (Figure 1-2 p.24). Most telling catalytically, the NMR structure of
UmuD' shows the active site serine and lysine dyad residues pointed away from each other such
that their functional groups are more than 8 A apart [142]. A conformation such as this would
not be competent for catalysis. In contrast, the crystal structure shows the catalytic serine and
lysine dyad residues pointed towards each other and less than 5 A apart [141]. In this structure,
the active site residues are poised for catalysis. It is possible that crystal packing forces caused
UmuD'2 to mimic the conformation adopted by UmuD2 when it is bound to RecA*. Upon
inspection, other differences become evident as well. The overall conformation of UmuD' in the
NMR structure is wider than it is tall, while that of the X-ray crystal structure shows a more
square overall shape. Although the majority of the secondary structure is a f3-sheet in both
methods of protein structure determination, the actual conformation of many amino acid residues
relative to their neighboring contacts is different between the two proposed protein structures
[141, 142]. This observation may give insight into how protein-protein contacts may affect the
structures of UmuD and UmuD', and it served as a first indication that at least UmuD' may have
a flexible structure.
Despite several attempts, the structure of UmuD2 has not been solved, either by NMR or
by X-ray crystallography. However, the X-ray crystal structure of the homologous protein LexA
has been solved [146], and the C-terminal region of this structure, together with those of the
post-translationally modified UmuD' 2, have allowed model calculation of full-length UmuD2.
Four symmetric energy-minimized structures have been proposed, and they differ in the
orientation of their N-terminal arms (see Figure 2-S 1, p.40) [147]. It is also possible that the two
N-terminal arms of UmuD2 may have different conformations, resulting in asymmetry [147].
The arms may be able to adopt a cis conformation such as that found in the crystal structure of
LexA, wherein the N-and C-termini of a single monomer remain on the same side of the protein,
or a trans conformation, wherein the N-terminus contacts the C-terminus of the opposing
monomer [147]. There is biochemical evidence that UmuD2 cleavage can occur intermolecularly
in the trans conformation [93, 148, 149], and although it has been largely accepted that LexA 2
cleavage occurs intramolecularly [81, 150], certain deletion mutants of LexA2 have also been
Figure 1-2: Comparison of the NMR and X-ray crystal structures of UmuD' 2.
Figure 2-2: Comparison of the NMR and X-ray crystal structures of UmuD' 2.(A) Cartoon of the NMR structure of UmuD' 2 as solved in [142]. (B) Cartoon of the X-ray
crystal structure of UmuD' 2 as solved in [141]. These images were reproduced from [134].
shown to undergo intermolecular cleavage [151]. Even in the X-ray crystal structure of LexA2, a
minor change in a flexible loop has been proposed to enable an interchange between the cis and
the trans conformations of the N-terminus [146]. In addition to the cis and trans proposed
structures of UmuD2, each possible conformation can adopt either a cleavable conformation, in
which the protease active site and cleavage site residues are near each other and can undergo
catalysis, or a noncleavable conformation, wherein the active site and cleavage site residues are
far apart [147]. If these models are accurate, the actual structure of UmuD2 may favor one of
these possible conformations, or it may be a heterogeneous mixture of a multitude of these
conformations.
Some data that suggest UmuD2 may have multiple conformations are obtained from
single-cysteine cross-linking and solvent accessibility studies. 3H-iodoacetate has been used to
modify cysteines introduced into UmuD2 and to determine their extent of solvent accessibility
[143]. Although certain single-cysteine derivatives had clearly higher or lower than average
solvent accessibility than other residues, the majority of single cysteine derivatives were
intermediately modified by iodoactate [143]. Single-cysteine cross-linking data for UmuD2 are
similarly unusual, as different cross-linking agents provide different results, with few clear trends
and the many positions resulting in cross-linking as UmuD2 homodimers with intermediate
efficiency [88, 143, 144]. Most surprisingly, air oxidation by dialysis of reducing agents should
be discriminatory because it is a very mild procedure and depends only on the proximity of two
cysteines to each other in the native structure [152], but in the case of single cysteine derivatives
of UmuD2, it was not in fact very discriminatory [144]. Nevertheless, those single cysteine
derivatives that cross-link robustly with iodine, which is a fast reaction that gives a snapshot of
conformational states [144] generally are predicted to be in the dimer interface by our current
models of UmuD2 [147].
Intrinsically Disordered Proteins
These unusual features of umuD gene products are at least partially explained in Chapter
4, which illustrates the ways in which umuD gene products are similar to a relatively newly-
discovered and poorly understood class of proteins currently termed intrinsically disordered
proteins [153]. Intrinsically disordered proteins have been variously called rheomorphic [154],
partially folded [155], flexible [156], mobile [157], natively denatured [158], natively unfolded
[159], intrinsically unstructured [160], and natively disordered [161], and the terminology is
likely to change again to more fully capture the essence of these proteins as our understanding
improves. Currently, they are characterized as having significantly less stable secondary or
tertiary structural characteristics than other proteins when purified and at neutral pH; they are
thought to undergo dynamic conformational transitions. The lack of secondary structure can be
determined using a number of techniques, including NMR, CD, SAXS, fluorescence, and limited
proteolysis [162, 163]. Many of these proteins obtain more typical secondary structure at an
elevated or lowered pH, after a post-translational modification or cofactor assembly, upon
binding to DNA, RNA, or another protein, or through other cellular conditions [164]. Some
proteins, for example certain hormones [165], chaperones [153], and voltage-gated ion channels
[166], maintain activity even in regions that lack secondary structure. In fact, some intrinsically
disordered proteins have been shown to maintain disorder in vivo [167].
Examples of intrinsically disordered proteins include transcription factors [168, 169],
other DNA or RNA binding proteins [163], chaperones [153], antibodies [153], proteases [163],
and signaling factors [153, 170], including kinases and phosphatases. Signaling factors are
particularly interesting in relation to umuD gene products (reviewed in [153]). Intrinsic disorder
is thought to aid in the function of these proteins by enabling a large transition from disorder to
order, but only under certain cellular conditions (such as the presence of a binding partner or
cofactor) [171]. This transition allows specific stabilization of the ordered form of an
intrinsically disordered protein and allows its functionality to be strictly regulated by the
presence or absence of another cellular factor [163].
Most known intrinsically disordered proteins are from multicellular eukaryotes, although
a fair number of unicellular and prokaryotic ones are also known [160, 172]. Intrinsically
disordered proteins that are specific to eukaryotes include cytoskeletal proteins [173] and those
that regulate cell cycle [174]. It is thought that eukaryotic cells have a greater need for precise
regulation than prokaryotic ones, and intrinsically disordered proteins are often used as
regulatory proteins [170, 172, 174-178].
A major advantage of intrinsically disordered proteins that enables them to have
important regulatory roles is that the lack of a rigid, defined structure can allow them to respond
quickly and efficiently to changes in their environment [174]. If the precise fold of a protein, or
the fact that it folds in a defined manner at all, depends on its surroundings, then the protein will
only adopt a certain structure when its environment dictates the correct conditions. In the case of
an interaction, the high entropic cost of the disorder-to-order transition involved in folding an
intrinsically disordered protein causes many of these interactions to be low affinity and highly
reversible [163]. Intrinsically disordered proteins often act as signaling molecules for precisely
this reason; these proteins can detect an environmental situation and adopt a conformation,
binding partner, or activity specific to the situation. The protein's change in conformation may
signal downstream responses to an environmental stimulus. It has also been proposed that the
relatively large volume of intrinsically disordered proteins may enable them to efficiently detect
a specific binding agent, and if any of several distinct peptide units is sufficient for binding, a
disordered structure with these peptides at different locations may increase binding kinetics
relative to a more rigid interaction domain [175, 179]. A compact globular protein would be
more limited by diffusion to find an interacting partner. Since the actual structure of an
intrinsically disordered protein may depend on its specific interactions, these proteins are often
able to make a large number of highly specific contacts despite a small size [180]. Intrinsically
disordered proteins can often bind to multiple partners [ 181-183], and multiple intrinsically
disordered proteins can sometimes independently conform to a single structured partner [171].
Furthermore, a lack of rigid secondary structure can sensitize proteins to degradation, and
intrinsically disordered proteins are therefore often unstable in vivo, ensuring that their activity is
limited to the correct conditions [160, 163, 174].
The actual structure of an intrinsically disordered protein can consist of a spectrum of
conformations, from having large, flexible loops or unfolded domains that flank generally well-
folded domains, to a non-random molten globule conformation or a more random, extended
structure [153, 174]. However, a completely random and extended structure is probably rare
[163, 174]. Even chemically denatured proteins may show a nonrandom structure that has some
a-helix or j3-sheet-like content but is more flexible than the classical secondary structures due to
limited hydrogen bonding [184-186]. Proteins that have more than one distinct conformation are
also thought of as intrinsically disordered if the transitions between the conformations are not
cooperative [153].
Efforts to further classify and characterize the precise structures of intrinsically
disordered proteins have begun. Two classes have been proposed based on extent of disorder as
measured by CD: coil-like and premoltenglobule-like intrinsically disordered proteins [187].
Coil-like proteins are more unfolded than premoltenglobules and can be truly random coils or a
less random, more extended poly-proline type II coil [188, 189]. Premoltenglobules are thought
of as a second unfolding intermediate, more unfolded than a molten globule, in certain protein
unfolding pathways [187]. A molten globule has a hydrodynamic radius that is about 15%
greater than the corresponding native globular protein, whereas the hydrodynamic radius of the
premoltenglobule protein is closer to 50% greater, and there is less secondary structure in the
premoltenglobule [187].
Bioinformatic approaches suggest that even regions that are currently thought of as
almost completely disordered have three distinct "flavors" [178]. The flavors, called V, C, and
S, were proposed based on protein disorder prediction training sets; the greatest prediction
accuracy was achieved if the set of known disordered sequences was randomly divided into three
subclasses and used to train separate predictors. Sequences were then tested by the disorder
prediction programs and reassigned to groups based on which program predicted the disorder
most accurately. The disorder predictors were retrained and the process repeated until all of the
disordered proteins were sorted most accurately by their own group's prediction program. Just
as ordered proteins usually have both a-helix and f3-sheet components, it is likely that
intrinsically disordered proteins also have more than one flavor of disorder. In fact, disordered
regions, like ordered ones, can be highly conserved between species [163].
The three flavors of disorder have different sequence properties and may have different
structural properties and behaviors [178]. In fact, unstructured proteins that have a particular
function tend to cluster in the same flavor. Flavor C has an overrepresentation of histidine,
methionine, and alanine compared to other proteins, and they often bind nucleic acids or have
modification sites. Conversely, flavor S has an underrepresentation of histidine and is likely to
be involved in protein-protein interactions. Interestingly, Flavor V has more cysteine,
phenylalanine, isoleucine, and tyrosine than the other two flavors of protein disorder, and these
amino acids are generally not considered flexible amino acids. Most unstructured ribosomal
proteins are of flavor V. All of these flavors have lower sequence complexity than the general
proteome [178], and although low sequence complexity is a good indication of disorder [163,
177], high sequence complexity is not a good predictor of rigid secondary structure [190, 191].
Proper in vivo folding and function of intrinsically disordered proteins is a topic of
intense study, as intrinsically disordered proteins may be more likely than their more rigid
counterparts to misfold, aggregate, and thereby cause diseases in multicellular eukaryotic
organisms [192]. An example of a protein whose aggregation causes human disease is a-
synuclein, a small, intrinsically disordered protein of unknown function in synaptic terminals
whose misfolding is associated with Parkinson's and other neurodegenerative diseases [193-
195]. In addition to having three separate alternative mRNA splicing isoforms [196], the
structure of a-synuclein resembles a random coil when in an aqueous environment [197, 198] (a
curiosity in the literature is that eukaryotic pre-mRNA segments that can be alternatively spliced
are more likely to code for regions of disorder than for rigid structures [199]. Although a-
synuclein is considered heat-stable because of its failure to form aggregates after boiling for 10
minutes [193], it can be heat-denatured when simultaneously incubated at low pH [200]. The N-
terminus adopts an a-helical structure when associated with membranes [198, 201] , and a
central part of the protein can become structured with protein-protein interactions [197]. The C-
terminal tail remains unstructured even in a hydrophobic environment [202]. Like many
intrinsically disordered proteins, a-synuclein can undergo several post-translational
modifications, including ubiquitination, sumoylation, phosphorylation, nitration, and oxidation
[196]. Each of these modifications influences the secondary and tertiary structure of the protein
or its stability [203]. Additionally, a-synuclein can undergo a pathology-inducing transition to
an a-pleated sheet, which forms aggregates and fibrils and can eventually lead to Parkinson's
disease [198, 202, 204-206]. Interestingly, although a-synuclein is a neuronal protein found only
in higher eukaryotes, its primary sequence shares some similarity with UmuD, including one of
the protease cleavage site residues (the other maintains homology with LexA) and one of the
active site residues (Figure 1-1 p. 18). Although a-synuclein is thought to be post-translationally
processed by proteolysis [196], the cleave site is not at the location of the semi-conserved
cleavage site in UmuD and LexA, and there is no evidence for autocleavage of a-synuclein.
When incubated under certain micellular conditions, a-sinuclein does form what appear to be
homodimers as visualized by western blot, but these homodimers are most likely due to protein
cross-linking rather protein folding forces such as hydrophobic interactions or hydrogen bonding
[207-209]. Because of its lack of significant secondary structure, a-synuclein was assumed to be
highly sensitive to protease digestion [210], but on the contrary, it is rather resistant to
chymotrypsin [200], cathepsin D [200], and cellular proteases [211]. The purification scheme
for a-synuclein involves heat denaturation [193] or a high percentage of acetonitrile and
purification by HPLC [200]. It may be interesting to see if structural features of a-synuclein
differ between these harsh and other, more gentle methods of purification.
UmuD 2 and UmuD' 2 share homology with the dimerization domains of certain bacterial
transcription factors, and transcription factors often have intrinsically disordered domains [168].
However, it is usually the DNA-binding domains or protein-protein interactions domains of
transcription factors that are disordered rather than their homodimerization domains.
Transcription factors may be divided into distinct modules that have different functions; intrinsic
disorder in some of these modules facilitates interactions that promote rapid responses to cellular
conditions [212].
In addition to specific interactions, nonspecific crowding effects may also induce
structure in intrinsically disordered proteins [213]. Conditions in the cytosol are very different
from in vitro conditions, partially because of macromolecular crowding [214]. Under crowded
conditions, excluded volume effects artificially increase the effective concentrations of certain
solutes, while steric hindrance limits the diffusion of large macromolecules [214]. Several
crowding or viscosity-enhancing agents are used to mimic the effects of cellular crowding in
vitro. Sugars have been shown to induce some CD structure in certain denatured proteins [215,
216]. High concentrations of salt also can do this, and sometimes even better than sugars [216],
although in this case the effects may be due to charge-charge interactions rather than crowding.
Free amino acids, methylamines, polyols, and other polymers have also been used to mimic a
crowded cytosol [217]. Although the crowding mechanisms of these agents are not known in
detail, multiple models have been proposed [216]. Polymeric crowding agents are thought to act
through the excluded volume model [216], in which crowding is caused by steric hindrance, an
increase in viscosity, and a decrease in the availability of water. Small osmolytes are thought to
act through the preferential solvation model [216]. In this model, small molecules act in the
opposite manner as denaturants in that they have an unfavorable interaction with the peptide
backbone of proteins and provide a strong driving force for stabilization of a folded protein form
[218]. Another possible model is the scaled particle theory [216].
Few intrinsically disordered proteins are known to form stable dimers in solution,
although some examples are present in the literature. The homodimeric E. coli antitoxin MazE
has both structured and unstructured domains [219]. Like eukaryotic a-synuclein, the Bacillus
pasteurii UreG protein, involved in urea metabolism, is thought to be nearly completely
unstructured and cross-links to form dimers when oxidized [220], although earlier studies did not
detect the disulfide bond [221]. The E. coli histone-like proteins HU-a and HU-P, like UmuD
and UmuD', form both homodimers and the heterodimer [222]. Interestingly, upon thermal
denaturation, they undergo the folded to unfolded transition before the dimer to monomer
transition, indicating that at certain temperatures, an unfolded dimer must be present [222]. In
the case of HU-P2, a significant amount of unfolded dimer is present even at room temperature in
vitro [222]. Human Papilloma Virus protein E7 is homodimeric and has characteristics of
intrinsically disordered proteins as shown by NMR, although the CD spectrum shows some a-
helix and P-sheet structure [2].
Many intrinsically disordered proteins are also "hub" proteins, which represent local
centers of an organism's interactome [223-226]. Although the exact definition of a hub protein
is not yet defined, researchers in S. cerevisiae consider any protein that makes interactions with 5
or more other proteins a hub [227]. By this definition, both of the homodimeric umuD gene
products would be hub proteins. Other researchers consider the definition of a hub protein to be
the 10% of proteins within an organism that make the most protein-protein contacts. UmuD,
though not specifically listed as a hub protein, has been found to make many interactions in a
high-throughput screen [135]. Unsurprisingly, targeted deletion of hub protein genes tends to
have greater and more pleiotropic phenotypic effects than deletions of other single protein-
encoding genes [228].
Some evidence suggests tha hub proteins can be subdivided into party hubs, which tend to
make simultaneous interactions, and date hubs, whose multiple interactions are usually separated
by time or space [227]. Date hubs appear to have a greater tendency towards disorder [224],
although hub proteins in general have a greater propensity for disorder than other proteins [225].
The current model is that the disorder prevalent in date hubs enables them to make multiple
nonsimultaneous interactions, perhaps using overlapping surfaces [153, 224, 227]. If umuD gene
products can be thought of as hub proteins, it is uncertain which, if any, of their interactions are
made simultaneously and whether they act more as date or as party hubs. The flexibility and
small size of UmuD2 and UmuD'2 suggest that they may act more like date hubs by making
nonsimultaneous interactions that help in timing the error-free and error-prone aspects of the
SOS response. The distinction between party hubs and date hubs has recently been called into
question using better-quality data sets and controlling for more variables than before [229, 230],
and further research will be necessary to determine the relevance of hub protein classification.
Chapter 2 of this thesis is a study in which quantification of the interaction between P and a
variant of UmuD 2 at the predicted P-binding motif showed that in fact, this region of UmuD2 is
not responsible for the strength of the interaction with P. However, the fluorescence spectrum of
the complex shows that this region of UmuD does affect the conformation of the complex,
explaining some of the phenotypes of the UmuD variant. Chapter 3 reports a novel interaction
for umuD gene products-with DinB, the error-free Y family DNA polymerase in E. coli.
Chapter 4 shows evidence that both UmuD 2 and UmuD' 2 share characteristics with intrinsically
disordered proteins, whose precise 3-dimensional fold depends on the protein's environment,
despite being stable homodimers. Conclusions are presented in Chapter 5.
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ABSTRACT
UmuD2 cleaves and removes its N-terminal 24 amino acids to form UmuD' 2, which
activates UmuC for its role in UV-induced mutagenesis in E. coli. Cells with a non-
cleavable UmuD exhibit essentially no UV-induced mutagenesis and are hypersensitive to
killing by UV light. UmuD binds to the beta processivity clamp ("beta") of the replicative
DNA polymerase, pol III. A possible beta-binding motif has been predicted in the same
region of UmuD shown to be important for its interaction with beta. We performed
alanine-scanning mutagenesis of this motif (14-TFPLF-18) in UmuD and found that it has a
moderate influence on UV-induced mutagenesis but is required for the cold sensitive
phenotype caused by elevated levels of wild-type UmuD and UmuC. Surprisingly, the wild-
type and the beta-binding motif variant bind to beta with similar Kd values as determined
by changes in tryptophan fluorescence. However, this data also implies that the single
tryptophan in beta is in strikingly different environments in the presence of the wild-type
versus the variant UmuD proteins, suggesting a distinct change in some aspect of the
interaction with little change in its strength. Despite the fact that this novel UmuD variant
is non-cleavable, we find that cells harboring it display phenotypes more consistent with
the cleaved form UmuD', such as resistance to killing by UV light and failure to exhibit the
cold sensitive phenotype. Cross-linking and chemical modification experiments indicate
that the N-terminal arms of the UmuD variant are less likely to be bound to the globular
domain than those of the wild-type, which may be the mechanism by which this UmuD
variant acts as a UmuD' mimic.
This paper has been published as Beuning, P.J. et al. JBC 281: 9633-9640 (2006).
INTRODUCTION
The umuDC gene products are induced as part of the SOS response and are responsible
for much of the UV-induced mutagenesis in E. coli [23 1]. These gene products are subject to an
elaborate set of controls that regulate their activity [231 ]. The LexA repressor provides
transcriptional control, and there are several proteolytic controls on both the umuD and umuC
gene products [231]. The homodimeric protein UmuD2 is the predominant species during the
first ca. 20-30 min after SOS induction [232]. UmuD2, together with UmuC, plays a role in a
DNA damage checkpoint, decreasing the rate of DNA synthesis and allowing time for accurate
repair processes to act [232]. This correlates with the cold sensitive phenotype observed under
conditions of overexpression of the umuDC gene products [232, 233]. As the SOS response
proceeds, UmuD2 binds the RecA/ssDNA nucleoprotein filament. This stimulates the latent
ability of UmuD2 to convert to UmuD'2 by cleaving off its N-terminal 24 amino acids, resulting
in UmuD'2 becoming the predominant species. The RecA/ssDNA nucleoprotein filament serves
to bring together the active site dyad residues Ser60 and Lys97, facilitating deprotonation of
Ser60 by Lys97 [234]. The activated Ser nucleophile then cleaves the peptide bond between
Cys24 and Gly25 of UmuD2 [231].
The wealth of structural data and models available for UmuD2 and UmuD' 2 provide
insight into how the two forms of the umuD gene products engage in multiple highly specific
interactions (Figure 2-1 p.36) [141, 234-237], including with the a, 3, and . subunits of the
replicative polymerase, pol III [238]. Of the two forms, UmuD 2 interacts more strongly with the
1 processivity clamp (also referred to as 1 or the 1 clamp) than does UmuD'2 [238, 239]. In full-
length UmuD2, the 39-amino acid N-terminal arms are stably bound to the globular C-terminal
domain [234, 236] and form a distinct interaction surface. In the cleaved form of the protein,
UmuD' 2, the remaining ca. 15 amino acids at the N-terminus appear unbound from the body of
the protein and solvent-exposed [141, 235], revealing the buried portion of the C-terminal
globular domain [234, 236]. A series of truncations at the N-terminal arm of UmuD 2 indicates
that the first eight amino acids of UmuD2 are dispensable for the UmuD2-1 interaction, while
deleting residues 2-18 results in a substantial decrease in, but not a complete loss of, cross-
linking efficiency with the P clamp [239]. Thus, the umuD gene products interact with the 1
clamp via both the N-terminal arms of UmuD2 and the globular domain of UmuD2 and UmuD'2
[239]. This differential interaction appears to control, at least in part, whether the umuDC gene
products act as part of a DNA damage checkpoint or as a
Figure 2-1: Homology model of the UmuD 2 dimer (trans, arms down).
Figure 2-1: Homology model of the UmuD2 dimer (trans, arms down). Also see Figure 2-S
(p.40). One monomer is in blue; the other is in red. The residues mutated in UmuD-3A [T14
(orange); L 17 F18 (purple)] are shown in space-filling rendering. The single Cys residue, Cys24,
is shown in yellow. Ser60 is shown in green.
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translesion polymerase [238, 239]. These interactions with the P clamp are of particular interest
since sliding clamps play a key role in coordinating the multiple DNA polymerases present in
cells [240-244]. The eukaryotic DNA sliding clamp PCNA interacts with multiple proteins.
These interactions are in part regulated by covalent modification of PCNA with monoubiquitin
or the small ubiquitin-like modifier (SUMO), which is distinct from the role of
polyubiquitination in proteolytic degradation [245-248]. Duzen et al have suggested that UmuD2
and UmuD'2 play conceptually similar roles in modulating the various clamp interactions [249].
A version of the canonical p clamp binding motif found in eubacterial polymerases as
well as other proteins involved in DNA metabolism was postulated to be present in UmuD at
residues 14-18 (Figure 2-2 p.38) [250]. A yeast two-hybrid experiment with the motif of UmuD
showed, however, that these five amino acids are not sufficient for the interaction with the 0
clamp [250]. Given the fact that this result was obtained utilizing only the five-amino acid motif
in UmuD, and cross-linking experiments showed that the region of UmuD between residues 9
and 19 is important for interactions with the 0 clamp [239], we undertook a site-directed
mutagenesis analysis of this motif. These studies led to the unexpected discovery of a new class
of UmuD variant proteins that fail to undergo cleavage but whose properties resemble those of
the cleaved version, UmuD'.
MATERIALS AND METHODS
Homology Model of UmuD- The models of the UmuD homodimer were created by the
combined use of the program LGA [251] for protein structure comparison and superposition and
the AS2TS program [252] for homology model-building. An initial model of the UmuD
monomer (single chain) was constructed based on the crystal structure of UmuD' (Protein Data
Bank [www.pdb.org] ID: lay9, chain A) [125]. The missing N-terminal arm was modeled by the
LGA loop building/grafting procedure [251], using mainly the arm conformation in ljhh_A,
from the X-ray crystallographic structure of LexA [253] as well as the other LexA structures
(ljhc, ljhe, ljhf) as template structures to guide the local and overall conformation. In the final
alignment (Figure 2-S1, p.40), UmuD Asp20 had to be inserted into the LexA template (between
residues 80 and 81 of LexA), and this was done by the LGA loop building procedure [251].
Finally, residues 1-14 are in an extended conformation (i.e., we make no prediction as to the
placement of these residues; they are only modeled in a formal sense).
Figure 2-2: The P-binding motif variants do not eliminate UV-induced mutagenesis.
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Figure 2-2: The P-binding motif variants do not eliminate UV-induced mutagenesis. (A) The
putative n-binding motif in UmuD, with the variants indicated. (B) Induced mutation frequency
of the indicated UmuD mutations in pGY9739 umuDC plasmids in GW8017 (AumuDC).
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In creating the full UmuD homodimeric complex, we used LGA to superimpose our
monomer model onto each of the template chains in the NMR structure of the UmuD'
homodimer [234] (1 i4v, chains A and B, model #1), but some minor clashes occurred which
were alleviated by following the LexA homodimer instead [253]. This procedure creates a cis
(non-domain swapped) conformation of the UmuD homodimer. Because there is a very small
"shoulder" region at the top of the arms, the trans UmuD homodimer model could be constructed
from the cis UmuD homodimer model by swapping the arms as follows: the first 39 residues in
the chain A of our trans model were taken from the chain B of the cis model, and vice versa. This
process of "arm swapping" was completed after applying the LGA loop building procedure to
residues 39-41 in the shoulder regions. Finally, the LexA structures appear as both "elbows up"
(N-terminal arm unbound) and "elbows down" (N-terminal arm bound to C-terminal domain),
allowing us to model both conformations (Figure 2-S1 p.40). Thus, we created four models, two
cis and two trans, each with an elbows up and an elbows down conformation (it is possible that
heterogeneous conformations also occur with one elbow up and one elbow down as in the ljhh
LexA structure). For all the cis and trans models of the UmuD homodimer, the conformations of
sidechains from residues either not present in I ay9_A or that presented a steric clash after
building the dimeric structures were modeled using the side-chain placement program SCWRL
[254].
Proteins, Strains and Plasmids- A plasmid expressing UmuD-3A was constructed in
pSG5 using mutagenic primers and the Quikchange kit (Stratagene) [255]. Wild-type UmuD and
UmuD-3A were purified according to the published procedure [255]. The plasmid expressing
His-HMK-0 was a gift from Prof. M. O'Donnell (Rockefeller University), and 0 was purified
according to the published procedure [256]. The strains and plasmids used in this study are listed
in Table 2-1 (p.42). Plasmid pSJS9 was a gift from Prof. Charles McHenry (Univ. Colorado).
Site-directed mutagenesis was performed using the Quikchange kit (Stratagene). Primer
sequences are in Figure 2-S3 (p.43).
Mutagenesis and Survival Assays- SOS mutagenesis assays were performed according to
the published method [255]. Briefly, cultures of GW8017 harboring various umuDC-expressing
plasmids growing exponentially in LB were washed with 0.85% saline, exposed to 25 J/m2 UV
light from a germicidal lamp (General Electric), and then plated on M9 minimal plates with trace
arginine (1 gtg/mL). Colony-forming units were scored after 48 hr of growth at 42 'C. Survival
Figure 2-S
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Figure 2-S1. (A) Alignment between sequences of UmuD and LexA proteins. The level of
sequence identity is 31%. This alignment was used to construct the UmuD N-terminal residues 9
- 39 (highlighted in green). In our 3D model of UmuD the residues highlighted in blue in the
alignment were taken from the PDB structure 1 ay9_A. (B-E) As a result of our approach we
have constructed four models: two trans versions (elbows down (B) and elbows up (C)) and two
cis versions (elbows down (D) and elbows up (E)). In all cases (B-E) the coloring is the same as
Figure 2-1 (p.36), as follows: one monomer is in blue; the other is in red. The residues mutated
in UmuD-3A [T14 (orange); L17 F18 (purple)] are shown in space-filling rendering. The single
Cys residue, Cys24, is shown in yellow. Ser60 is shown in green.
D
olc umuD'C; pSC101-derived
olC umuDC, pSC 101-derived
Vector; pSC 101-derived
Ts X repression, KanR
Table 2-1: Strains and Plasmids
Strain Relevant Genotype
AB 1157 argE3
GW8017 AB1157 AumuDC
Reference
Laboratory stock
[257]
Reference
[258]
[258]
[259]
[260]
Plasmid
pGY9738
pGY9739
pGB2
pSJS9
Figure 2-S3: Primer sequences
DT14Acode
5'GCGAAATTGTGGCTTTTCCGCTATTTAGCG
DT14Anonc
5'CGCTAAATAGCGGAAAAGCCACAATTTCGC
DF15A
5'-CCGCGAAATTGTGACTGCTCCGCTATTTAGC
DF15A-r
5'-GCTAAATAGCGGAGCAGTCACAATTTCGCGG
DL 17Acode
5'GTGACTTTTCCGGCATTTAGCGATCTTGTTC
DL 17Anonc
5'GAACAAGATCGCTAAATGCCGGAAAAGTCAC
DF 18Acode
5' GTGACTTTTCCGCTAGCTAGCGATCTTGTTC
DF18Anonc
5' GAACAAGATCGCTAGCTAGCGGAAAAGTCAC
D-T14AL17AF18A-C
5' GCGAAATTGTGGCTTTTCCGGCAGCTAGCGATCTTG
D-T14AL17AF18A-C-r
5'CAAGATCGCTAGCTGCCGGAAAAGCCACAATTTCGC
D-Ser60Ala
5'-GCAAGTGGTGATGCTATGATTGATGGTGG
D-Ser60Ala-r
5'-CCACCATCAATCATAGCATCACCACTTGC
Dseq
5'-GCCTGAATCAGTATTGATCTGCTGGC
UmuCseqF
5'-GGTGATCCACGTCGTTAAGGCGA
UmuC3' seq
5'-CGCTAATCCATTCGGCGCTCCTGC
pET11T-3seq
5'-GCTCAGCGGTGGCAGCAGCC
was determined by plating on M9 minimal plates with 40 jtg/mL arginine. Non-UV irradiated
cultures were treated identically to assess the spontaneous mutation frequency. UV survival
curves were obtained after treating cells suspended in 0.85% saline in a Petri dish with the
indicated doses of 254-nm light. Each sample was serially diluted and the dilutions plated on M9
minimal media plates supplemented with 1% casamino acids, 0.005% tryptophan, and 1.5%
agar. Plates were incubated overnight at 42 OC.
Quantitative Transformation Assays- Transformation assays were performed essentially
as described [255]. Plasmids (0.1 rtg) were added to 25-50 jiL competent AB1157 cells and
incubated on ice for 10 min. After a 5-min heat shock at 37 oC, and a further 10-min incubation
on ice, transformation mixtures were allowed to recover in 750 1tL LB at 37 'C for 1.5 hr with
gentle shaking. Equal volumes were plated on LB plates containing the appropriate antibiotics
for incubation under different temperatures as indicated in the figure legends.
Immunoblots- To determine UmuD expression levels, cells were harvested from
exponentially growing cultures in LB, lysed by boiling for 15 min, and loaded on 4-20% SDS-
polyacrylamide gradient gels (Cambrex). Electrophoresed proteins were transferred to PVDF
membrane (Millipore) in 10 mM CAPS, pH 8, 10% methanol. After blocking, membranes were
probed with anti-UmuD/D', and antibody interactions were detected with SuperSignal substrate
(Pierce). Antibodies to UmuD/D' were raised against purified UmuD in rabbits
(Immunodynamics, Inc., La Jolla, CA). For UV-induced expression and cleavage experiments,
an aliquot of ca. 2.5 x 1010 cells from an exponentially growing culture at OD600 = 0.2-0.3 was
harvested, washed in 0.85% saline and UV-irradiated at 25 J/m2 . Irradiated cells were then
transferred to LB and grown at 37 'C for the times indicated in the figure legend.
UmuD in vitro Cleavage Assay- RecA/ssDNA nucleoprotein filament-facilitated UmuD
cleavage was assayed [255, 257, 261] in LG buffer for 30 min. Reactions were quenched by
addition of SDS-PAGE buffer to Ix, and products were analyzed on 4-12% gradient
polyacrylamide gels. Alkaline cleavage of UmuD was carried out [255, 262] in 100 mM glycine,
pH 10, 10 mM CaCI2, 50 mM NaCl, 10 mM DTT, and 0.25 pgg/mL BSA for 48 hr at 37 'C.
Reaction products were analyzed by 14% polyacrylamide gel electrophoresis. The extent of
UmuD cleavage was quantified using the Line Profile feature of National Instruments Vision
Assistant.
Cross-linking and Chemical Modification- Cross-linking was performed essentially as
described [263] with bis-maleimidohexane (BMH, Pierce). Reactions were incubated at room
temperature for the times indicated. For chemical modification with 5,5'-dithiobis(2-
nitrobenzoate) (DTNB) [264], DTNB was dissolved at 2 mM final concentration in 50 mM
HEPES, pH 7.5. Reactions were performed with 10-20 ýtM DTNB and 10-20 gM UmuD
proteins in 50 mM HEPES, pH 7.5. The concentration of accessible thiols was calculated with an
extinction coefficient of 13600 cm'1 M-' at 412 nm. Several trials were performed, and
representative data is shown.
Fluorescence Determination of Binding Constants- Binding constants between UmuD
and 0 were determined essentially as described, with a PT1 QM-20000-4SE spectrofluorimeter
(Lawrenceville, NJ) [255]. The 1 clamp has a single Trp (residue 122), while UmuD has none.
The 12 concentration was constant at 2.5 pM. Emission from UmuD or UmuD-3A without 12
was subtracted from emission of the complex, and the center of spectral mass was calculated for
each [UmuD]. Excitation was at 278 nm, and emission was monitored from 300 to 400 nm.
Excitation and emission path polarizers were oriented perpendicularly. The data represent the
average of at least three independent experiments + one standard deviation.
RESULTS
Mutations in "/ -binding motif' of UmuD do not result in complete loss of induced
mutagenesis- We used alanine-scanning mutagenesis to make single alanine mutations in the
putative P-binding motif in UmuD (Figure 2-1, p.3 6 and Figure 2-2, p.38) and investigated the
consequences of these variants on known phenotypes of UmuD. These plasmid-borne variants
were assayed for their ability to complement a AumuDC null strain for UV-induced mutagenesis.
In addition to single alanine variants of UmuD, we constructed one variant with alanines at the
first and last two positions in the motif (UmuD-3A, Figure 2-2, p.38), the positions most
conserved among all p-binding motifs [250]. In the case of UmuC, the analogous mutation in its
P-binding motif results in a complete loss of UV-induced mutagenesis [240, 241]. No single
mutation or set of multiple mutations in this motif in UmuD failed completely to complement a
AumuDC strain. However, plasmids expressing either the F 18A UmuD variant, which is located
at the top of the arm over the C-terminal globular domain, or the T14A L17A Fl8A ("UmuD-
3A") variant resulted in substantial decreases in induced mutagenesis, down to about 15-20% of
the wild-type (Figure 2-2, p.38). Curiously, this decrease in mutagenesis of cells harboring these
variants was not accompanied by a corresponding decrease in survival after UV irradiation
(Figure 2-5, p.49); yet, typically, increased mutagenesis due to translesion synthesis by UmuD'2C
is associated with increased survival after treatment with UV.
Cleavage of the N-terminal 24 amino acids from the arm of UmuD to yield UmuD' is
required to activate UmuC for its role in translesion synthesis [231]. Since the UmuD arm
harboring these mutations would be removed upon cleavage, we reasoned that the defect in
induced mutagenesis of strains expressing the F 18A and Ti 4A L 17A F 18A (UmuD-3A) variant
proteins might be due to defects in cleavage. Given their positions in the N-terminal arm (Figure
2-1, p.36), it might be expected that these residues would play a role in properly positioning the
arm in the active site for cleavage. We tested whether these mutations in the N-terminal arm of
UmuD interfered with cleavage after UV-exposure. The F15A and L17A mutants showed a
slight decrease in cleavage and an approximately 1.5-fold decrease in induced mutagenesis
compared to the wild-type (Figure 2-2 p.38, Figure 2-3, p.4 7 and data not shown). The two
UmuD variants (F18A and UmuD-3A) that showed essentially no cleavage up to 3 h after UV
exposure (Figure 2-3, p.47), or even after 14 h (data not shown), resulted in the greatest
reduction in induced mutagenesis (ca. 15-20% of wild-type). This is in contrast to non-cleavable
UmuD active site variants that have been assayed previously, which showed essentially complete
loss of induced mutagenesis (the limit of detection of this assay is ca. 1000-fold, or 0.1% of wild-
type) [265, 266]. Thus, there are two groups of non-cleavable UmuD variants, one of which
renders cells partially mutable and the other that renders cells essentially non-mutable.
The wild-type and UmuD-3A variant proteins were purified in order to assess their
efficiency in in vitro cleavage facilitated by the RecA/ssDNA nucleoprotein filament. Under
these conditions, UmuD2 is cleaved efficiently to form UmuD'2, while UmuD-3A 2 exhibits little
detectable cleavage (Figure 2-3, p.47). Here again, the lack of cleavage is similar to that
exhibited by the active site mutant of UmuD2, UmuD-S60A2 [265]. We note that there is a lower
band present in some of the samples incubated without the RecA/ssDNA nucleoprotein filament.
This lower band is often observed in preparations of UmuD, and even in some preparations of
UmuD-S60A. However, in the case of UmuD-3A, the intensity of the lower band does not
increase after incubation with the RecA/ssDNA nucleoprotein filament.
Figure 2-3: UmuD variants are defective in cleavage.
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Figure 2-3 (continued): UmuD variants are defective in cleavage.
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Figure 2-3. UmuD variants are defective in cleavage. (A) Immunoblot showing the stable
production of UmuD variant proteins. (B) Immunoblot showing in vivo cleavage of UmuD
variant proteins. Time points for each sample are 0 (before UV-irradiation) and 1, 2, and 3 h after
UV irradiation. (C) UmuD cleavage in vitro. The (+) sign indicates the presence of the
RecA/ssDNA nucleoprotein filament. The last two lanes show alkaline cleavage of UmuD. The
percentage of the cleaved product was determined as the proportion of total density of each lane.
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Figure 2-5: UV survival of UmuD variants.
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Figure 2-5: UV survival of UmuD variants. Assays were performed with pGY9739 plasmids
and derivatives in GW8017 (AumuDC): pGY9738 (umuD'C, +); pGY9739-F18A (umuDC F18A,
e); pGY9739-D3A S60A (umuDC D3A S60A, +); pGY9739-FI8A S60A (umuDC F18A S60A,
-); pGY9739-D3A (umuDC D3A, *); pGY9739 (umuDC, m); pGB2 (empty vector, A);
pGY9739-S60A (umuDC S60A, x).
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UmuD forms exchangeable dimers [265], so wild-type UmuD2 was combined with
UmuD-3A 2, and cleavage was observed (Figure 2-3, p.47). Since UmuD-3A cannot cleave its
own arm, the observed cleavage is likely due to the active site catalytic dyad of UmuD-3A acting
on the wild-type partner's arm, although the reverse is also possible. In this experiment it is also
possible that the cleavage observed is due entirely to a small population of wild-type UmuD2
homodimers. To eliminate this possibility, UmuD-3A 2 was incubated with the active site variant
UmuD-S60A 2, and some cleavage was still detected (Figure 2-3, p.47). This slight cleavage must
be due to the active site residues of UmuD-3A cleaving the arm of UmuD-S60A, which suggests
that the active site of UmuD-3A is proficient for cleavage and that the cleavage defect is isolated
to its arm. The mutations in UmuD-3A at the top of the arm may disrupt folding of the arm over
the globular domain or may interfere with specific protein-protein contacts required to facilitate
cleavage (Figure 2-1, p.36).
To ensure that the cleavage defect was not due to defective interactions of UmuD-3A 2
with the RecA/ssDNA nucleoprotein filament, we also carried out cleavage under alkaline
conditions in the absence of the RecA/ssDNA nucleoprotein filament. The RecA/ssDNA
nucleoprotein filament serves to facilitate deprotonation of Ser60 by a neutral Lys97 [234, 253].
In the absence of the RecA/ssDNA nucleoprotein filament, the activation of Ser60 as a
nucleophile can be accomplished under alkaline conditions. Under these conditions, UmuD2
cleavage is inefficient but can be detected [262]. We found that cleavage of UmuD-3A 2 was
substantially decreased compared to that of the wild-type (Figure 2-3, p.47). This suggests that
the cleavage defect of UmuD-3A 2 is due to a defect intrinsic to the UmuD-3A 2 variant rather
than deficient interactions with the RecA/ssDNA filament.
UmuD-3A fails to exhibit the cold sensitive phenotype- Strains with elevated levels of the
umuDC gene products exhibit a cold-sensitive phenotype that correlates with a DNA damage
checkpoint [232, 233]. Cells harboring plasmids overexpressing the cleavable umuD variants
Tl4A and Fl5A (+ wild-type umuC) were also cold sensitive, while those overexpressing the
L 7A variant displayed an intermediate phenotype. The T14A and F 15A variants behave
similarly to wild-type in terms of their ability to exert the cold sensitive phenotype, to be cleaved
to UmuD', and to act in UV-induced mutagenesis. The cold sensitive phenotype is substantially
enhanced in cells overexpressing the non-cleavable variant UmuD-S60A (Figure 2-4, p.51)
[267]. Thus, we were surprised to find that strains harboring plasmids expressing the
Figure 2-4: UmuD variants result in loss of the cold-sensitive phenotype.
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Figure 2-4: UmuD variants result in loss of the cold-sensitive phenotype. The ratio of colony-
forming units (cfu) of AB 1157 per gtg of transformed plasmid DNA when grown at 42 'C versus
30 'C is plotted for each UmuD construct.
bý 0 A?" cý_C!?*N N
noncleavable umuD arm variants (UmuD-F18A and UmuD-3A) failed to display this cold-
sensitive phenotype (Figure 2-1, p. 3 6 and Figure 2-4, p.51).
We hypothesized that the loss of the cold sensitive phenotype was due to the specific arm
mutations of UmuD, regardless of their cleavage defect. To test this, we combined in single
constructs either the UmuD-F18A or UmuD-3A arm mutations with the S60A mutation that
renders UmuD catalytically inactive. Even though they are not cleavable, the arm mutations
F I 8A and UmuD-3A alleviated the extreme cold sensitivity exhibited by strains with elevated
levels of UmuD-S60A (Figure 2-4, p.5 1). Although strains harboring plasmids overexpressing
the UmuD F 18A S60A double mutant display a cold sensitive phenotype that is intermediate
between that of cells with each corresponding single mutant, the cold sensitive phenotype of
cells overexpressing UmuD-S60A is suppressed by two orders of magnitude by the presence of
only a single mutation in the N-terminal arm, F 18A. These arm variants must disrupt a specific
molecular interaction necessary to cause the cold sensitive phenotype that is independent of
whether they can be cleaved.
Simultaneously elevated levels of the umuD, umuC, and dnaN (which codes for the 3
clamp) gene products cause a lethal phenotype, which has been interpreted as an exaggeration of
the cold sensitive phenotype [268]. A strain harboring a plasmid expressing UmuD-3A and
UmuC, when combined with high levels of the 3 clamp, fails to exhibit the synthetic lethal
phenotype (Table 2-2, p.53). This suggests that a critical aspect of this complex formation with [
is disrupted in the UmuD-3A variant.
Sensitivity to UV exposure- Given the cleavage defect of the UmuD-3A and F I 8A N-
terminal arm variants, we decided to look more closely at the curious lack of a correlation
between UV mutability and survival after exposure to UV that we had noted earlier for cells
expressing the F I8A and UmuD-3A variants. It is known that E. coli strains harboring a non-
cleavable UmuD variant are hypersensitive to killing by UV light and are non-mutable [232,
265] (Figure 2-5, p.49). In order to determine whether this is also true of the non-cleavable
UmuD Fl8A and UmuD-3A variants, strains harboring plasmid-borne umuD variants were
assayed for their resistance to UV light. Strains with plasmids expressing either of the non-
cleavable variants Fl 8A or UmuD-3A showed a similar level of resistance to UV light as those
expressing wild- type UmuD or a synthetic construct of UmuD' (Figure 2-5, p.49). We suspected
that the resistance to killing by UV of the Fl 8A and UmuD-3A variants was due to a
Table 2-2: Loss of Synthetic Lethality due to Mutations in UmuD P-binding motif
AB1157 pSJS9 cfu (37 OC, per pg DNA per mL)
pGY9738 (WT) 0
pGB2 1040
pGY9739-UmuD-3A 1400
specific feature of the arm mutants, unrelated to their cleavage defect. Cells with plasmids
expressing the non-cleavable arm variants constructed in the context of the UmuD-S60A active
site variant were assayed for their resistance to UV light. Strains with plasmids expressing either
the F 18A or UmuD-3A arm variants combined with UmuD-S60A exhibited a striking resistance
to UV light that was similar to strains with wild-type UmuD (Figure 2-5, p.49). This suggests
that alterations in the N-terminal arm of UmuD are able to suppress the extreme UV-sensitive
phenotype of non-cleavable UmuD-S60A, even though they are also non-cleavable. In light of
the dramatic changes in the phenotypes of cells expressing the UmuD-3A variant compared to
those with previously characterized non-cleavable variants of UmuD [265], we investigated the
conformational consequences of the UmuD-3A variant compared to the wild-type.
Chemical cross-linking and modification of UmuD homodimers- We hypothesized that
these non-cleavable UmuD variants are able to confer resistance to UV light, as well as to
suppress the cold sensitive phenotype, by mimicking the conformation of UmuD'. To examine
this possibility, we analyzed the conformation of the N-terminal arm of the UmuD-3A variant
compared to that of the wild-type UmuD. UmuD, which possesses a C2 axis of symmetry, has a
single Cys residue, Cys24, at the cleavage site in the N-terminal arm. In order to determine
whether UmuD-3A is a UmuD' mimic with respect to the position of its arms, cross-linking was
performed with the thiol-specific homobifunctional 16 A cross-linker bis-maleimidohexane
(BMH). Our model allows us to put a lower limit of 20 A on the distance between these two Cys
thiols. This lower limit represents an implausible path for the cross-linker, since it is the direct
distance between the two Cys thiols (Figure 2-1, p.36). Thus, cross-linking should only be
detected when the arms are "up", i.e. not bound to the C-terminal globular domain of UmuD.
tJmuD-3A was more readily cross-linked by BMH than either wild-type UmuD or UmuD-S60A
(Figure 2-6, p.55), suggesting that the arms of UmuD-3A are less likely to be bound to the
globular domain of UmuD. Therefore they are more often close enough to be cross-linked.
One of the models of UmuD that we have proposed ("trans, elbows down", see Figure 2-
1, p. 3 6 and Figure 2-S1, p.40) predicts that the thiol group of the single Cys24 residue is partially
buried under the peptide backbone of the N-terminal arm. However, if the UmuD arms are in an
"up", or more flexible, conformation, then the Cys should be more accessible to a thiol- specific
reagent. We performed a titration of the Cys residue at the Cys24-Gly25 cleavage site
Figure 2-6: UmuD-3A arms are more easily cross-linked with BMH and more accessible to
chemical modification than wild-type.
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Figure 2-6 (continued): UmuD-3A arms are more easily cross-linked with BMH and more
accessible to chemical modification than wild-type.
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Figure 2-6: UmuD-3A arms are more easily cross-linked with BMH and more accessible to
chemical modification than wild-type. (A) Cross-linking the UmuD arms with BMH. Each
UmuD variant that was cross-linked is indicated under the lanes. The time points were 0, 15, and
30 min after addition of BMH. The first lane shows molecular weight standards, indicated in
kDa. Proteins were visualized by Coomassie staining. (B) DTNB titration of free thiol in UmuD.
The complete reaction without protein was used as a blank, protein was added and absorbance
was recorded at 412 nm for 15 min. UmuD2 (n) and UmuD-3A 2 (*) were present at 10 CýM with
20 ýtM DTNB.
with 5,5'-dithiobis(2-nitrobenzoate) (DTNB). The thiol moiety of UmuD-3A was more reactive
to DTNB and therefore slightly more accessible than that of the wild-type UmuD (Figure 2-6,
p.55). We determined that there is 1.0 reactive Cys residue per wild-type UmuD2 and 1.2
reactive Cys residues per UmuD-3A 2, supporting the idea that in the UmuD-3A variant, the N-
terminal arms undergo a shift in equilibrium to a less bound, arms-up state.
Determination of Kd of UmuD and the Pf clamp- In order to quantify the binding of UmuD
and the UmuD-3A variant to the P clamp, we determined the Kd for this interaction. Surprisingly,
we found that although the Kd is similar for P binding to either wild-type UmuD (5.5 + 0.8 p.M)
or UmuD-3A (6.1 + 0.5 tM), the mode of binding is different for each protein. Namely, the
fluorescence emission from the tryptophan in P shifts to a longer wavelength upon binding to
UmuD, while the shift is to a shorter wavelength in the presence of UmuD-3A (Figure 2-7, p.58).
Tryptophan fluorescence emission peaks at a longer wavelength in a polar environment and at a
shorter wavelength in a hydrophobic one, indicating that the partially-exposed tryptophan in P
(Figure 2-1, p.36) becomes more solvent-exposed upon binding to wild-type UmuD and buried
upon binding to UmuD-3A [269]. Accordingly, unlike canonical P-binding motifs [240, 241,
270, 271], this motif in UmuD is not responsible for the strength of the interaction with 0, but
rather for a qualitatively different mode of binding.
DISCUSSION
Although this work was initiated to determine the role of the putative P-binding motif
(14-TFPLF- 18) in UmuD function, we found that alterations in the motif do not prevent binding
to the p clamp, unlike corresponding mutations in UmuC, DinB, and the pol III a subunit [240,
241, 250, 270, 271]. Instead, we show here that the UmuD-3A variant alters the N-terminal arm
conformation in a way that dramatically changes UmuD activity, and seems to exhibit properties
of UmuD', particularly with respect to resistance to killing by exposure to UV light and lack of
the cold sensitive phenotype when overexpressed together with UmuC. The UmuD-3A variant
shows no defect in survival but decreases UV mutagenesis. This suggests that this variant may
allow selective bypass of T:T cyclobutane pyrimidine dimers (CPDs) but not [6-4]
photoproducts, since lethality is associated with T:T CPDs and mutagenesis with [6-4]
photoproducts [231].
Figure 2-7: UmuD binding as observed by (3 tryptophan fluorescence.
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Figure 2-7 (continued): UmuD binding as observed by 0 tryptophan fluorescence.
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Figure 2-7: UmuD binding as observed by P tryptophan fluorescence. (A) UmuD (filled
circles) and UmuD-3A (open circles) bind with similar affinity yet cause opposite shifts in the
Trp fluorescence emisson wavelength. The Kd of UmuD 2 is 5.5 ± 0.8 rpM, while that of UmuD-
3A2 is 6.1 ± 0.5 pM. Representative fluorescence emission curves, as well as the full data set of
the Centers of Spectral Mass as a function of UmuD concentration, are presented as Figure 2-S2
(p.60) and Table 2-S1 (p.61). (B) Structure of the P clamp (entry 2POL from the Protein Data
Bank) showing the known sites of interaction of UmuD based on cross-linking experiments (red)
[249] versus the site of interaction of the canonical P-binding motif (green) and the second site of
interaction observed in the co-crystal structure with DinB (green, labeled "second site") [272,
273]. The single tryptophan, W122, is also indicated in yellow. Arrows indicate the dimer
interface. The domains are labeled I, II, and III. This image was prepared with VMD [274].
B
Figure 2-S2: Fluorescence emission spectra of 2.5 ýiM p2 excited at 278 nm.
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Figure 2-S2: Fluorescence emission spectra of 2.5 fIM p2 excited at 278 nm. The fluorescence
emission of UmuD2 or UmuD-3A 2 alone was subtracted from that of the complex as appropriate.
The minimum value was set to 0 by addition or subtraction before calculation of the center of
spectral mass, which was necessary because the subtracted fluorescence of P2 in the presence of
75 pM UmuD 2 was negative between 300 and 335 nm.
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Table 2-S 1: Fluorescence Center of Spectral Mass of 2.5 pM p2 Bound to Wild-Type UmuD 2
or UmuD3A 2
UmuD2
Interacting
Protein
Concentration
(ýIM)
0
2.5
5
10
20
30
40
50
60
75
Center of
Spectral Mass
(nm)
339.8
344.5
350.5
356.6
360.7
362.3
362.3
362.9
363.3
363.1
Standard
Deviation
0.34
1.1
2.5
1.3
0.97
0.47
0.53
0.45
0.46
0.62
Center o:
Spectral
(nm)
339.8
335.9
334.1
331.5
329.2
328.1
327.4
326.7
326.3
326.1
UmuD3A 2
f Standard
Mass Deviation
0.14
0.45
0.34
0.36
0.32
0.23
0.34
0.15
0.53
0.25
How could an uncleaved UmuD mimic the cleaved form, UmuD'? Current evidence
suggests that the N-terminal arms of UmuD are usually bound to the C-terminal globular domain
of the protein, i.e. it is usually in the "elbows down" conformation [236]. Even when the arms
are covalently bound to the globular domain, UmuD can be cross-linked to the P clamp with
almost no decrease in efficiency [239]. When UmuD is cleaved to UmuD', the remainder of the
N-terminal arm (residues 25-39) is able to move relatively freely [125, 235]. The UmuD-3A
variant seems to have enough flexibility in its arms that it is at least a partial mimic of UmuD'.
Although residues 14-18 of UmuD are predicted from our model to be only partially buried
(Figure 2-1, p.36), the UmuD-3A variant may disrupt optimal packing of the arm against the
globular domain. The mutations in UmuD-3A are at the point of the N-terminal arm that begins a
downward turn over the C-terminal globular domain, and disruption of this turn is consistent
with the more extended UmuD' arm structure. In addition, the cleavage of UmuD exposes a
different surface of UmuD' for protein-protein interactions. Thus, the cleavage reaction serves
the dual function of removing a portion of the N-terminal arms and presenting a dramatically
different surface of the protein for interactions.
We were able to create models of the UmuD homodimer in both the elbows up and the
elbows down conformation because both conformations are observed in the LexA structures
[253]. The LexA structure is in a cis conformation (non-domain swapped) with respect to the
positioning of the arms [253]. We have noticed, however, that in the UmuD'2 structures the
truncated arms point in the trans direction, suggesting that perhaps the trans conformation is
actually preferred for UmuD [141, 235]. It has been shown that UmuD can undergo cleavage in
trans (Fig 3) [235, 275]. The model of UmuD most consistent with the available biochemical
evidence is one in which the arms are in the trans conformation [236].
In constructing the UmuD-3A variant, we have made a version of UmuD that binds to the
3 clamp with a similar affinity as the wild-type, but with a subtle change in the specific
interaction as evidenced by the strikingly different tryptophan fluorescence emission spectra.
This change would not have been detected by many of the techniques commonly used to detect
protein-protein interactions, such as co-immunoprecipitation or two-hybrid analysis. Recent
evidence suggests that the domains of the sliding clamps are rigid bodies joined by flexible
linker regions [276]. The single tryptophan of 3 is on a long flexible loop between rigid Domains
I and II (Figure 2-7, p.58) [277], so UmuD binding at a distal site to the tryptophan could cause a
slight conformational rearrangement of the domains that alters the environment of the tryptophan
in the loop. The distinct fluorescence spectra are indicative of at least a slight change in the
conformation of the P clamp when bound to either wild-type UmuD or UmuD-3A. UmuD-3A
exhibits similar biological functions to those of UmuD', yet UmuD-3A retains both the arm
length and the strength of the interaction with P of wild-type UmuD. This suggests that the
change in conformation of the P clamp, along with the relative conformational freedom of the
UmuD-3A N-terminal arms, may be partially responsible for the UmuD'-like phenotype of
UmuD-3A. UmuD and DinB/pol IV bind to P at overlapping sites (Figure 2-7, p.58) [249, 272].
One of these sites is the hydrophobic channel between 1 Domains II and III where all known 3-
binding motifs interact [272, 273, 278]. Although UmuD possesses a similar motif to a canonical
P-binding motif that modulates its interaction with the 1 clamp, and UmuD has been shown to
bind to the same site on 0 as other P-binding motifs, it does so in a way that is distinct from other
proteins that bind P via their P-binding motifs [278].
Processivity clamps play a critical role in controlling traffic at the replication fork and in
cell cycle checkpoints. Polymerase binding to the P clamp regulates access to the primer
terminus by replicative or translesion synthesis DNA polymerases [242, 243]. Moreover, it has
been shown that UmuD interacts more strongly with P than UmuD' does [238]. The interaction
of UmuD with the p clamp seems to be important for facilitating a DNA damage checkpoint in
E. coli [232, 233], and the cleavage of UmuD to UmuD' may attenuate this checkpoint function
[239]. The UmuD-3A variant seems to bypass this switch, yet still binds the 3 clamp. In
eukaryotes, covalent modification of PCNA with monoubiquitin or SUMO determines whether
the cell utilizes DNA repair or potentially mutagenic translesion synthesis [246]. Thus, access to
sliding clamps is universally important for control and regulation of proteins acting at the
replication fork.
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Summary
DinB is the only mutagenic Y-family DNA polymerase conserved among bacteria,
archaea, and eukaryotes. DinB and its orthologs possess a specialized lesion-bypass
function but also display potentially deleterious -1 frameshift mutagenic phenotypes
when overproduced. We show that the mutagenic capability of E. coli DinB is genetically
separable from its translesion synthesis function and that the DNA damage inducible
proteins RecA and UmuD2 act in concert to modulate its potentially mutagenic activity.
Structural modeling suggests that the relatively open active site of DinB is enclosed by
interaction with these proteins. Intriguingly, residues that define the UmuD 2 interacting
surface on DinB statistically co-vary throughout evolution, suggesting a driving force for
the maintenance of a regulatory protein-protein interaction at this site. Together, these
observations indicate that proteins like RecA and UmuD2 may be responsible for
managing the mutagenic function of DinB orthologs throughout evolution.
Introduction
Decades after their discovery [71, 76], DinB (DNA pol IV) [73] and UmuD'2C (DNA pol
V) [75, 108] were shown to be specialized Y-family DNA polymerases that catalyze the
insertion of deoxyribonucleoside triphosphates (dNTPs) opposite to potentially lethal
replication blocking lesions in a process termed translesion synthesis (TLS) [15, 58].
TLS can proceed with a range of fidelities [58], but in all cases Y-family polymerases
replicate undamaged DNA with a reduced fidelity relative to the enzymes that replicate
the majority of the genome [279]. Therefore, Y-family polymerases must be excluded
from improper access to the replication fork to maintain genomic integrity [23].
DinB is the only Y-family DNA polymerases conserved among all domains of life
[15] and under conditions of DNA damage it is the most abundant DNA polymerase in E.
coli [136]. We recently elucidated the function of DinB and its orthologs in proficient and
accurate TLS past DNA damage at the N2 position of deoxyguanosine [53]. On the
surface, these observations seemed incompatible with known, albeit enigmatic, DinB
associated -1 frameshift mutagenic phenomena [280-282]. Although the molecular details
of these phenomena have been the subject of intense debate [283-285], the role of
elevated DinB function is clearly established [281].
Both dinB and umuDC are regulated transcriptionally by the SOS regulatory
network [286], and biochemical regulation of the UmuD'2C is remarkably complex and
relatively well characterized. The RecA nucleoprotein filament promotes umuDC
expression, the conversion of UmuD2 to UmuD' 2 required for activation of UmuC
polymerase function [75, 108] and activation of UmuD'2C in trans [111, 287] via
multiple protein-protein interactions. RecF, RecO, and RecR also cooperate to alleviate
the inhibition of UmuD'2C mediated TLS that is brought about by DNA pol III [288].
Despite the remarkable evolutionary conservation of DinB, the details of its biochemical
regulation are comparatively unknown [289]. Previous studies have focused on the
pivotal role of processivity clamps in regulation of TLS and mutagenesis promoted by
DinB, UmuD' 2C, and other Y-family DNA polymerases in both prokaryotic and
eukaryotic systems [ 18, 290-296]. However, regulation of DinB function is crucial given
its deleterious -1 frameshift mutagenic signature relative abundance [136, 297]. We
therefore sought to identify and characterize additional regulatory factors that might
manage this potentially problematic function. Remarkably, we found that UmuD, UmuD',
and RecA regulate both the activity and mutagenic properties of DinB via protein-protein
interactions that enclose its active site. Intriguingly, features of these mechanisms may be
maintained in eukaryotes, suggesting a common pattern of regulation for these DNA
polymerases through evolution.
Results
DinB Interacts with Numerous Cellular Factors
To identify proteins that regulate DinB function we employed an affinity chromatography
scheme in which purified recombinant DinB was covalently coupled to an affinity resin
(Figure 3-SI, p.68). Lysates from constitutively SOS-induced E. coli were passed over
the DinB column and interacting proteins were eluted and separated by SDS-PAGE.
Those that bound in a DinB dependent fashion were excised and identified. Included in
this set of proteins were the chaperones GroEL and DnaK and also the ribosomal protein
L3. The presence of the chaperones was anticipated since GroEL has been shown to
regulate the function of both DinB [298] and UmuD' 2C (Pol V) [299] and DnaK regulates
Figure 3-S 1: Experimental scheme for identifying DinB interaction partners
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UmuC levels in vivo [300]. Ribosomal protein L3 seems less likely to be a bonafide
regulator of DinB function although this remains a formal possibility. However, we also
identified UmuD, UmuD', and RecA as DinB interacting proteins. This was a complete
surprise because, despite their intensively studied highly nuanced roles in regulating
UmuC function [286, 297, 301], none of these factors have hitherto been implicated in
regulating DinB function aside from the indirect role of RecA in mediating DinB
induction via the SOS regulatory network. We therefore investigated the ability of these
proteins to affect DinB function in vivo and in vitro.
DinB Forms a Stable Interaction with UmuD 2 and RecA
To ascertain whether the interactions we observed between DinB, RecA, UmuD, and
UmuD' were direct, we performed a farwestern blot in which we probed membranes
containing UmuD, UmuD', and RecA with DinB. Each of the interactions appears to be
direct in nature (Figure 3-1A, p.70). To analyze the stoichiometry of the DinB-UmuD
interaction, we crosslinked DinB and UmuD with formaldehyde and analyzed the
products by immunoblot using an antibody against DinB. The crosslinked species
corresponds to the molecular weight of a DinB-UmuD 2 complex and the reaction appears
to be inhibited by high concentrations of NaCl (Figure 3-1B, p.70), suggesting that the
interface may partly involve ionic or polar interactions. The propensity of RecA to
multimerize [302] made it difficult to establish the stoichiometry of the DinB-RecA
interaction.
To test whether DinB, UmuD2 and/or UmuD'2, and RecA form a stable ternary
complex in solution, a DinB variant with a hexahistidine affinity tag at its C-terminus
Figure 3-1: DinB interacts directly with UmuD2 and RecA.
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Figure 3-1 (continued): DinB interacts directly with UmuD 2 and RecA. (A) Farwestern
blot demonstrates that UmuD directly interacts with 32 P-labeled (His) 6HMK-DinB.
Either 50 or 100 pmols of UmuD or UmuD' were separated by 12% SDS-PAGE and
transferred to a PDVF membrane. The HMK-DinB protein probe was radioactively
labeled and incubated with the membrane for 15 min. after which the membrane was
exposed to film. (B) Crosslinking experiment suggests that DinB interacts with the
UmuD2 homodimer. One hundred pmol of DinB and UmuD2 were mixed in a 10 gL
volume in 50 mM Hepes pH 7.5, 25-500 mM NaCl, and 1 mM DTT and incubated for 10
min at 250C. C. DinB forms a stable binary and ternary complexes with RecA and
UmuD2. DinB(His) 6 pulls down UmuD, UmuD', and RecA on a Ni2+ affinity resin. The
presence of RecA slightly increases the amount of UmuD that is recovered.
(DinB(His) 6) was incubated with RecA - both alone and in combination with UmuD2,
UmuD'2, and the heterodimeric species UmuDD' [121]. Complexes that formed with
DinB were isolated using Ni2+ affinity resin. Using approximately physiological
concentrations (2.5 giM) of each protein, we determined that DinB interacts stably with
each of the UmuD species used in the experiment. We also observed the formation of a
stable stoichiometric complex between DinB and RecA (Figure 3-1C, p.70), despite the
previous report that fluorescence anisotropy does not reveal such an association [287].
Moreover, it appears that RecA stimulates DinB association with UmuD, but not UmuD'
or UmuDD', by approximately two-fold (Figure 3-1C, p.70). Taken together, these data
indicate that DinB, RecA, and UmuD2 and to a lesser extent UmuD' 2, can form ternary
complexes under physiological conditions.
UmuD Suppresses DinB-dependent Mutagenic Phenomena in vivo
We investigated the influence of the interactions we observed on the TLS function of
DinB. Surprisingly, deletion of umuD has no effect on NFZ resistance. Although ArecA
strains do exhibit sensitivity to this agent (data not shown), the multitudinous roles of
RecA [302] complicate the interpretation of this result. Because the cellular levels of
UmuD are much higher than those of UmuC and instead mirror those of DinB [297], we
also investigated the consequences of overproducing the umuD gene products.
Strikingly, we observed that overproduction of UmuD and to a lesser extend UmuD'
profoundly inhibits the ability of DinB to promote -1 frameshift mutagenesis (Figure 3-
2A, p.74). Indeed, overproduction of UmuD reduces the frequency of CC108 -1
frameshift mutagenesis nearly to the extent that it is DinB dependent, while UmuD'
Figure 3-2: UmuD 2 regulates the -1 frameshift activity of DinB in vivo.
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Figure 3-2: UmuD 2 regulates the -1 frameshift activity of DinB in vivo. (A) Lac+
reversion assay of the frameshift allele in CC 108 demonstrates that UmuD2 modulates
DinB's -1 frameshift function (B) UmuD2 also affects the number of Lac+ revertants in
an adaptive mutagenesis experiment.
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causes a more modest reduction. A noncleavable UmuD2 variant, UmuD(S60A), was
able to fully suppress DinB dependent frameshift mutagenesis (Figure 3-2A, p.74),
suggesting that full-length UmuD is sufficient for maximal inhibition.
We then considered that the umuD gene products might also modulate the
phenomenon of adaptive mutagenesis [303], which is dependent on DinB promoted -1
frameshifts during stationary phase [281, 304]. Under the conditions required to observe
such mutagenesis DinB levels are elevated by approximately four-fold [136].
Remarkably, overproduction of UmuD or UmuD' profoundly reduced adaptive
mutagenesis (Figure 3-2B, p.74). The UmuD-dependent 5-fold reduction is comparable
to the degree of adaptive mutagenesis that is DinB dependent [281, 304]. These
observations suggest that the umuD gene products are able to modulate the -1 frameshift
activity of DinB in both exponential and stationary phase.
To investigate whether DinB reciprocally affects UmuD function, we examined
the effect of DinB overproduction on UV-induced mutagenesis, a umuDC-dependent
phenomenon [76]. Coexpression of dinB from a low copy number plasmid suppressed
UV-induced mutagenesis by a factor of 8.9 (+ 2.2). This effect is likely related to DinB
dependent inhibition of UmuD2 autocleavage, which we observed in vitro (Figure 3-5E,
p.76). These observations are consistent with the notion that DinB interacts with UmuD2
and in doing so sequesters it from an interaction, perhaps with the RecA-nucleoprotein
filament, that facilitates its autoproteolysis.
Figure 3-5: UmuD2 and RecA directly modulate DinB -1 frameshift function.
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Figure 3-5 (continued): UmuD2 and RecA directly modulate DinB -1 frameshift
function.
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Figure 3-5 (continued): UmuD2 and RecA directly modulate DinB -1 frameshift
function.
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Figure 3-5 (continued): UmuD 2 and RecA directly modulate DinB -1 frameshift
function. (A) Schematic of a mismatched DNA substrate that can be extended either by
dGTP to generate a full length product or by dATP, thereby forming a dNTP stabilized
misalignment and generating a -1 frameshift product. (B) Plot of reaction velocity vs.
dNTP substrate concentration for DinB alone and in combination with RecA and UmuD2.
Extension of the GG mismatch by DinB alone with dATP (open squares) is detectable but
weaker than extension of a GC basepair in the same sequence context (open circles). The
addition of RecA in stoichiometric ratios with DinB and saturating (10 pM) UmuD2
profoundly inhibits DinB activity on a GG mismatch (closed squares) but stimulates
DinB activity on a GC (closed circles) by more than 20-fold. (C) recA+ is required for
UmuD dependent inhibition of DinB promoted -1 frameshift mutagenesis in vivo.
Overeproduction of DinB promotes -1 frameshift mutagenesis in a ArecA background but
the co-overproduction of UmuD2 has little effect on mutation frequency. (D) Plot of
percent frameshift inhibition vs. UmuD variant concentration. The frameshift activity of
DinB is efficiently inhibited by UmuD2 (closed circles) but the frameshift activity of
DinB(F172A) is more inert to UmuD2 supression (open circles). The UmuD(D91A)
variant is also very inefficient at inhibiting the -1 frameshift activity of wild-type DinB
(open triangles). (E) DinB efficiently inhibits UmuD2 autocleavage in vitro. Wild-type
DinB (open circles) inhibits UmuD2 autocleavage far better than DinB(F172A) (closed
circles).
Identification of the Molecular Interface Between DinB and UmuD 2
Our observation that UmuD suppresses the -1 frameshift activity of DinB in vivo was
especially intriguing in light of structural studies of archaeal DinB homologs, which have
been shown to possess remarkably open active sites. We therefore analyzed the
interaction between DinB and UmuD2 using cellulose filter peptide arrays. The
membranes were probed with either DinB or UmuD2, and interacting peptides were
identified and mapped onto structural models of DinB [53] or UmuD 2 [134, 147].
Interestingly, the UmuD2 interacting peptides on DinB localize to a single face of the
protein (Figure 3-3A, p.81). Further, the presence of an extended interacting surface on
DinB suggest that its interaction with UmuD2 is qualitatively different from its
interaction with the 0 processivity clamps, which depends on a highly conserved peptide
motif [294, 305]. Most intriguingly, the interaction interface suggests that UmuD2 may
enclose the relatively open active site of DinB, which has been proposed to play a crucial
role in its mutagenic function [45, 306]. The DinB interacting interface forms a
somewhat less contiguous surface when mapped onto a UmuD 2 model. However, the
DinB binding interace forms a contiguous surface when mapped onto certain isoenergetic
models of UmuD2 [147], in which its N-terminal arm is raised to reveal an interacting
surface across the side of the protein (Figure 3-3B, p.81). These observations may hint at
biological function for alternative UmuD2 conformers.
In an effort to design a DinB variant that is unable to interact with UmuD2, we
identified a strongly interacting group of peptides from the DinB peptide array and
examined conservation of this region in numerous umuD-containing organisms. Three
residues, P166, F 172, and L 176 were strikingly conserved and we determined the effect
Figure 3-3: Molecular characterization of the interaction between DinB and UmuD2.
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Figure 3-3 (continued): Molecular characterization of the interaction between DinB
and UmuD 2.
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Figure 3-3 (continued): Molecular characterization of the interaction between DinB
and UmuD 2. (A) Peptide array mapping of the UmuD binding interface on DinB reveals
a surface composed of the thumb and finger domains of the polymerase. Several
hydrophobic residues in the most strongly interacting peptide are conserved among DinB
orthologs from organisms containing umuD. (B) Peptide array mapping of the DinB
binding interface on UmuD2 reveals a discontinuous interface on a structural model of
trans-UmuD2 that is rendered contiguous in an alternative isoenergetic trans-UmuD2
conformer. (C) Alanine mutants of DinB Phe 172 or UmuD Asp 91 result in a weakened
interaction determined by fluorescence spectroscopy. (D) A low-copy number plasmid
encoding DinB(F 172A) is fully able to rescue the NFZ sensitivity of a AdinB E. coli
strain.
of changing each residue to an alanine (Figure 3-3A, p.81). Although the mutant proteins
DinB(P 166A) and DinB(L 176A) were insoluble (data not shown), we were able to
express and purify DinB(F172A) in soluble form (Figure 3-S3, p.85). Moreover, we
found that the dinB allele encoding DinB(F 172A) complements the NFZ sensitivity of a
AdinB strain (Figure 3-3D, p.81), indicating that this mutant is TLS proficient in vivo. A
reciprocal approach was used to generate a UmuD2 mutant that would be impaired with
respect to its ability to interact with DinB. The variant UmuD(D91A) is soluble and
proficient for facilitated autoproteolysis (Figure 3-S4, p.86).
We determined that the dissociation constant between DinB and UmuD 2 is
approximately 0.620 1tM using fluorescence spectroscopy (Figure 3-3C, p.81; Figure 3-
S5, p.87). Provocatively, the levels of UmuD2 rise from ca.0.35 CýM under non-SOS-
induced conditions to ca. 4.5 [iM under conditions of SOS-induction [136], indicating
that DinB and UmuD2 are capable of interaction within the range of physiologically
relevant concentrations. Futhermore, the DinB(F172A) and UmuD(D91A)2 proteins
were each greatly impaired with respect to their ability to bind UmuD2 and DinB,
respectively (Figure 3-3C, p.81).
Mutation of the Interface Between DinB and UmuD 2 Impairs Function in vivo
To determine whether the physical interaction between DinB and UmuD2 that we
observed in vitro is important for modulation of DinB dependent frameshift mutagenesis
in vivo, we examined whether the -1 frameshifts produced by DinB(F172A) could be
inhibited by UmuD. Overproduction of DinB(F172A) results in an increase in -1
frameshift mutagenesis by approximately 6-fold (Figure 3-4A, p.88). Unlike the
Figure 3-S3: Purified DinB(F172A) is soluble and migrates identically to wild-type
DinB on SDS-PAGE.
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Figure 3-S5: Interaction between UmuD2 and DinB or DinB(F172A).
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Figure 3-4: Single amino acid changes on the interface between DinB and UmuD
perturb regulation of -1 frameshift activity.
300W
250
200
ISO
100
50
0---• • - •L- L
19~ C~Q
1800
1400
1200
600
400
200
0 . . ..... ..
, D4;'
1z pq 9~At
Figure 3-4: Single amino acid changes on the interface between DinB and UmuD
perturb regulation of -1 frameshift activity. (A) The DinB(F 72A) variant has a lower
affinity for UmuD2 and is not as responsive as wild type DinB to regulation by UmuD 2.
(B) The UmuD(D91A) variant has a lower affinity for DinB and does not regulate -1
frameshift activity as well as wild type UmuD.
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situation with wild-type DinB (Fig 2A), co-overproduction of UmuD or UmuD' does not
substantially reduce the -1 frameshift mutation frequency (Figure 3-4A, p.88). These
data suggest that a direct interaction between DinB and UmuD2 or UmuD'2 at the
interface we have identified is important for modulation of-1 frameshift mutagenesis.
Reciprocally we examined whether UmuD(D91A) could suppress the -1
frameshift mutagenesis promoted by overproduction of wild-type DinB. Overproduction
of UmuD(D91A) only modestly suppresses -1 frameshift mutagenesis (ca. 1.5-fold vs.
>25-fold for WT UmuD) (Figure 3-4B, p.88). Moreover, even significant overproduction
of DinB(F 172A) was insufficient to impair UV-induced mutagenesis, in contrast to wild-
type DinB (data not shown). These observations suggest that the direct interaction
between DinB and UmuD2 is crucial for the ability of each protein to modulate the
function of the other in vivo.
UmuD 2 Inhibits DinB-dependent -1 Frameshift Activity in vitro
To understand the mechanisms governing modulation of DinB function by UmuD in
vivo, we reconstituted DinB dependent -1 frameshift activity in vitro with a substrate
containing a G:G mispair that can be extended with either with dGTP to generate a full-
length product or with dATP to generate a -1 frameshift product that is one nucleotide
shorter than the template (Figure 3-5A, p.76) [73, 307]. DinB is unable to extend from
this mispair using dGTP under our experimental conditions (data not shown). In contrast,
DinB can readily act on this substrate using dATP albeit at a rate that is 10-fold lower
than its ability to extend from a G:C basepair in the same sequence context (Figure 3-5B,
p.76). We were initially surprised when we found that the addition of UmuD2 alone did
not alter the -1 frameshift activity of DinB (data not shown). Unexpectedly, the addition
of UmuD2 nearly completely inhibits the reaction when RecA is added in a stoichiometric
ratio with DinB (Figure 3-5B, p.76). Strikingly, the addition of UmuD2 and RecA
enhances the ability of DinB to extend from a G:C basepair in the same sequence context
(Figure 3-5B, p.76). These observations indicate that UmuD2 and RecA act in concert to
sculpt DinB function in a highly nuanced manner. The requirement of RecA to
reconstitute UmuD2 modulation of DinB mutagenic function in vitro led us to examine
whether recA+ is required for suppression of-1 frameshift mutagenesis in vivo. Indeed,
overproduction of UmuD was virtually unable to alter the frequency of frameshift
mutagenesis in a ArecA strain (Figure 3-5C, p.76). Taken together, these findings
indicate that RecA is required for UmuD2 dependent modulation of DinB function.
In vitro, UmuD reduced the maximal -1 frameshift activity of wild-type DinB by
one half at a concentration of 1.7 ýiM (840 nM UmuD2), while a concentration of 7.1 1 M
(3.6 jtM UmuD2) is needed to cause an equivalent effect on DinB(F172A) (Figure 3-5D,
p.76). UmuD(D91A) also shows a marked 10-fold decrease in its ability to inhibit DinB
dependent -1 frameshift activity relative to wild-type UmuD2. Additionally, we observed
that DinB was able to inhibit the facilitated autoproteolysis of UmuD2 in vitro, and
moreover that the DinB(F172A) variant was unable to efficiently do so (Figure 3-5E,
p.76). All of these data underscore the notion that a physical interaction between DinB
and UmuD2 exists under physiological conditions and is required for UmuD2 dependent
modulation of DinB function. Furthermore, perturbation of that interaction compromises
the ability of UmuD2 to control the -1 frameshift mutagenic function of DinB.
A TLS-deficient DinB Variant is Proficient for -1 Frameshift Function
It has been suggested that the -1 frameshift mutagenic signature of DinB arises from its
open active site because of its specialized TLS function [45]. To ascertain whether DinB
dependent -1 frameshift activity is separable from its function in TLS, we employed a
DinB(F 13V) variant, which is able to catalyze DNA synthesis on undamaged DNA, but
is virtually unable to perform TLS on certain adducted templates [53]. We found that this
mutant is able to promote -1 frameshift mutagenesis in vivo (Figure 3-6A, p.92),
indicating that DinB function in TLS and frameshift mutagenesis can be separated.
Curiously, the mutation frequency induced by overexpression of DinB(F 13V) is about 5-
fold greater than that produced by overexpression of wild-type DinB even though the
levels of each protein are comparable in vivo (Figure 3-S6, p.92). This observation
suggests either that DinB(F 13V) has an increased -1 frameshift activity or that some
other mechanism is responsible for this phenomenon in vivo. Although the first
explanation is formally possible, the -1 frameshift activity of DinB(F13V) in vitro is
slightly reduced (ca. 3-fold) relative to wild-type DinB. This observation suggests that
DinB(F 13V) promotes increased frameshifts by virtue of either its recruitment to, or
association with, frameshift intermediates. Curiously, we were unable to observe UmuD2
dependent inhibition of DinB(F13V) -1 frameshift activity either in vivo or in vitro
(Figure 3-6 A-B, p.92). These observations may be at least in part due to the fact that
DinB(F 13 V) has a reduced affinity for UmuD2 relative to the wild-type enzyme (Figure
3-S7, p.95).
Figure 3-6: A TLS deficient variant of DinB is proficient for -1 frameshift function.
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Figure 3-6: A TLS deficient variant of DinB is proficient for -1 frameshift function.
(A) The DinB(F13V) variant can promote -1 frameshift mutagenesis but is not controlled
by co-overproduction of UmuD. (B) The -1 frameshift activity of DinB(F 13V) is poorly
inhibited by UmuD2 in vitro. Plot of frameshift activity vs. UmuD concentration
indicates that DinB(F13V) (open squares) retains much of its frameshift activity at
concentrations of UmuD that inhibit virtually all DinB frameshift activity (closed circles).
All reactions contain RecA in stoichiometric ratios with DinB.
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Figure 3-S6: DinB(F13V) is expressed at levels comparable to wild-type DinB in
vivo.
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RecA and UmuD 2 Modulate DinB Function by Restricting its Open Active Site
In an effort to understand how UmuD2 suppresses the intrinsic -1 frameshift mutator
activity of DinB in a RecA dependent manner, we generated a model of a ternary
complex among DinB, RecA, and UmuD2. The structure of RecA [308] and models of
DinB [53] and UmuD2 [147] were docked using several constraints. First, UmuD2 was
positioned on DinB using the peptide array data (Figure 3-3A-B, p.81), ensuring that
there were no steric collisions between the two proteins. We then used distance
constraints between RecA and UmuD 2 from published monocysteine crosslinking studies
[88] to orient RecA relative to UmuD2. Finally, we analyzed the RecA binding interface
on DinB with a peptide array experiment (Figure 3-S8). Together, these data were used to
generate a working model shown in Figure 3-7A-B (p.97), which indicates that RecA and
UmuD2 act in concert to enclose the relatively open active site of DinB, perhaps thereby
restricting its mutagenic potential. It is also curious that the molecule of RecA is
positioned appropriately to interact with the end of a RecA-nucleoprotein filament,
suggesting that this interaction may also play a pivotal role in targeting DinB to RecA-
coated substrates, a concept that has been previously proposed for UmuD' 2C [110, 309].
Although the UmuD protein is only conserved among certain bacteria, we
wondered whether the UmuD-binding interface on DinB might be maintained throughout
evolution to interact with a highly diverged UmuD2 or a different but functionally
equivalent partner protein. The eukaryotic ortholog of DinB, pol K, also promotes
frameshift mutagenesis in overproduction [310], and it is possible that a putative
eukaryotic protein might interact in a similar location on pol K. Although residues on
Figure 3-S7: Interaction between UmuD2 and DinB(F13V)
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Figure 3-S8: Predicted binding interface with RecA is shown in red on a model of
DinB.
Figure 3-7: RecA and UmuD2 enclose the open active site of DinB.
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Figure 3-7: RecA and UmuD 2 enclose the open active site of DinB. A-B. In silico
modeling of a ternary complex of the proteins. The surface representation of DinB is
shown in blue, UmuD 2 in yellow, and RecA in orange. The DNA is relatively enclosed in
the complex. C-D. Statistical covariance of DinB/pol K residues across evolution.
Residues that display statistical covariance with the UmuD 2 binding interface on E. coli
DinB define an interface in a similar position on pol K, suggesting a possible rationale for
the maintenance of this interface as a site of regulatory protein-protein interactions.
DinB that participate in the interface are only cryptically conserved, we considered
whether they would exhibit statistical covariance through evolution. We therefore
assembled an alignment of 84 DinB and pol K sequences from all domains of life and
examined which positions showed statistically significant covariance with at least two of
three residues that define the UmuD2 interacting interface of DinB using the CRASP
algorithm (Figure 3-7C, p.97) [311]. Strikingly, these residues define a similar interface
on pol K as that identified experimentally on DinB (Figure 3-7D, p.97). These
observations suggest that there may be an evolutionary driving force for the maintenance
of this interface, perhaps as a site for regulatory protein-protein interactions.
Discussion
The SOS network regulates the transcription of numerous gene products,
including Y-family DNA polymerases, in response to DNA damage and environmental
stress. In addition to a demonstrated biochemical preference for adducted DNA
substrates [43, 53] exquisite protein-protein interactions extending well beyond the
replicative processivity subunit [23, 312] govern the activity of Y-family DNA
polymerases. UmuD'2C is regulated by diverse cellular factors including RecA, UmuD2,
and UmuD' 2 [75, 98, 108, 111, 131, 313]. Strikingly, we report that DinB is subject to
regulation by these same proteins in vivo and in vitro.
We observe direct interactions between DinB, UmuD2, UmuD' 2, and RecA using
several methods (Figure 3-1A-C, p.70) and importantly these interactions are
physiologically relevant. The dissociation constant between DinB and UmuD2 is 620 nM
while the uninduced cellular concentrations of DinB and UmuD are approximately 400
nM and 350 nM respectively. Thus, there are sufficient cellular quantities of UmuD to
interact with nearly every molecule of DinB. The estimated Kd between DinB and RecA
is ca. 1 ýpM and RecA concentration under normal conditions is 2.5 1iM. The cellular
levels for these proteins rise at least 10-fold upon SOS induction [96, 136, 314]. Thus,
DinB is likely to exist as at least a binary and perhaps ternary complex under many
physiological conditions. Indeed, we have been able to isolate a ternary complex of these
three proteins that is stable on the minute timescale (Figure 3-1C, p.70).
We find that the -1 frameshift mutagenesis that is induced by overproduction of
DinB can be suppressed by co-overproduction of UmuD (Figure 3-2A-B, p.74).
Moreover, a noncleavable UmuD variant, UmuD(S60A), fully suppresses -1 frameshift
mutagenesis, indicating that only the function of full-length UmuD is required to control
it (Figure 3-2A, p.74). The DinB-binding deficient UmuD(D91A) variant (Figure 3-3C,
p.81), although perfectly proficient at facilitated autoproteolysis (Figure 3-S4, p.86), does
not efficiently reduce DinB dependent-i frameshift mutagenesis (Figure 3-4B, p.88).
Curiously, the residue Asp91 in UmuD does not form a contiguous interface with the
other residues identified as part of the DinB-binding interface as it is occluded by the
curled N-terminal arm of UmuD (Figure 3-3B, p.81). However, computational modeling
has suggested that an isoenergetic conformation of UmuD 2 can be formed in which the
N-terminal arm of UmuD 2 is raised [147], thereby potentially favoring interaction with
DinB but also rendering it incompetent for autoproteolysis (Figure 3-S2, p. 10 1). Our
observation that DinB inhibits UmuD 2 autoproteolysis in vitro and UV-induced
mutagenesis in vivo, is consistent with this notion. Overproduction of UmuD' can also
suppress -1 frameshift mutagenesis, albeit to a lesser degree, indicating that the
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Figure 3-S2: Models of UmuD 2 with DinB-interacting residues highlighted in red.
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Figure 3-S2 (continued): Models of UmuD2 with DinB-interacting residues
highlighted in red.
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interface between DinB and UmuD2 or UmuD' 2 does not substantially involve the UmuD
N-terminus, in agreement with our observations using cellulose filter peptide arrays
(Figure 3-3B, p.81). Overproduction of UmuD, and to a lesser extent UmuD', also
inhibits adaptive mutagenesis (Figure 3-2B, p.74), which occurs via a -1 frameshift event
[303]. Irrespective of the precise molecular mechanism of this type of mutagenesis, it is
clear that the umuD gene products play a role in modulating it.
Perhaps the umuD gene products also regulate the fidelity of the Y-family DNA
polymerases in response to DNA damage or environmental stress. Under normal
conditions the levels of UmuD2 are relatively low, increasing over approximately 30
minutes upon SOS induction. During this phase of the SOS response in which high
fidelity repair mechanisms predominate [100], the mutagenic activity of DinB may be
restricted. The subsequent, and highly regulated, conversion of UmuD2 to UmuD' 2 marks
the beginning of a more mutagenic phase of the SOS response (Figure 8).
Remarkably, examination of the molecular interface between UmuD2 and DinB
by peptide array mapping indicates that UmuD 2 may enclose the relatively open active
site of DinB (Figures 3-3A, p.81 and 3-7A-B, p.97). Using this information, we
constructed a mutant, DinB(F172A), which has a >50-fold reduced affinity for UmuD2
(Figure 3-3C, p.81). Overproduction of this DinB variant induces -1 frameshift
mutagenesis, albeit to a slightly lesser extent than the wild-type enzyme, and is relatively
inert to the action of UmuD both in vivo and in vitro (Figure 3-4A, p.88; Figure 3-5D,
p.76). Overproduction of mammalian pol K has similarly deleterious mutagenic
consequences as DinB overproduction [315], despite the fact that its active site appears to
be comparatively closed [316]. The umuD gene is only present in certain prokaryotic
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species, but it is tempting to speculate that there may be a functional ortholog in
eukaryotes that might similarly modulate Pol K function. Moreover, even though the
UmuD-binding interface of DinB is only cryptically conserved between prokaryotes and
eukaryotes, the residues that define this interface display statistical covariance through
evolution (Figure 3-7C-D, p.97), suggesting the possible presence of a driving force for
the maintenance of this surface.
To our surprise, in vitro reconstitution the UmuD 2 modulation of DinB frameshift
activity using a mismatched substrate [73, 307] is only efficient when RecA is present in
stoichiometric quantities with DinB. Moreover, the addition of RecA and UmuD2 to an
assay in which DinB replicates a normal template of the same sequence context results in
a profound (ca. 20-fold) increase in DinB catalytic proficiency (Figure 3-5B, closed
circles, p.76). We also found that recA is required for the suppression of DinB
dependent -1 frameshift mutagenesis in vivo, as the co-overproduction of UmuD 2 does
not suppress this mutagenesis in a recA strain (Figure 3-5C, p.76). Based on the
observation that a noncleavable UmuD(S60A) variant is fully proficient for suppression
of -1 frameshift mutagenesis (Figure 3-2A, p.74), we infer that the function of RecA in
this inhibition is not to promote UmuD2 autoproteolysis. These observations suggest that
UmuD 2 is able to modulate the activity of DinB in a highly nuanced fashion that depends
on the presence of RecA.
We anticipated that deletion of either umuD or recA would affect DinB TLS
function. Surprisingly, deletion of umuD had no effect on dinB dependent resistance to
NFZ in a wild-type E. coli strain. Deletion of recA caused sensitivity to NFZ, likely due
to the central role of RecA in coordinating numerous aspects of the DNA damage
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response [286], but also perhaps because of its interaction with DinB. We wondered
whether the frameshift activity of DinB is genetically separable from its function in TLS.
We have previously characterized a separation of function mutant of DinB's steric gate
residue, DinB(F13V), which is entirely active as a conventional DNA polymerase but is
virtually unable to catalyze TLS on N2-dG adducted templates [53]. In vivo, DinB(F13V)
is exceptionally proficient at promoting -1 frameshift mutagenesis, although its levels are
comparable to wild type by immunoblot (Figure 3-S6, p.93), indicating that TLS function
is not required for this property of DinB (Figure 3-6A, p.92). In vitro, DinB(F13V) can
catalyze frameshift formation, albeit at a 3-fold reduced rate relative to wild-type DinB,
suggesting that this variant may either obtain or retain increased access to frameshift
intermediates in vivo. These observations indicate that TLS and -1 frameshift function are
distinct phenomena.
We propose, as have others [45, 306], that the modest -1 frameshift activity of
DinB and its orthologs may arise as a result of its unique active site that is specialized for
TLS function. Under most cellular conditions, UmuD2 and RecA are present at sufficient
levels not only to prevent rampant -1 frameshift mutagenesis but also to control DinB
polymerase function, suggesting a mechanism through which the mutagenic potential of
DinB is regulated, and perhaps exploited, by the cell. Elevation of DinB levels above
those of its UmuD2 manager protein, as occurs in both adaptive and spontaneous -1
frameshift mutagenesis, renders the cell vulnerable to the full mutagenic potential of
DinB. Under conditions of DNA damage, the UmuD2 predominant phase of the SOS
response may serve to delay the lower fidelity facets of Y-family polymerase function.
Indeed, the precise tuning of DinB levels relative to those of UmuD2 under both basal and
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SOS induced conditions may facilitate the modulation of its function in response to
environmental stress.
Experimental Procedures
Protein Expression and Purification
DinB, UmuD, UmuD', and RecA were purified as described previously [53, 317, 318],
but 50 mM Hepes pH 7.2 was used exclusively. Expression plasmids for DinB(F172A)
and UmuD(D91A) were constructed from pDFJ1 and pSG5 [317], respectively, using a
Quikchange kit (Stratagene). Both DinB(F172A) and UmuD(D91A) behaved as wild-
type DinB and UmuD during purification. A plasmid encoding a (His) 6HMK-DinB
derivative [319] was constructed in pET16B using standard cloning procedures. The
HMK-DinB protein derivative was purified using Ni2+-NTA affinity resin (Qiagen)
following the manufacturer's instructions.
Affinity Chromatography
The details of the procedure are described in supplemental material accompanying this
manuscript.
Crosslinking and Binding Measurements
UmuD and DinB were mixed and crosslinking reactions were initiated as described [131]
and allowed to proceed for 10 min before quenching with SDS-PAGE loading buffer
containing 5% P-mercaptoethanol. Fluorescence center of spectral mass were performed
and analyzed as described previously [317].
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Farwestern assays and Peptide Array Experiments
Farwestern blots were performed previously described [131]. Abimed cellulose filter
peptide arrays were synthesized with overlapping 12-mer peptides offset by two residues
scanning the primary sequences of DinB and UmuD (MIT Center for Cancer Research
Core Facility). The arrays were probed with 1 tM UmuD2 or DinB, and washed and
developed as described [320]. Control arrays were performed using DinB or UmuD2
antibodies alone.
Mutagenesis Assays
DinB dependent -1 frameshift mutagenesis experiments were performed as described
[282] except that IPTG was not added to the media. Ampicillin (100 pLg/mL) and
spectinomycin (60 ýlg/mL) were used as necessary for plasmid maintenance. Adaptive
mutagenesis was performed as previously described [321]. A table of the strains and
plasmids used in this study is available as supplemental material (Table 3-S1).
DinB and UmuD 2 Activity Assays
DinB was assayed as described previously [53] except 50 nM enzyme and 10 nM
primer/template was used. The oligonucleotides 5'-
ATCCTAGTCCAGGCTGCTGACAACTCGGGAACGTGCTACATGAAT-3', 5'-
ATTCATGTAGCAGCGTTCCC-3', and 5'ATTCATGTAGCAGCGTTCCG-3' were
designed based on those used previously [73]. Reactions were initiated with the
appropriate dNTP, quenched after 20 min with 95% formamide, 25 mM EDTA, 0.5%
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bromophenol blue, and 0.5% xylene cyanol, and separated on a 16% denaturing
polyacrylamide gel, which was quantified using a Typhoon phosphorimager (GE
Healthcare). UmuD 2 autocleavage reactions were performed as described previously
[317].
Molecular Modeling and Statistical Covariance
A model of the DinB-UmuD 2 complex was constructed using the application 3D-dock
based on the following constraints: E168 < 6 A from either UmuD chain, and L176,
P177, K180, and F172 < 8 A from D91 of either UmuD chain. The UmuD2-RecA model
was made using the following constraints: RecA S 117 < 7 A from either UmuD chain
[88], UmuD residues L101, R102, V34, S81 are 6-12 A from RecA, and UmuD residue
Ell is 6-25 A from RecA. Resulting complexes were filtered based the RecA residues
T243 and R244 < 10 A from DinB to generate a model of the DinB-RecA-UmuD 2 ternary
complex. We performed the same procedure by docking DinB to the UmuD 2-RecA
models using the constraints described above and obtained similar results. Statistical
covariance was performed by aligning 84 DinB and pol K sequences from diverse
organisms using ClustalW and analyzing significant pairwise correlation of alignment
positions with the CRASP algorithm [311].
Supplemental Data
Supplemental Data includes 8 figures, supplemental References, and supplemental
experimental procedures.
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Abstract
Products of the umuD gene in E. coli play key roles in coordinating the switch
from DNA repair to mutagenic translesion DNA synthesis (TLS) during the SOS
response to DNA damage. Homodimeric UmuD2 is upregulated approximately 10-fold
during the beginning of the SOS response, after which a slow post-translational
autocleavage step removes the N-terminal 24 amino acids of each UmuD monomer. The
remaining C-terminal fragment, UmuD'2, is required for mutagenic TLS. The small
proteins UmuD2 and UmuD' 2 make a large number of specific protein-protein contacts
for their roles in regulation, including interactions with three of the five known E. coli
DNA polymerases, parts of the replication machinery, and RecA recombinase. We show
that, despite forming stable homodimers at a wide range of protein concentrations,
UmuD2 and UmuD'2 have a CD spectrum with almost no a helix or P sheet signal at
physiological concentrations in vitro. High protein concentrations, osmolytic crowding
agents, and specific interactions with a partner protein can induce CD spectra that more
closely resemble the expected P sheet signature. A lack of secondary structure in vitro is
characteristic of a class of proteins termed intrinsically disordered proteins, many of
which act as regulators. A stable homodimer that lacks significant secondary structure is
unusual but not unprecedented. Furthermore, previous single-cysteine cross-linking
studies of UmuD2 and UmuD' 2 show that they have a nonrandom structure at
physiologically relevant concentrations in vitro. Our results offer insights into structural
characteristics of the relatively poorly understood class of proteins designated as
intrinsically disordered and provide a model for how the umuD gene products can
regulate diverse aspects of the bacterial SOS response.
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Introduction
The bacterial SOS response is a tightly regulated cellular reaction to stress-
induced DNA damage (reviewed in [3]). It is temporally divided into at least two phases;
an early, relatively accurate DNA repair phase and a later, more mutagenic damage
tolerance phase for persistent damage [97]. This timing is regulated in part by products
of the umuD gene. The initial product of umuD is a homodimer of 139-amino acid
subunits that appears early after SOS induction [97]. Expression of UmuD 2 is associated
with a reduction in the rate of DNA replication and an increase in survival after UV-
induced DNA damage [97]. UmuD2 has also been shown to interact with DinB (the Y
family DNA Pol IV) and reduce the frequency of DinB-induced -1 frameshift mutations
[77]. Damage-induced RecA:ssDNA nucleoprotein filaments mediate a slow
autocleavage reaction of UmuD2 that is mechanistically similar to inactivation of the
LexA and k CI repressors [101-103, 322]. The N-terminal 24 amino acids of each
subunit of UmuD2 are removed, producing a homodimer of the C-terminal 115 amino
acid subunits, UmuD' 2 [101-103]. UmuD' 2 interacts with UmuC, the catalytic subunit of
the Y family DNA Pol V, thereby activating UmuC for TLS [75, 108, 120]. UmuD' 2C is
responsible for most damage-induced point mutations in E. coli [91, 120]. Full-length
UmuD 2 is rapidly and continuously degraded by Lon protease, whereas UmuD' 2 first
exchanges with UmuD2 to form the thermodynamically most stable UmuD'D heterodimer
[121, 126]. It is in the context of the heterodimer that the UmuD' subunit is degraded by
ClpXP protease to end the mutagenic phase of the SOS response [323].
For such small proteins, UmuD 2 and UmuD' 2 make a remarkable number of
highly specific protein-protein contacts, many but not all of them to DNA polymerases
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(Figure 4-5A, p. 1 14). Both proteins have been shown to interact with UmuC [120], DinB
[77], and the catalytic, processivity, and proofreading subunits of the E. coli replicative
DNA polymerase, Pol III [131]. Additionally, both interact with RecA:ssDNA
nucleoprotein filaments [101-103, 111].
However, despite the nearly identical primary sequence between UmuD2 and
UmuD'2, their interactions with the same partner can differ in affinity and functional
significance. As mentioned above, only UmuD2 prevents DinB-induced -1 frameshifts
[77], whereas only UmuD' 2 activates UmuC for TLS [75, 108, 120]. UmuD 2 interacts
more strongly with the 0 processivity subunit of Pol III, presumably to slow DNA
replication, whereas UmuD' 2 interacts preferentially with the a catalytic subunit, which
may facilitate TLS by UmuD'2C [131]. RecA:ssDNA interacts with UmuD2 to promote
cleavage to UmuD'2 [103], whereas UmuD'2C requires trans RecA:ssDNA for efficient
TLS [111]. The fact that such small proteins (no more than 30 kDa in their dimeric
forms) can make so many highly specific protein-protein interactions is intriguing, and so
high resolution structural studies were undertaken in an effort to find an explanation.
The X-ray crystal structure [141] and an NMR solution structure [142] of the
cleaved form UmuD'2 offer some insight. Although both methods of structure
determination indicated that UmuD'2 has an overall 3 sheet fold with a C2 axis of
symmetry, a detailed comparison between the two structures reveals substantial
differences [142]. The overall shape of the protein is less globular in the NMR structure
[142], and the protease active site residues are only poised for catalysis in the X-ray
crystal structure [141]. The differences in structural features between the two methods of
structure determination suggested that UmuD'2 may have considerable plasticity.
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Figure 4-5: A model for sequential protein-protein interactions by intrinsically
disordered proteins.
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Figure 4-5 (continued): A model for sequential protein-protein interactions by
intrinsically disordered proteins.
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Figure 4-5 (continued): A model for sequential protein-protein interactions by
intrinsically disordered proteins. (A) UmuD2 and UmuD' 2 make a variety of distinct
protein-protein interactions. Where such information is available, the relative binding
affinities between UmuD 2 or UmuD' 2 and an interaction partner are represented by thick
arrows (for strong interactions) or thin ones (for weak interactions). (B) Model for
sequential protein-protein interactions with an intrinsically disordered protein. An
intrinsically disordered protein (IDP) may first bind to one interaction partner (1), which
stabilizes a particular conformation. If a second binding interface becomes exposed in
this conformation, another protein may now bind (2). Subtle conformational changes in
this context may destabilize the first protein-protein interaction, causing the original
protein to exit the complex and possibly exposing a different interface. If so, a different
partner (3) can bind at this site. (C) UmuD2 and UmuD' 2 may act as interchangeable
protein-protein interaction domains for E. coli Y family DNA polymerases. Y family
DNA polymerases have conserved catalytic domains (large boxes), and many eukaryotic
Y family polymerases have extended N-terminal or C-terminal protein-protein interaction
domains (lines on bottom three representations). Although these interaction domains are
missing in the two E. coli Y family DNA polymerases, both of them interact with umuD
gene products, which may serve as interchangeable protein-protein interaction domains in
a streamlined genome (top two representations).
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Although no high-resolution structural data are available for UmuD2, we have recently
proposed four energy-minimized symmetrical models [147] based on the UmuD'2
structures [141, 142], the homologous protein LexA [146], and single-cysteine studies
[134]. The models all suggest that the C-terminal domain of UmuD2 has substantial P
sheet content, but they differ in the locations of the N-terminal amino acids relative to the
C-terminal globular domains. Previous single cysteine studies of UmuD2, which probed
the structure of UmuD2 in solution at physiologically relevant concentrations, have
generally been consistent with our current models of UmuD2. Single cysteine derivatives
of many amino acids that are predicted to be close to the C2 axis of symmetry robustly
cross-link to covalent dimers [143, 144]. Interestingly, some positions that are predicted
to be far away from the C2 axis of symmetry also cross-link to form covalent dimers [88,
143]. However, these residues can form a dimer interface if the N-terminal arms are in
an intermediate conformation between the cis and trans proposed models [147]. These
results are consistent with the hypothesis that UmuD2 can interchange between multiple
conformations that resemble those presented in our four models.
We used CD spectroscopy to compare the secondary structure of UmuD2 with that
of the known P-sheet protein UmuD'2, but we were surprised to find that, at physiological
concentrations, both proteins show a spectrum that more resembles a random coil than
the expected 3-sheet structure. These results are typical of a previously defined class of
proteins, called intrinsically disordered proteins, whose precise structures depend on their
environment and which often have regulatory functions [160, 163, 164, 324]. However,
UmuD2 and UmuD'2 form stable homodimers at physiological concentrations in vitro,
and previous single-cysteine studies show that both proteins have a nonrandom structure
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at these concentrations [88, 134, 143, 144]. Our results provide a rare opportunity to
probe the actual structure of proteins that appear unfolded by CD and limited proteolysis.
Results
UmuD2 and UmuD'2 have extremely different CD spectra at uM and mM concentrations.
As part of our effort to compare the secondary structure of UmuD 2, whose three-
dimensional structure is unknown, to the known structure of its derivative UmuD' 2 [141,
142], we measured the CD spectrum of UmuD' 2 at 5 [tM, the concentration found in
SOS-induced cells [77]. We were startled to discover that the CD spectrum of UmuD' 2 at
the physiologically relevant concentration more closely resembles a random coil than the
expected P-sheet structure (Figure 4-1A, p. 1 19). In an attempt to reconcile these results
with the two previous high resolution analyses of UmuD' 2, which had revealed it to be a
P-sheet rich protein [141, 142], we took the CD spectrum of UmuD' 2 at the high,
nonphysiological protein concentration used to solve the solution structure by NMR
[142]. Consistent with the previous structural analysis [141, 142], the CD spectrum of
UmuD' 2 at 2 mM displays more typical 3-sheet character (Figure 4-1A, p. 1 19).
Examination of UmuD 2 reveals exactly the same striking anomaly, a CD spectrum
resembling a random coil at tiM concentrations and one consistent with a P-sheet rich
protein at mM concentrations (Figure 4-1 B, p. 119).
These unexpected findings suggested to us that UmuD2 and UmuD' 2 must be
undergoing a transition from a folded state at mM concentrations to a more disordered
state upon dilution to ptM concentrations. We therefore examined the effect of dilution
on the susceptibility of UmuD' 2 and UmuD2 to limited proteolysis over a 5-minute time
window. UmuD' 2 or UmuD 2 that has been pre-equilibrated at 10 [iM results in more
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Figure 4-1: UmuD 2 and UmuD' 2 have extremely different CD spectra at I.M and mM
concentrations
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Figure 4-1 (continued): UmuD 2 and UmuD' 2 have extremely different CD spectra at
ftM and mM concentrations
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Figure 4-1 (continued): UmuD 2 and UmuD' 2 have extremely different CD spectra at
pM and mM concentrations. CD spectra of 5 1iM (dashed line) and 2 mM (solid line)
UmuD'2 (A) or UmuD2 (B) at 25 'C. (C) Limited chymotrypsin proteolysis of 5 iM
UmuD'2 (lanes 1-3) and 5 pM UmuD2 (lanes 4-6) at 37 'C for 5 minutes. Lanes are: (1) 5
giM UmuD'2 with no protease (2) UmuD' 2 pre-equilibrated at 10 iM and diluted 1:1 with
5 mg/mL chymotrypsin (3) UmuD' 2 freshly diluted to 10 jtM 1 minute before 1:1 dilution
with 5 mg/mL chymotrypsin (4) 5 jIM UmuD2 with no protease (5) UmuD2 pre-
equilibrated at 10 jtM and diluted 1:1 with 5 mg/mL chymotrypsin (6) UmuD2 freshly
diluted to 10 jM 1 minute before 1:1 dilution with 5 mg/mL chymotrypsin.
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complete proteolysis by chymotrypsin than UmuD' 2 or UmuD 2 that has been freshly
diluted from a 2 mM stock (Figure 4-1C, p. 1 19). The extent of degradation of freshly
diluted UmuD' 2 is about 60% of that of pre-equilibrated UmuD' 2, whereas freshly diluted
UmuD 2 is degraded at about 85% the level of pre-equilibrated UmuD2. These results
would be consistent with a model in which UmuD' 2 and UmuD2 fold only at higher than
physiologically relevant concentrations.
The CD and proteolysis results at physiological concentrations are typical of a
class of proteins called intrinsically disordered proteins, which lack significant a helix
and P3 sheet structure in vitro (reviewed in [160, 163, 187, 324]). We therefore used
PONDR protein disorder prediction programs [325, 326] to test the similarity of UmuD' 2
and UmuD 2 to known disordered sequences and found that the extreme N-terminus of
UmuD' 2 and much of the C-terminal regions of both UmuD' 2 and UmuD are predicted to
be disordered (Figure 4-S1, p. 123). Nevertheless, both proteins are active in vitro at
physiologically relevant concentrations (Figure 4-S2, p.125).
Crowding agents and specific protein-protein interactions induce secondary
structure in UmuD2 and UmuD'2.
To test whether the P-sheet rich CD spectra of UmuD 2 and UmuD' 2 at mM
concentrations result from specific self-self interactions or from more general crowding
effects, we took the CD spectrum of umuD gene products in the presence of the osmolytic
crowding agent proline [217]. Proline at 200 mM increases the secondary structure
content of both UmuD' 2 (Figure 4-2A, p.1 2 6 ) and UmuD 2 (Figure 4-2B, p.126). Less
profound but consistent results are obtained with 2.5 M glucose (Figure 4-S4, p. 13 1).
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Figure 4-S 1: PONDR analyses predict that UmuD 2 and UmuD'2 have regions of
intrinsic disorder.
A
1.0
0.8
0.6
0.4
0.2
0.0
0 10 20 30 40 50 60 70 80 90 100 110 120 130
Residue Number (UmuD Numbering)
123
Figure 4-Si (continued): PONDR analyses predict that UmuD 2 and UmuD' 2 have
regions of intrinsic disorder.
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Figure 4-S1: PONDR analyses predict that UmuD 2 and UmuD'2 have regions of
intrinsic disorder. Prediction of disordered regions in the sequence of UmuD'2 (A) and
UmuD2 (B) using PONDR protein disorder prediction programs VLXT (solid line), XL 1-
XT (long dash), and CAN-XT (short dash). Residues with a PONDR score of > 0.5 using
any of these programs are predicted to be disordered.
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Figure 4-S2: UmuD 2 and UmuD' 2 are active in vitro at physiologically relevant
concentrations.
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Figure 4-S2: UmuD 2 and UmuD' 2 are active in vitro at physiologically relevant
concentrations. (A) UmuD2 is active for in vitro RecA*-mediated cleavage to yield
UmuD' 2. RecA* was formed from RecA, ssDNA, and ATP-y-S and added to 5 pM
UmuD2. Aliquots were removed at t=O (lane 1) and t=1 hr (lane 2), after which most
UmuD 2 had been converted to UmuD'2. (B) Both UmuD2 and UmuD' 2 are active for
heterodimer formation and ClpXP proteolysis. UmuD2 and UmuD'2 were coincubated
for 30 min to allow formation of the UmuD'D heterodimer and added to ClpXP protease
and ATP. Aliquots were removed at t=0O (lane 1) and t=2 hr (lane 2), after which most
UmuD' 2 had been degraded by ClpXP. Assay procedures are in [317].
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Figure 4-2: Crowding agents and specific protein-protein interactions induce
secondary structure in UmuD 2 and UmuD' 2.
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Figure 4-2 (continued): Crowding agents and specific protein-protein interactions
induce secondary structure in UmuD2 and UmuD' 2.
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Figure 4-2 (continued): Crowding agents and specific protein-protein interactions
induce secondary structure in UmuD 2 and UmuD' 2.
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Figure 4-2 (continued): Crowding agents and specific protein-protein interactions
induce secondary structure in UmuD2 and UmuD' 2.
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Figure 4-2 (continued): Crowding agents and specific protein-protein interactions
induce secondary structure in UmuD2 and UmuD' 2. CD spectra of UmuD' 2 (A) or
UmuD 2 (B) in the absence (dashed line) or presence (solid line) of 200 mM proline. (C)
CD spectrum of UmuD2 alone (dashed line) or in the presence of DinB (solid line). The
CD signal of DinB alone was subtracted from that of the complex to obtain the latter
spectrum. (D) CD spectrum of UmuD 2 alone (dashed line) or in the presence of the P
processivity subunit of Pol III (solid line). The CD signal of P3 was subtracted from that
of the complex.
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Figure 4-S4: The osmolytic crowding agent glucose causes some secondary structure
formation in both UmuD2 and UmuD' 2.
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Figure 4-S4 (continued): The osmolytic crowding agent glucose causes some
secondary structure formation in both UmuD2 and UmuD' 2.
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Figure 4-S4: The osmolytic crowding agent glucose causes some secondary structure
formation in both UmuD 2 and UmuD' 2. The CD spectrum of 5 giM UmuD'2 (A) or 5
p.M UmuD2 (B) in the absence (dashed lines) or presence of 2.5 M glucose (solid lines).
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Interestingly, certain other crowding agents such as PEG 8000, 1M NaCI, and glycerol
did not increase the secondary structure of either UmuD2 or UmuD'2 (data not shown).
We have previously shown that UmuD2 interacts with DinB (KD = 0.64 jtM) [77]
and with the 13 processivity subunit of DNA Pol III (KD = 5.5 giM) [147]. To test whether
these specific protein-protein interactions induce secondary structure in UmuD2 at jtM
concentrations, we took the CD spectrum of 50 jtM UmuD2 in the presence of 50 jtM
interacting protein. After subtracting out signal from the interacting protein alone, the
resulting spectra of UmuD2 in the presence of DinB (Figure 4-2C,p. 126) or of the P
subunit (Figure 4-2D,p. 126) reveal an increase in the 0 sheet content. Both spectra show
nearly identical secondary structure content. Since both the [ subunit and DinB have
more typical secondary structure than UmuD2 (data not shown), it is likely that the
increase in secondary structure in the complex is mostly due to an increased P-sheet
content of UmuD2 . However, we cannot rule out the possibility that binding of UmuD 2
may cause a conformational change in the interacting proteins as well [77, 147].
UmuD2 and UmuD'2 are dimeric at physiologically relevant concentrations.
The above data would be consistent with a model wherein umuD gene products
are dimeric and folded at mM concentrations but dissociate into monomers and unfold at
physiological concentrations. However, several lines of evidence are inconsistent with
monomeric umuD gene products at physiological concentrations. Gel filtration of
UmuD' 2 or UmuD2 shows that their elution volume is between the expected size of a
dimer and that of a trimer (See [120] and Figure 4-S3A,p. 134). Independent biochemical
and biophysical evidence shows a dimeric form of UmuD2, UmuD'2, and UmuD'D [120,
121, 327, 328], whereas no evidence for a trimer has been found. Although the proteins
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Figure 4-S3: UmuD2 and UmuD' 2 are dimeric at physiological concentrations in
vitro.
A
,,
I .z
1.0
E
0 0.8
o
00.0
-0.2
-0.4S0.4
-0.4
0 10 20 30 40 50 60
Elution volume (mL)
70 80 90 100
134
Figure 4-S3 (continued): UmuD2 and UmuD' 2 are dimeric at physiological
concentrations in vitro.
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Figure 4-S3 (continued): UmuD 2 and UmuD' 2 are dimeric at physiological
concentrations in vitro.
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Figure 4-S3: UmuD 2 and UmuD' 2 are dimeric at physiological concentrations in
vitro. (A) Superdex 75 gel filtration of 5 pM UmuD' 2 (black solid line) or 5 [iM UmuD 2
(black dashed line) as compared to size standards (gray solid line). Size standards are as
follows: BSA (dimer of 132 kDa eluting at 34 mL and monomer of 66 kDa eluting at 41
mL), ovalbumin (43 kDa, eluting at 46 mL), chymotrypsin (26 kDa, eluting at 55 mL),
and lysozyme (14 kDa, eluting at 75 mL). (B) Lysozyme, chymotrypsin, and 5 jiM
UmuD' 2 or UmuD 2 were denatured in 6 M guanidinium for 2 hours before loading and
elution from a Superdex 75 gel filtration column in buffer containing 6M guanidinium
hydrochloride. Note that all proteins eluted at a lower volume than their native
counterparts in (A). (C) Native gel electrophoresis of 500 nM (lanes 1-5) or 5 [M (lanes
7-11) UmuD2 (lanes 1 and 7), UmuD' 2 (lanes 2 and 8), UmuD'D (lanes 3 and 9), Cross-
linked UmuD(F94C) 2 (lanes 4 and 10), and mock-treated UmuD(F94C) 2 (lanes 5 and 11).
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elute slightly earlier than expected for a globular dimer, these data are best explained by a
nonglobular dimer of both UmuD2 and UmuD'2, consistent with other proteins that lack
significant secondary structure [329]. Denatured UmuD' and UmuD behave as
monomers, eluting earlier than their native counterparts and just before denatured
chymotrypsin (14 kDa) (Figure 4-S3B, p. 134).
A native PAGE gel of UmuD2 and UmuD'2 at 500 nM (20 ýpL) and 5 IlM (2 iL)
shows that the proteins are dimeric at both uninduced and SOS-induced physiological
concentrations (Figure 4-S3C, p.134), consistent with earlier studies at 6 pM [328]. The
major UmuD2 band runs nearly identically to a UmuD derivative, UmuD(F94C)2, that has
been covalently cross-linked in the dimeric form by disulfide bonds [134, 330]. An
equimolar mixture of UmuD and UmuD' at these concentrations shows a predominant
intermediate band, corresponding to the UmuD'D heterodimer, rather than two distinct
monomeric bands. The theoretical pI of all of these proteins is 4.5, making charge effects
on migration negligible. A Ferguson plot of UmuD2 and UmuD' 2 compared to native
PAGE standards shows that both UmuD2 and UmuD' 2 are most similar to the 45 kDa size
standard (Figure 4-3A, p.138), consistent with gel filtration and inconsistent with a
monomeric form of UmuD or UmuD' at physiological concentrations.
In an effort to determine the KD of UmuD2 and UmuD'2 homodimers, equilibrium
analytical ultracentrifugation was performed at three rotor speeds. The best fit of the data
is to a single species model (Figures 4-3 B and C, p.138). The predicted molecular
weight of UmuD' at 20 pM is 25.4 kDa, compared to the monomer molecular weight of
12.5 kDa (Figure 4-3B, p.138). The same model for UmuD at 40 gpM (Figure 4-3C,
p. 13 8) results in a fitted molecular weight of 31.0 kDa, in comparison with the predicted
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Figure 4-3: UmuD 2 and UmuD' 2 are dimeric at physiologically relevant
concentrations.
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Figure 4-3 (continued): UmuD 2 and UmuD' 2 are dimeric at physiologically relevant
concentrations. (A) Ferguson plot of native PAGE size standards (gray circles), UmuD'2
(black square), and UmuD2 (black triangle). The KT for each protein was determined by
plotting the retention factor (log scale) vs. acrylamide concentration (linear scale) for
each protein and finding the slope of the best fit regression line. The best fit of the plot of
-KT vs. molecular weight is to y=7.3408x-686 8 . R=0.958. Solving for the molecular
weight of UmuD gives an estimate of 46 kDa and for UmuD' an estimate of 49 kDa; the
difference is not statistically significant. Native gel standards are: Jack bean urease
hexamer (545 kDa) equine spleen ferritin (440 kDa), jack bean urease trimer (272 kDa),
bovine liver catalase (232 kDa), bovine heart lactate dehydrogenase (140 kDa), bovine
serum albumin (66 kDa), and chicken egg white ovalbumin (45 kDa). Where more than
one data point is present, multiple protein isoforms were analyzed. Equilibrium
analytical ultracentrifugation of 20 [LM UmuD'2 (B) and 40 [tM UmuD 2 (C). Data for 3
different rotor speeds (16,000 rpm, black circles; 20,000 rpm, dark gray circles; and
30,000 rpm, light gray circles) are plotted with the best fit theoretical curve (single
species of dimeric molecular weight) overlaid. (D) Residuals from data fitting to (B).
(E) Residuals from data fitting to (B).
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monomeric molecular weight of 15.1 kDa. If data are fit to a monomer-dimer
equilibrium model, the KD generated is infinitely low. Residuals, though somewhat
nonrandom (Figures 4-3 D and E, p. 1 3 8), are small and do not improve with fits to other
theoretical models. The lower limit of KD determination for a simple monomer-dimer
equilibrium using analytical ultracentrifugation is about 10 " M [331]. Thus, despite the
CD spectra at low concentrations, both UmuD 2 and UmuD' 2 are dimers with KDS of <10
pM. Interestingly, the KD of the related protein LexA has also been shown to be in the
pM range [1].
A covalently linked variant of UmuD2 has as CD spectrum resembling a random coil.
To confirm that the random coil CD signal of UmuD 2 does not require a
monomeric species, we took the spectrum of disulfide cross-linked UmuD(F94C) 2, which
has been shown to bind the P3 processivity subunit of DNA Pol III in a similar manner to
wild-type [330]. Surprisingly, even though this variant cross-links nearly quantitatively
(Figure 4-4A, p.141), it shows slightly less propensity for secondary structure than an
otherwise equivalent mock-treated sample of UmuD(F94C) (Figure 4-4B, p.141).
We have no evidence of stable higher-order oligomers of UmuD 2 or UmuD' 2 at 2
mM, wherein the CD spectrum shows considerable secondary structure, and UmuD' 2 at
these concentrations has been shown to be dimeric [142]. Native PAGE of 5 [iM (20 PL)
and 2 mM (0.5 pL) UmuD 2, UmuD' 2, and UmuD'D shows that all proteins have a
consistent retention factor regardless of starting concentration (Figure 4-4C, p. 141).
Discussion
These studies have led us to conclude that, at physiologically relevant
concentrations, UmuD' 2 and UmuD 2 have structural characteristics of intrinsically
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Figure 4-4: A covalently linked variant of UmuD2 has a CD spectrum resembling a
random coil.
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Figure 4-4 (continued): A covalently linked variant of UmuD 2 has a CD spectrum
resembling a random coil.
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Figure 4-4: A covalently linked variant of UmuD 2 has as CD spectrum resembling a
random coil. (A) Extent of cross-linking of UmuD(F94C). Lanes are: (1) mock-treated
UmuD(F94C), no reductant (2) cross-linked UmuD(F94C), no reductant, (3) mock-
treated UmuD(F94C) with 1 mM DTT (4) cross-linked UmuD(F94C) with 1 mM DTT.
(B) CD spectra of cross-linked (dashed line) or mock-treated (solid line) UmuD(F94C).
(C) Native gel electrophoresis of physiological and high concentrations of umuD gene
products. Lanes are: 5 iM (lanes 1-3) or 2 mM (lanes 5-9) UmuD2 (lanes 1 and 5),
UmuD' 2 (lanes 2 and 7), or UmuD'D (lanes 3 and 9).
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disordered proteins. Little is known about the precise structures of intrinsically
disordered proteins, although several efforts to further characterize them have begun
[178, 187]. However, in the case of UmuD2 and UmuD'2, a considerable amount of
structural information is already available from studies of single cysteine cross-linking
and solvent accessibility at physiologically relevant concentrations [88, 134, 143, 144].
Consistent with an unfolded or flexible structure, cross-linking of single cysteine
derivatives of UmuD2 by slow, gentle methods such as dialyzing out the reducing agent
shows that most derivatives will cross-link to form covalent UmuD2, with only a few
positions that cross-link much more or less than average [144]. However, certain amino
acid positions are consistently more solvent-exposed than others, and faster methods of
cross-linking that give a snapshot of protein-protein contacts distinguish residues that are
near the homodimer interface [88, 143, 144]. The homodimer interface shown by these
methods is consistent with the structures of UmuD' 2 [141, 142] and our four models of
UmuD2 [147], or with intermediate conformations between these models, suggesting that
UmuD2 is likely to have a flexible but nonrandom structure in solution.
The insights obtained here suggest that at least one type of disorder may have a
structure that is not very dissimilar to a 03 sheet. This is consistent with theories of
protein unfolding that suggest some secondary-like structure persists in unfolded
proteins, but it involves fewer hydrogen bonds and allows more possible conformations
than native secondary structure [184, 185]. Therefore, the high resolution structures of
UmuD' 2 [141, 142] both may have relevance to its structure in vivo, although inside the
cell, umuD gene products are likely to be surrounded by interaction partners that may
influence their actual structure (Figure 4-5A, p. 1 14).
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It is not known whether multiple interactions with umuD gene products occur
simultaneously or in a stepwise fashion. Hub proteins, which are found in the
interactomes of many organisms and make a multitude of protein-protein contacts, can be
distinguished by which mechanism they use [227]. We suggest that the properties of
intrinsically disordered proteins such as UmuD 2 and UmuD' 2 might provide a simple
mechanism for temporally ordering multiple protein interactions. One can easily imagine
that an initial protein-protein interaction may constrain the conformations of an
intrinsically disordered protein in such a manner as to expose a preferential binding
interface for a second protein. After the second protein binds, the structure may change
even more to expose or occlude other binding interfaces (Figure 4-5B, p. 1 14). The
interactions between UmuD 2 and the 0 subunit of Pol III or DinB result in a similar
secondary structure for UmuD2 (Figure 4-4, p. 14 1), but the amino acids in UmuD2 that
are important for each interaction are different. UmuD2 seems to interact with P mainly
through a patch of amino acids near the N-terminus [330], whereas the interaction with
DinB requires a distinct patch of amino acids in the C-terminal domain [77]. It is
possible that DinB may bind first by virtue of its lower KD and induce a conformation of
UmuD 2 that exposes a binding site to the P processivity subunit, increasing the affinity of
the UmuD2-f interaction.
Although many proteins bind to the 13 processivity subunit of Pol III, the
interaction between 0 and UmuD 2 is unusual in that a specific three-dimensional fold
exposing particular amino acids of UmuD 2 appears to be necessary [330]. Other 3-
interacting proteins often have a variant of a conserved pentapeptide P-binding motif that
is proposed to bind to a single position on P [305]. Since P is a dimer [332], a maximum
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of two of these proteins may bind to P at any given time. However, UmuD2 does not
have this p binding motif [147, 333]; its interactions with P therefore might not interfere
with proteins that bind through the pentapeptide motif. For intrinsically disordered
proteins, a requirement for a particular fold ensures that protein-protein interactions only
occur when the necessary conditions are met [160]. Perhaps for the UmuD2-3
interaction, one necessary condition is a prior contact with DinB.
The crystal structures of the catalytic domains of several DNA polymerases have
been solved, but N-terminal or C-terminal protein-protein interaction domains are
sometimes removed to enable crystallization [334]. It is possible that a tendency towards
disorder in these regions in the absence of their interaction partners precludes their
representation in the crystal structures. Although UmuC and DinB do not have regions
that align with these protein-protein interactions domains, they both interact with the
quasi-disordered umuD gene products [77, 120]. We suggest that, instead of being fused
to a particular DNA polymerase, UmuD2 and UmuD' 2 may act as interchangeable
protein-protein interaction domains for the two Y family DNA polymerases in E. coli,
thus allowing for a streamlined genome while maintaining the regulatory sensitivity of an
intrinsically disordered interaction domain (Figure 4-5C, p. 1 14). A flexible structure that
can adapt to multiple distinct protein-protein interactions helps explain how the small
umuD gene products can make many specific protein-protein interactions, and a post-
translational modification further differentiates these interactions (Figure 4-5A, p. 1 14).
Although intrinsically disordered proteins are often involved in protein-protein
contacts, few are known homodimers in solution. Stable quaternary structure in the
absence of rigid secondary structure is counterintuitive to the current protein folding
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paradigm [162]. However, limited examples are present in the literature. E. coli MazE
antitoxin has both a disordered domain and a structured dimerization domain [219]. The
homodimeric bacterial histone-like proteins HU-a 2 and HU-P2 first undergo an order-to-
disorder transition upon thermal denaturation and only subsequently dissociate [222].
Most similar to UmuD2 and UmuD' 2 is human papillomavirus (HPV) protein E7, which is
both dimeric in vitro and has characteristics of intrinsically disordered proteins [2].
Interestingly, UmuD' 2 and UmuD 2 show less secondary structure by CD than HPV E7
[2].
How much of a protein must be rigidly structured in order to allow
homodimerization? Type II restriction endonucleases such as EcoRV undergo massive
domain rearrangements upon binding to DNA while maintaining a constant dimer
interface representing about 10% of the amino acid sequence [335]. The dimerization
interface of the 115 amino acid protein UmuD' comprises about 16 amino acids,
including the C-terminal P sheet and the a helix at the base of the N-terminal arms [142].
The dimer interface of the 139 amino acid UmuD is predicted to involve about 21
residues, again including the C-terminal P sheet in addition to extensive contacts of the
N-terminal arms along the C-terminal globular domain [147]. These dimer interfaces
represent between 10% and 15% of amino acid composition, and a rigid P-sheet like
structure stabilizing the dimer through these residues would not make a significant
contribution to an overall random coil CD spectrum. Interestingly, two of three regions
of the umuD gene products that disorder prediction programs calculate to have the
greatest propensity for secondary structure (Figure 4-S1, p. 123) are known to be at the
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dimer interface of UmuD'2 (amino acids 40-45 and 131-139), as would be expected for
proteins that are largely disordered but still form stable dimers [142].
UmuD2 and UmuD' 2 share homology with the dimerization domains of certain
bacterial transcription factors [91]. Transcription factors often have large regions of
intrinsic disorder, either in their DNA binding domains or in protein interaction domains
[168]. The seemingly unrelated tendencies for transcription to be homodimeric and
intrinsically disordered suggests that more homodimers with a large degree of structural
plasticity may be found soon.
Materials and Methods
Materials. Copper phenanthroline, jack bean urease, chymotrypsin, chicken egg white
ovalbumin, BSA, and lysozyme were purchased from Sigma-Aldrich. RecA protein was
purchased from New England Biolabs. High molecular weight native PAGE standards
were obtained from GE Healthcare. 7.5%, 10%, 12%, and 15% acrylamide PAGE gels
were obtained from BioRad. 4-20% PAGEr tris-glycine gradient gels were obtained
from Cambrex Pharmaceuticals.
Protein Purification. Purification of UmuD' 2, UmuD2, and UmuD(F94C) 2 was
performed as previously described [317]. A plasmid encoding UmuD(F94C) was
produced from pSG5 using the Stratagene QuikChange site-directed mutagenesis kit
[317]. Copper phenanthroline cross-linking was performed as previously published
[112]. Protein concentration was determined using the BioRad Protein Assay. DinB was
a kind gift from Daniel Jarosz [317]; the f3 processivity subunit of Pol III was generously
provided by the Beuning Lab at Northeastern University [147] and ClpXP protease from
the Baker Lab at MIT [127].
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CD Spectroscopy. Circular dichroism was performed on an Aviv Model 202 CD
spectrometer. Spectra were recorded at 25 'C; each data point represents the average of
three seconds of data collection. Proteins at physiological concentrations were monitored
using a 350 ptL 0.1-cm cuvette (Hellma Glassware), whereas proteins at 50 .iM or greater
concentrations were recorded using a 4 pL 0.01 cm cuvette (Wilmad Glass, Buena, NJ).
Spectra of umuD gene products alone were recorded in 10 mM Na3(PO 4) pH 6.8, 100
mM NaC1, 0.1 mM EDTA, ImM DTT. For protein-protein interaction studies, the buffer
was 50 mM Hepes pH 7.4, 100 mM KC1, 5 mM MgCl 2, 5% glycerol. The spectrum of a
buffer blank was subtracted from the spectrum of protein. Spectra in the presence of
crowding agents were taken in CD buffer with addition of 0.2 M proline or 2.5 M glucose
as indicated.
Limited proteolysis. UmuD' 2 or UmuD 2 was diluted to 10 VpM in CD buffer and either
incubated on ice for 2 hours or used within 1 minute. Proteolysis reactions were begun
by adding 10 [tL 5 mg/mL chymotrypsin to 10 pL UmuD' 2 or UmuD 2 and incubating at
37 'C for 5 minutes. Reactions were stopped by addition of 4 tL 6x SDS-PAGE loading
buffer (lx is 25 mM Tris-HC1, pH 6.8, 5% glycerol, 0.1% bromphenol blue, 2% SDS, 1
mM DTT) and freezing in liquid nitrogen. Proteins were run on 4-20% Tris-glycine gels,
stained with lx SYPRO Orange (Molecular Probes) in 7.5% acetic acid, and quantified
using ImageQuant software.
Protein Disorder Prediction. Access to PONDR® was provided by Molecular Kinetics
(6201 La Pas Trail - Ste 160, Indianapolis, IN 46268; 317-280-8737; E-mail:
main@molecularkinetics.com). VL-XT is copyright 1999 by the WSU Research
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Foundation, all rights reserved. PONDR® is copyrightc2004 by Molecular Kinetics, all
rights reserved.
Gel filtration chromatography. Gel filtration was performed using a 100 mL Superdex
75 column on an Akta FPLC system (GE Healthcare). One mL of protein solution was
injected; UmuD2 and UmuD' 2 were 5 jLM at injection. CD buffer described above was
used as running buffer. For denatured gel filtration, UmuD' 2, UmuD2, and each size
standard was denatured separately in CD buffer + 6 M guanidinium hydrochloride for 2
hours, centrifuged for 1 minute in a microcentrifuge at 14,000 rpm to pellet aggregates,
and injected as above. CD buffer + 6 M guanidinium hydrochloride was used for elution.
Native PAGE. Proteins were diluted into lx PAGE Loading Buffer lacking SDS (25 mM
Tris-HC1, pH 6.8, 5% glycerol, 0.1% bromphenol blue, 1 mM DTT), incubated for 30
min at 25 "C to promote heterodimer formation, and run at 20 V at 4 OC overnight.
Cross-linked UmuD(F94C)2 was diluted into lx PAGE Loading Buffer lacking both SDS
and DTT. Gels were soaked in 0.05% SDS for 30 min and stained with lx SYPRO
Orange (Molecular Probes) in 7.5% acetic acid after running. Ferguson plots were
calculated as described using 5 gLM UmuD2, UmuD'2, and UmuD'D [336].
Sedimentation Equilibrium. Experiments were performed on a Beckman Model XL-I
analytical ultracentrifuge at 20 oC. Proteins were dialyzed against 3 changes of 500 mL
CD buffer at 4 oC over 12 hours. The reference solution was the final dialysis buffer.
Protein gradients were monitored by interference. Each rotor speed was centrifuged for
12 hours to attain equilibrium, scanning every hour, and WinMatch software was used to
confirm that equilibrium had been reached. Rotor speeds were 16000, 20000, and 30000
rpm; the same protein samples experienced all three rotor speeds. Only the last scan for
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each speed was used in data analysis. Protein concentration was determined by direct
analysis of each sample after the last scan. Data analysis was performed using the
software WinNonlin.
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CHAPTER 5
CONCLUSIONS AND FUTURE DIRECTIONS
I have shown that umuD gene products are a new member of the family of
intrinsically disordered proteins, which lack a precise three-dimensional fold in vitro at
physiological concentrations but instead are made up of an ensemble of freely
exchanging conformations [153, 162, 163, 174, 325, 337, 338]. In one respect, this
characterization is completely consistent with previous literature. The mystery of how
such small proteins can be involved in such a diverse array of protein-protein contacts
can finally be explained by umuD gene products' high degree of flexibility. Many
intrinsically disordered proteins are thought to be able to use their flexible nature to make
a number of highly specific but low affinity interactions to effect diverse regulatory
processes [96, 120, 131, 135, 339]. UmuD shares qualities with other intrinsically
disordered proteins via its protease and regulatory activities and through its homology to
several dimeric transcription factors [168], although umuD gene products do not bind
DNA themselves [91, 340]. The primary structures of UmuD and UmuD' also share
similarities to other known intrinsically disordered proteins by virtue that they are small
proteins with repetitive sequences and have a pI value (pI = 4.5) is far from neutral [341].
However, one might not have predicted this intrinsically disordered
characterization outright because a wealth of structural information is already available
for umuD gene products. UmuD'2 has been crystallized [141, 342] and its structure
confirmed by NMR [142, 327], and although several attempts at high resolution structure
determination of UmuD2 have not yielded results, it is thought that UmuD2 is less flexible
in solution than UmuD'2 [100, 134]. This characterization is consistent with preliminary
data that suggest that polymeric crowding agents can induce a 13-sheet conformation in
UmuD2 but not in UmuD'2 (Chapter 4). Finally, a number of single and double-cysteine
studies suggest that, although they may be flexible in solution, both UmuD2 and UmuD'2
have defined homodimer interfaces and nonrandom structures in general [88, 134, 143,
144]. These studies, in conjunction with those presented in Chapter 4, may shed light on
the nonrandom characteristics of intrinsically disordered proteins. Preliminary results
show that the UmuD'D heterodimer, which is thermodynamically more stable than either
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UmuD 2 or UmuD' 2, is also disordered at 5 jiM, and its spectrum is very close to the
averaged spectra of UmuD and UmuD' (Figure 5-1, p. 15 3).
Because both UmuD2 and UmuD' 2 share the common feature of intrinsic disorder
at physiological concentrations and a more ordered structure at higher concentrations, the
differences between UmuD 2 and UmuD'2 have not been highlighted in this report. It
would be interesting in the future to study the differences between all three dimeric umuD
gene products and the underlying causes of these differences. Intrinsic disorder helps
explain how UmuD2 and UmuD'2 can make as many highly specific protein-protein
contacts as they do, but it remains a mystery how the relatively small change of removing
24 amino acids causes a large difference in preferences for different binding partners.
One possibility is that when the N-terminal arms of UmuD2 fold over the C-terminal
gobular domain, a binding interface on UmuD' 2 is obscured, and a new one is formed by
the arms. However, the fact that residues on the N-terminal arms of UmuD2 can form a
dimer interface [143] suggests that the N-terminal arms may not always obscure the C-
terminal globular domain (Figure 5-2, p. 154). In favor of this hypothesis, cross-linked
single-cysteine derivatives on the N-terminal arm of UmuD2 cannot undergo RecA*-
mediated cleavage, whereas cross-linked derivatives on the C-terminal globular domain
can [112], suggesting that the arms are far away from the active site in these cross-linked
conformations. Computational studies of the dynamics of UmuD2 conformational
exchange may be able to estimate the relevance of an "arms-up" conformation of UmuD 2
and test the hypothesis that differences in binding preference result from different binding
interfaces with and without the N-terminal arms.
Several biochemical differences between UmuD2 and UmuD'2 become evident
when working with these proteins. UmuD'2 purification generally results in a better yield
and cleaner protein than UmuD2 purification [317]. However, addition of a single
protein-protein interactor in stoichiometric quantities tends to cause aggregation of
UmuD'2 instead of the stable complex usually seen with UmuD2. Furthermore,
equilibrium guanidinium denaturation curves of UmuD2 and UmuD'2 at two different
protein concentrations differ (Figure 5-3, p. 156). Whereas the curves for UmuD' 2 are
offset relative to each other, confirming that denaturation is not a simple unimolecular
process
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Figure 5-1: CD spectrum of 10 pM UmuD'D.
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Figure 5-1: CD spectrum of 10 pM UmuD'D. The CD spectra of 5 p.M UmuD2 and 5
pM UmuD' 2 were added mathematically and are plotted as the gray line. The CD
spectrum of 10 p.M UmuD'D (5 pM UmuD2 and 5 ýpM UmuD' 2 combined) is plotted as
the black line. CD signal was measured at 1 nm intervals.
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Figure 5-2: A model for an alternate UmuD2 dimer interface
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Figure 5-2 (continued): A model for an alternate UmuD 2 dimer interface. (A) Single-
cysteine cross-linking studies have generally found that residues that are near the C2 axis
of symmetry in UmuD'2 [142] cross-link robustly as homodimers in UmuD2 (A
representative residue from [143] is shown in cartoon form). (B) Some residues that are
on the N-terminal arms also cross-link robustly even though they are predicted to be far
from the dimer interface (data from [143]). Based on our four proposed models of
UmuD2 [147], it is possible that the N-terminal arms may spend considerable time
between the cis and trans forms, forming a temporary dimer interface that would explain
the unexpected cross-linking results.
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Figure 5-3: Differences in equilibrium guanidinium denaturation activity of UmuD 2
and UmuD' 2
A
0.8
0.6
0.4
0.2
0.0
-0.2
-0.4
-0.6
0 1 2 3 4 5
[Guanidinium] (M)
156
Figure 5-3 (continued): Differences in equilibrium guanidinium denaturation activity
of UmuD 2 and UmuD' 2
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Figure 5-3: Differences in equilibrium guanidinium denaturation activity of UmuD 2
and UmuD' 2. (A) Guanidinium denaturation of UmuD'2 at 5 pM (black symbols) and 50
pM (white symbols). (B) Guanidinium denaturation of UmuD2 at 5 pM (black symbols)
and 50 1 M (white symbols).
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[343], those for full-length UmuD2 overlap almost completely. Nevertheless,
denaturation of UmuD2, like UmuD' 2, involves a dimer-to-monomer transition (Chapter
4). These differences in guanidinium denaturation behavior are not well understood but
may result from multiple distinct conformations of UmuD2 in solution [344], which have
been proposed to occur [147]. Experiments are currently underway in P.J. Beuning's lab
to further characterize this phenomenon.
The structure of the dimer interface of UmuD'D appears to be more similar to that
of UmuD2 than UmuD'2 [134]. It is likely that the heterodimer has many of the same
structural characteristics of the two homodimers (CD in Figure 5-1, p. 153, and native
PAGE in Chapter 4), but aside from studies of ClpXP [126, 127, 323, 328], functions and
characteristics of the thermodynamically most-stable [121] heterodimer are poorly
understood. Given its similarity to UmuD2 and UmuD'2, the heterodimer may make
many more protein-protein contacts than is currently known, and it may have other
important roles in regulating the timing of the SOS response than are currently
appreciated. In fact, UmuD'D is known to bind DinB (V. Godoy and D. Jarosz, personal
communication), although its interaction with UmuC results in aggregation [128].
The concept of an intrinsically disordered protein that has a stable quaternary
structure is counterintuitive to the current protein folding paradigm, where primary
structure dictates secondary structure, which is required for tertiary structure and finally
quaternary structure [162]. However, there are known examples of dimeric proteins that
are either characterized as intrinsically disordered (such as HPV protein E7 [2]) or
otherwise exhibit substantial flexibility (E. coli MazE [219] and the histone-like proteins
HU-a and HU-03 [222]), showing that exceptions to the ordered protein folding paradigm
are already known.
It is likely that the paradoxical of a dimeric intrinsically disordered protein stems
from a general lack of understanding about the actual structures of intrinsically disorderd
proteins. In fact, many of these proteins have nonrandom structures [174], and just as
there are several types of rigid secondary structure, three types of disorder have been
proposed [178]. Disordered regions can also be highly conserved [163], although it has
also been proposed that intrinsically disordered proteins might have evolved through their
ability to perform a function while maintaining a flexible structure that is resistant to
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mutation [191]. Point mutations in umuD gene products, however, may not favor the
latter hypothesis. Almost every point mutation that has been made for umuD gene
products, including very conservative ones, disrupts at least one of its functions
(Appendix II). Furthermore, umuD gene products do appear to be highly conserved,
including in Pelagibacter ubique, the bacterium with the smallest known genome to date
[137].
Products of umuD share homology to the dimerization domains of certain
transcription factors, proteins that are more likely than many others to be intrinsically
disordered [168]. However, it is usually the DNA-binding or protein-protein interaction
domains of transcription factors that are intrinsically disordered, not their dimerization
domains. LexA2, the transcription factor most homologous to umuD [91], is nevertheless
relatively well folded in vitro [345]. However, once its N-terminal domain is removed,
the C-terminus, which has the most homology to UmuD', tends to aggregate, consistent
with the notion that it, like UmuD' may not have its own stable fold in vitro (R. Mohana-
Borges, personal communication). The C-terminal domain of LexA is rapidly degraded
in vivo, preventing aggregation inside the cell [87]. Additionally, X-ray crystallography
of LexA2 shows substantial disorder in one of the two monomers of the dimeric unit
[146]. Furthermore, the C-terminal domain of the X CI repressor protein, which has
homology to LexA, unfolds at a higher temperature than the N-terminal domain [82],
consistent with disordered protein segments [159].
Examples of dimeric transcription factors with intrinsically disordered domains
include the viral Tax protein [188] and the bacterial ParG required for plasmid separation
[346, 347]. In both of these cases, individual domains have been studied and classified as
intrinsically disordered. The well-structured dimerization domain is removed for these
studies, similarly to how poorly folded domains are often removed for crystallization.
Our current model for the functions of umuD gene products is that they act as
interchangeable protein-protein interaction domains for the two E. coli Y-family DNA
polymerases (Chapter 4), whereas Y family DNA polymerases in eukaryotes tend to have
protein-protein interaction domains that are contiguous with the catalytic domain [334].
In E. coli, the constitutively-expressed DNA Pol I, involved in error-free DNA repair
processes, does not interact with umuD gene products and has a contiguous intrinsically
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disordered domain [348]. E. coli DNA Pol III, the replicative polymerase, also has an
extended C-terminal region that was removed to allow crystallography [34].
Intrinsically disordered proteins have been further classified into more-
unstructured "coil-like" proteins and intermediate "premoltenglobule-like" proteins based
on the ratio of their CD signals at 200 nm (indicative of disorder) vs 222 nm (indicative
of rigid secondary structure) [187]. UmuD2 and UmuD' 2, have CD spectra more
consistent with the intermediate premoltenglobule-like intrinsically disordered proteins,
as might be predicted due to their stable quaternary structures. This is also true of HPV
protein E7, which is another dimeric intrinsically disordered protein [2], and human a-
synuclein, which has some primary structural similarity to UmuD (Figure 1-1) [159].
It is not certain how much rigid secondary structure, if any, must be present for a
protein to form a stable dimer. However, studies of the type II restriction endonuclease
EcoRV may provide a clue [335]. Several crystal structures of this protein have been
solved under many conditions, showing that despite massive domain rearrangements that
depend on crystallization conditions, the dimer interface remains constant. The dimer
interface represents about 10% of the protein's size, suggesting that as little as 10% of a
protein must be rigid in order to maintain dimerization; the rest of the protein may be free
to move about independently. The dimer interfaces of UmuD2 and UmuD' 2 make up
more than 10% of these proteins, but even if they are rigid under all circumstances, the
dimer interfaces may not significantly contribute to an otherwise random coil CD
spectrum. Alternatively, dimerization may not always require recognizable a-helix or f3-
sheet structures for stabilization. As an example, the T7 gene 2.5 protein is a well-folded
dimer, but the dimer interface is composed mostly of loops [349].
One aspect of umuD gene products that has not been studied in detail yet is the
wealth of UmuD variants that appear to be deficient in dimerization, particularly mutants
at the dimer interface [143, 145, 350]. Some of these proteins, though not all, are less
stable than wild-type UmuD in vivo [145, 350]. If the monomer of UmuD or UmuD' is
even structured than the dimer, it would be an ideal substrate for rapid proteolysis in vivo
[160, 163, 174]. It would be interesting to characterize the proteins that are stable and yet
apparently deficient in homodimerization. They may be stabilized by other protein-
protein contacts even in the monomeric form, either by enabling an otherwise inefficient
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dimerization or simply through binding as a monomer. Protein-protein contacts
involving RecA are already known to stabilize UmuD' 2 in vivo [351]. Alternatively, even
a monomeric UmuD, though rare, may have enough nonrandom structure to be protected
from proteolysis.
It is not known if umuD gene products are unfolded under cellular conditions as
they are in vitro. Increased folding in vivo seems likely, since the cellular environment
both is more crowded and contains a number of proteins with which umuD gene products
interact. UmuD and UmuD' activity assays, including primer extension, RecA*-mediated
autocleavage, and ClpXP proteolysis, almost invariably involve interactions with one or
more additional proteins (the exception is base-catalyzed autocleavage of UmuD2, which
is an excessively slow in vitro reaction) [317]. Additionally, the cellular environment is
crowded with macromolecules, and certain crowding agents have an effect on both
UmuD2 and UmuD'2 (Chapter 4). Therefore, even in the absence of protein-protein
interactions, UmuD2 and UmuD'2 may adopt a better defined structure in vivo than at
physiological concentrations in vitro. A small group of scientists has proposed more
emphasis on biochemical studies in the presence of crowding agents rather than in simple
aqueous solution, as cellular crowding may have important effects on proteins that
biochemical researchers are missing [213].
Since umuD gene products are likely to be highly flexible, how relevant are the
X-ray and NMR structures of UmuD'2 [141, 142] and the models of UmuD2 [134, 147]?
It is likely that they have some relevance in vivo, since the two high resolution structures
both agree on several aspects of the protein fold (it is dimeric, it is largely a 3-sheet, and
the regions of a-helicity are in the same locations), and the X-ray crystal structure shows
the known active site residues in a conformation that is poised for catalysis [141]. Under
conditions used to solve the NMR structure of UmuD'2 [142], even the full-length
UmuD2 protein, whose structure has not been solved, shows a signal that is consistent
with the expected P-sheet [134, 147]. Additionally, both the high-resolution structures
[141, 142] and the models [134, 147] are consistent with the single-cysteine data [88,
134, 143, 144]. Although the crystallography and NMR studies were performed at
protein concentrations that are much higher than are physiologically relevant [77, 141,
142], macromolecular crowding by high concentrations of protein may mimic in vivo
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conditions in a way that in vitro experiments at physiologically relevant concentrations
do not [213, 214].
An interesting characteristic of UmuD2 is that, although it is not strictly an
enzyme [92], it does have proteolyic activity [101-103]. However, in contrast to most
metabolic enzymes, and even relative to other similar autocleavage proteins, this activity
is not very fast [113]. Many proteases are intrinsically disordered, and some of them rely
on this disorder to accept a wide range of substrates [163]. Disorder may help UmuD2
regulate the timing of its transition to UmuD' 2 by undergoing efficient cleavage only in
the presence of RecA* [142]. However, disorder may also play a role in allowing
efficient cleavage. At low concentrations wherein umuD gene products are more
disordered than at high concentrations, more spontaneous UmuD' reproducibly forms
during native gel electrophoresis (Chapter 4). It is possible that some of the more ordered
forms present at higher protein concentrations are less likely to undergo spontaneous
cleavage.
One explanation for why UmuD conversion to UmuD' may appear inefficient in
vivo is that low levels of UmuD' may be present mostly in the UmuD'D heterodimer,
which would rapidly be degraded by ClpXP [323]. Heterodimer formation at the
beginning of the SOS response may occur through subunit exchange [121], or it is
possible that the initial product of UmuD 2 cleavage is the UmuD'D heterodimer rather
than UmuD'2. An intriguing result is that a UmuD variant, UmuD(C24A), that has been
shown to undergo RecA*-mediated cleavage more quickly than wild-type [112] has a
defect in in vivo mutagenesis (Appendix II), suggesting a role of intact UmuD2 in
mutagenesis. This result is dependent on the wild-type promoter sequence for reasons
that are not yet understood (Appendix II). Additionally, a AclpXP strain is nonmutable,
as would not be expected given the role ClpXP has in ending the mutagenic phase of the
SOS response [126], and Lon protease that degrades UmuD 2 does not appear to
efficiently degrade UmuD'D heterodimers [323]. It is possible that, ifUmuD'D is the
immediate product of UmuD2 cleavage, UmuD2 may also serve as a competitive substrate
for ClpXP [127], protecting a subset of UmuD'D until it can form the mutagenically
active UmuD'2 [93].
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It is uncertain whether multiple protein-protein interactions with umuD gene
products do, or even can, happen simultaneously. Even though they can participate in a
relatively large number of protein-protein interactions, umuD gene products are small
proteins. Therefore, unless each of the interactions took up only a very small amount of
surface space and did not occlude nearby binding sites by steric hindrance, there cannot
be more than a few distinct simultaneous protein-protein interactions with umuD gene
products.
However, UmuD' 2 is symmetrical except for the highly unstructured N-terminal
15 amino acids [142], and it is quite possible that UmuD2 may also be symmetrical [134,
147]. Most of the known interaction partners are asymmetrical. Presumably an identical
surface interface is available for a protein-protein interaction on each side of the dimer.
In the case of the interactions between UmuD2 and DinB or the 3 processivity subunit of
Pol III, all three proteins interact with each other, and the predicted binding sites do not
overlap to a great extent (Chapter 4). It is possible that all three proteins are in contact
with each other at the same time, at least transiently. The different affinities between
UmuD2 and DinB or 0 suggest that there may be an order of addition effect such that
UmuD2 binds DinB first, exposing a binding site for 1 on UmuD2. Alternatively, DinB
and p may already be in a complex before binding to UmuD2, facilitating UmuD2's
interaction with 3.
Modern biophysical techniques allow determination of detailed, high-resolution
protein structures, but the prevalence of intrinsically disordered proteins (an estimated
60% of eukaryotic proteins and 10-30% of prokaryotic ones) may illustrate the limits of
this type of focus. Currently, high-resolution structural data are only available for a
subset of proteins, mostly enzymes that make up much but certainly not all of the
proteome [162]. Although certain membrane proteins have recently been crystallized,
they, like intrinsically disordered proteins, remain technically difficult [352, 353]. Even
as structure-determination technology improves on a daily basis, concerns as to the
relevance of structures gathered at such high homogenous protein concentrations and the
current technical limitations ensure that other methods of studying and computing protein
structure, dynamics, function, and mechanistic details will be important to capture the full
essence of proteins and their genetic and biochemical interactions. In the case of the
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structures of UmuD'2, two possible dimer interfaces were seen in the X-ray crystal
structure [141], and NMR and biochemical studies were necessary to determine the
correct dimer interface [88, 134, 142-144, 327]. As is becoming increasingly obvious,
interdisciplinary approaches to problem-solving are necessary to give the most complete
answers to biological questions.
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APPENDIX I
Characterization of Escherichia coli
Translesion Synthesis Polymerases
and their Accessory Factors
Published as part of: Beuning, P.J., Simon, S.M., Godoy, V.G., Jarosz, D.F., and Walker, G.C.
"Characterization of Escherichia coli Translesion Synthesis Polymerases and their Accessory
Factors." Methods in Enzymology Volume 408 (2006) p. 318-340.
Only sections to which S.M. Simon contributed significantly are included.
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ABSTRACT
Members of the Y family of DNA polymerases are specialized to replicate lesion-containing
DNA. However, they lack 3'-5' exonuclease activity and have reduced fidelity compared to
replicative polymerases when copying undamaged templates, and thus are potentially mutagenic.
Y family polymerases must be tightly regulated to prevent aberrant mutations on undamaged
DNA while permitting replication only under conditions of DNA damage. These polymerases
provide a mechanism of DNA damage tolerance, confer cellular resistance to a variety of DNA-
damaging agents, and have been implicated in bacterial persistence. The Y family polymerases
are represented in all domains of life. Escherichia coli possesses two members of the Y family,
DNA pol IV (DinB) and DNA pol V (UmuD' 2C), and several regulatory factors, including those
encoded by the umuD gene that influence the activity of UmuC. This chapter outlines procedures
for in vivo and in vitro analysis of these proteins. Study of the E. coli Y family polymerases and
their accessory factors is important for understanding the broad principles of DNA damage
tolerance and mechanisms of mutagenesis throughout evolution. Furthermore, study of these
enzymes and their role in stress-induced mutagenesis may also give insight into a variety of
phenomena, including the growing problem of bacterial antibiotic resistance.
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Purification and Characterization of umuD Gene Products
Expression and Purification of UmuD and UmuD'
Expression and purification of the umuD gene products have been typically accomplished
using umuD' E. coli strain BL21(DE3) harboring a umuD expression plasmid. Unfortunately, a
drawback of the use of this strain for the preparation of UmuD variants is that some
contaminating wild-type protein will be present due to expression from the chromosomal copy of
the gene. Therefore, a chloramphenicol-resistant AumuDC derivative of E. coli BL21 was
constructed by P1 transduction from GW8017 [144, 354, 355]. UmuD and UmuD' expression
plasmids, pSG5 and pSG4, respectively, are based on pETI It [356] and were constructed from
pMAD (UmuD) or pMADp (UmuD'), respectively [357]. An Ndel site was added 5' of the umuD
gene in pMAD or the umuD' gene in pMADp, by site-directed mutagenesis, and the Ndel-BamHI
fragment was ligated into the NdeI-BamHI linearized pETI It. The integrity of the construct was
confirmed by sequencing. Colony-dependent variation in expression has been observed in our
laboratory when using the pETI It expression plasmid so several colonies are routinely screened
for efficient overexpression.
The major advantage of this purification protocol over those published previously [102,
143, 327] is the use of fast flow FPLC columns, reducing purification time greatly. Using a single
FPLC, two UmuD variants can be purified simultaneously, with one preparation on the
instrument while the other is assayed. One should allow two consecutive days after growth,
induction, and harvesting for the preparation of UmuD proteins.
Transformed BL2I(DE3) AumuDC are grown at 370C in LB medium or M9 medium
[358] supplemented with 100 gg/ml ampicillin in baffled flasks until an OD 600 of 0.6 to 0.8 is
reached. Isopropyl-j3-D-thiogalactoside (IPTG) is added to 1 mM, at which time the culture is
transferred to 300C for 3-4 h. Cells are harvested by centrifugation at 5000g for 30 min and
resuspended in 15 ml lysis buffer (50 mM Tris-HCI, pH 8.0, 2 mM EDTA) per liter of culture.
After resuspension, cells can be frozen dropwise in liquid nitrogen and stored at -800C
indefinitely or can be lysed immediately. Typically, protein from 2 to 4 liters of culture is purified
at once.
Frozen cells are thawed on ice overnight at 40 C. All subsequent steps are performed at 40
C. Cell lysis is accomplished by two passages at 10 kpsi through a French press (Thermo
Spectronic) or via sonication at 50% output with alternating 15-s bursts followed by 15-s rest
periods for 3-4 min. After lysis, cell debris is pelleted by centrifugation at 14,000g for 30 min.
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The first ammonium sulfate precipitation of the supernatant is to 20% saturation (0.121 g/ml).
The precipitate is removed by centrifugation at 14,000g for 30 min, and the supernatant is
subjected to a second ammonium sulfate precipitation, this time adding ammonium sulfate to
40% saturation (0.151 g/ml). Centrifugation is the same as for the first ammonium sulfate
precipitation, but the pellet is retained. The pellet itself may be stored on ice overnight. However,
once chromatography is started, it must be completed within the same day, as either extensive
storage at 40C or freezing and thawing results in a loss of yield.
The pellet is resuspended in 50% PSA (10 mM sodium phosphate, pH 6.8, 0.1 mM
EDTA, 1 mM dithiothreitol [DTT], 1 M [NH 4 12SO4) and 50% PSB (10 mM sodium phosphate,
pH 6.8, 0.1 mM EDTA, I mM DTT) plus one Complete, EDTA-free protease inhibitor cocktail
tablet (Roche Molecular Biochemicals), until there is no visible debris (about 10 ml per liter
original culture). The sample is centrifuged at 14,000g for 30 min to pellet remaining debris and
then filtered through a 0.25-jim Millex GV syringe filter. The filtered sample is loaded onto a
HiTrap fast flow, low substitution phenyl-Sepharose column (GE Healthcare) preequilibrated
with PSA. The protein is eluted with a gradient of 0-100% PSB over 5 column volumes at a flow
rate of 5 mI/min. Fractions are collected at the end of the gradient, after 80% PSB is reached, and
during a 2 column volume wash with PSB. UmuD proteins will elute as the last peak, starting at
100% PSB. Aliquots (10 [l) of each fraction are assayed by 14% SDS-PAGE and stained with
Coomassie blue.
Fractions that contain UmuD are pooled and applied to a HiTrap fast flow Q-Sepharose
column (GE Healthcare) equilibrated with QA (10 mM sodium phosphate, pH 6.8, 0.1 mM
EDTA, 1 mM DTT, 100 mM NaCI). The protein is eluted with a gradient of 0-100% QB (10 mM
sodium phosphate, pH 6.8, 0.1 mM EDTA, 1 mM DTT, 1 M NaCl) over 10 column volumes at a
flow rate of 5 ml/min. UmuD elutes at approximately 400 mM NaCI. Fractions are analyzed by
SDS-PAGE.
Fractions chosen for further purification are concentrated using spin concentrators with a
5-kDa molecular weight cutoff membrane (VivaSpin) to 1-3% of the volume of a Superdex 75
gel filtration column (GE Healthcare). After concentration, the sample is filtered through a Millex
GV syringe filter before injection onto the column. The column is run isocratically at 1.5 ml/min
with buffer QA. UmuD elutes as the last peak. Fractions are analyzed for purity by SDS-PAGE.
Fractions with pure UmuD are pooled, concentrated to 0.1-4 mM, and flash frozen in liquid N2 in
conveniently sized aliquots. The purified proteins are stored at -800 C, and once an aliquot is
thawed, it should be used the same day. The protein is more stable when concentrated than when
left dilute after purification. Each liter of induced BL2I(DE3) will yield 10-20 mg protein. Both
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UmuD2 and UmuD' 2 can be purified with this protocol, although purifying UmuD' 2 will tend to
result in higher yields than UmuD 2.
ClpXP Degradation Assay
UmuD and UmuD' exist in three dimeric species: UmuD2 or UmuD' 2 homodimers or the
most thermodynamically stable UmuD'D heterodimer [121, 143, 339]. When UmuD2 or UmuD' 2
homodimers are coincubated in vitro at 250 C in equal concentration, the only dimeric species
detectable after 30 min is the UmuD'D heterodimer [121]. In this context, the purified ClpXP
protease will specifically target the UmuD' partner of the heterodimer for degradation in the
presence of ATP [328].
This assay allows for evaluation of the ability of a protein to act as either a substrate of
ClpXP degradation, as do UmuD' and UmuD, or an adaptor protein delivering substrates to
CIpXP, as does UmuD [127]. It is important when making these comparisons that a wild-type
UmuD'D control is included in each assay, as the extent of UmuD' degradation can vary with
ClpXP preparation and length of storage.
ClpX and ClpP were a gift from Professor Tania Baker at MIT [127, 359]. UmuD'D is
formed by coincubating 4.5 gtM UmuD 2 and 4.5 gIM UmuD' 2 with 0.8 RLM CIpP 14 in 50 mM Tris-
HCI, pH 8.0, 100 mM KCI, 10 mM MgCl2, 1 mM DTT at 300 C in 38-pl reactions for 30 min. A
2-pl aliquot of 20x ATP regeneration mix [50 mM creatine phosphate, 1 mg/ml rabbit muscle
creatine kinase (both from Sigma-Aldrich), and 80 mM ATP] is added. The reaction is initiated
with addition of ClpX6 to 0.3 gLM. At this point, a 20-~l aliquot of the reaction is removed and
quenched with 5 gl 4x SDS-PAGE loading buffer as a t = 0 control. The quenched reaction is
flash frozen in liquid N2 and stored at -20 0C until analysis. The remaining reaction is incubated at
300 C for a given time, at which point it is quenched and frozen as described earlier. Typically, the
reaction is complete after 2 h.
Samples are boiled 2 to 3 min and analyzed by 14% SDS-PAGE. Due to the small
molecular weight difference between UmuD and UmuD', the gel must be run to completion to
resolve both species. The gel is stained with SYPRO Orange (Molecular Probes), and
UmuD/UmuD' are visualized and quantitated by phosphorimager and ImageQuant software (GE
Healthcare). It is possible that UmuD bands will become fainter over the time course of the
reaction as well, as ClpXP will degrade one UmuD in the context of the homodimer in the
absence of the UmuD'D heterodimer (Figure AI-2, p. 170) [127].
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Figure AI-2
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FIG. 2. (A) In vitro RecA/ssDNA filament-facilitated cleavage of UmuD. Lane 1, -RecA;
lane 2, 1 RecA I -::-: 1 h. A small amount of autocleavage is observed in lane 1. Unlabeled bands
are impurities in the UmuD preparation. (B) In vitro ClpXP proteolysis of wild-type UmuD'
with wild-type UJmuD as adaptor protein. Lane 1, =- 0: lane 2, 1 - 2 h.
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Using Intrinsic Tryptophan Fluorescence to Determine Binding Constants between UmuD
Proteins and Their Interaction Partners
Dimeric forms of the UmuD proteins interact with a variety of other E. coli proteins [75,
109, 120, 131, 287, 328, 339, 340, 360, 361]. Although the interactions made with UmuD 2 or
with UmuD' 2 largely overlap, some differ in magnitude [131, 330] or result in different effects on
the interacting protein. Namely, UmuD'2 activates UmuC as a translesion polymerase [75, 108,
109, 357], while UmuD 2C is involved in a DNA damage checkpoint [97, 100]. In an effort to gain
insight into the myriad roles that the different forms of the UmuD protein play in regulation of the
E. coli SOS response, it is important to quantitate the affinity of the dimeric UmuD proteins for
their interactors.
Because UmuD has no tryptophan, binding of UmuD proteins to most other proteins will
not contribute significantly to the overall emission spectrum of the complex. Samples are
prepared in 50 mM HEPES, pH 7.5, 0.1 mM EDTA, 100 mM NaCI. Unless there is danger of
aberrant disulfide bond formation, no reductant is added due to the intrinsic fluorescence of DTT
and the high volatility of 3-ME. To measure the effect of UmuD binding on the intrinsic
tryptophan fluorescence of other proteins, the tryptophan-containing protein should be kept at a
convenient concentration (on the order of 5 igM), while the concentration of the interacting
UmuD protein can be varied from 0 to 200 liM or more, if necessary. A separate sample of
UmuD at the same concentration is made in the absence of an interactor. The fluorescence of
UmuD alone is subtracted from the spectrum of the combined proteins to eliminate noise from the
aromatic residues in UmuD. For each binding curve, the fluorescence from a sample of the
interacting partner in the absence of UmuD is made as a starting point.
Samples with more than one protein present are preincubated at room temperature for 2 h
prior to data collection in order to allow the protein complex to reach equilibrium. The samples
are excited at either 278 nm for measurement of all aromatic residues or at 295 nm to selectively
excite tryptophan. Emission is measured from 300 to 400 nm. To ensure that the complex has
reached equilibrium, the emission spectrum is acquired at additional 1- to 2-h intervals until no
change in the spectrum is observed.
The center of spectral mass E(xxl1)/)li is calculated for each sample, where A is the
wavelength in nanometers and I is the intensity in arbitrary units for each step i. The center of
spectral mass is plotted vs. [UmuD], and the plot is fit to:
obs= [2 1 [(Co+D+KD)-((Co+DKD)2-4CoxD)o 5]]/(2Co)
171
[362], where Aobs is the variable center of spectral mass at UmuD protein concentration D, with lo
as Lobs at D = 0, and Co is the fixed concentration of interacting protein.
If UmuD'D is tested, an additional step is required to generate UmuD'D from purified
UmuD and UmuD'. The two proteins are mixed in equimolar concentrations and are allowed to
equilibrate for 30 min at room temperature before addition of the interacting protein.
Conclusions
We have illustrated common techniques for in vivo and in vitro analysis of Y family
polymerases from E. coli. The experiments described here lend insight into the functions of these
specialized polymerases and their accessory factors in cellular survival and mutagenesis. Major
unanswered questions about these polymerases include detailed methods of regulation, especially
temporal control of activity and polymerase switching according to specific lesions. Further
characterization will undoubtedly continue to address these questions and reveal the properties of
the Y family polymerases and their accessory factors.
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APPENDIX II
Mutations in
umuD Gene Products
and Their Resultant Phenotypes
173
Residue # Side Chain Observations
1 M
2 L
3 F
4 I
5 K
6 P
7 A
8 D UmuDA2-8 cannot target UmuD' for ClpXP proteolysis; it
can be targeted for proteolysis but not as well as UmuD'
(Figure All-1, p. 175). The defect may be in
heterodimerization or in recognition.
9 L Implicated in targeting UmuD' for proteolysis by ClpXP but
not by Lon [127, 328, 363]. UmuD L9A R10A EllA I12A
is proficient for RecA cleavage and has greater stability in
vivo than wild-type UmuD [328]; it has greater than wild-
type in vivo mutagenesis activity [363].
10 R Implicated in targeting UmuD' for proteolysis by ClpXP but
not by Lon [127, 328, 363]. UmuD L9A R10A EllA Il2A
is proficient for RecA cleavage and has greater stability in
vivo than wild-type UmuD [328]; it has greater than wild-
type in vivo mutagenesis activity [363].
11 E Implicated in targeting UmuD' for proteolysis by ClpXP but
not by Lon [127, 328, 363]. UmuD L9A R10A E11A I12A
is proficient for RecA cleavage and has greater stability in
vivo than wild-type UmuD [328]; it has greater than wild-
type in vivo mutagenesis activity [363]. UmuD El 1V I12V
V13K is more efficient than wild-type UmuD at targeting
UmuD' for ClpXP-mediated proteolysis [127].
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Figure AII-1
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Figure legend: ClpXP proteolysis of UmuDA2-8. (A) Gel of proteolysis reactions. Lanes
are: (1) wild-type UmuD and UmuD', no ClpXP, t = 0 (2) wild-type UmuD and UmuD',
no ClpXP, t = 2 hr (3) wild-type UmuD and UmuD', + ClpXP, t = 0 (4) wild-type UmuD
and UmuD', + ClpXP, t = 2 hr (5) UmuDA2-8 and UmuD', no ClpXP, t = 0 (6) UmuDA2-
8 and UmuD', no ClpXP, t = 2 hr (7) UmuDA2-8 and UmuD', + ClpXP, t = 0 (8)
UmuDA2-8 and UmuD', + ClpXP, t = 2 hr (9) wild-type UmuD and UmuDA2-8, no
ClpXP, t = 0 (10) wild-type UmuD and UmuDA2-8, no ClpXP, t = 2 hr (11) wild-type
UmuD and UmuDA2-8, + ClpXP, t = 0 (12) wild-type UmuD and UmuDA2-8, + ClpXP,
t = 2 hr. (B-D) Density scan of the lower bands of +ClpXP lanes in the gel in (A). In
each case, t = 0 is on the left; t = 2 hr is on the right. (B) Wild-type UmuD and UmuD'.
(C) UmuDA2-8 and UmuD'. (D) Wild-type UmuD and UmuDA2-8. Procedure is in
[317].
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12 I Implicated in targeting UmuD' for proteolysis by ClpXP but
not by Lon [127, 328, 363]. UmuD L9A R1OA E11A I12A
is proficient for RecA cleavage and has greater stability in
vivo than wild-type UmuD [328]. it has greater than wild-
type in vivo mutagenesis activity [363]. UmuD El 1V I112V
V13K is more efficient than wild-type UmuD at targeting
UmuD' for ClpXP-mediated proteolysis [127].
13 V UmuD E11V 112V V13K is more efficient than wild-type
UmuD at targeting UmuD' for ClpXP-mediated proteolysis
[127].
14 T
15 F Implicated in targeting UmuD for proteolysis by Lon
protease [363]. UmuD F15A P16A L17A F18A is
noncleavable and nonmutable in vivo [363].
16 P Implicated in targeting UmuD for proteolysis by Lon
protease [363]. UmuD F15A P16A L17A F18A is
noncleavable and nonmutable in vivo [363].
17 L Implicated in targeting UmuD for proteolysis by Lon
protease [363]. UmuD F15A P16A L17A F18A is
noncleavable and nonmutable in vivo [363].
18 F Implicated in targeting UmuD for proteolysis by Lon
protease [363]. UmuD F15A P16A L17A F18A is
noncleavable and nonmutable in vivo [363].
19 S Mutation to Cysteine in UmuD has a defect in mutagenesis
and RecA* cleavage [143]. The corresponding residue in
LexA also has a RecA*-cleavage defect [364, 365]. Single
cysteine at this position is moderately solvent accessible;
cross-links as UmuD2 poorly with iodine, robustly with
BMH, and only moderately with Cu phenanthroline [143].
Extent of single-cysteine Cu phenanthroline cross-linking as
UmuD2 does not depend on protein concentration [143].
Single-cysteine mutant cross-links as UmuD2 moderately by
dialyzing out DTT [144]. A single-cysteine variant of
UmuD2 at this position cross-links poorly to RecA* [88,
112]. Single cysteine derivative of UmuD at this position
cross-links as UmuD 2 moderately with AIA [88]. UmuD
S19C C24A does not cross-link efficiently to P3 [330].
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20 D UmuD D20C C24A F94C forms poor covalent iodine-
induced cross-links [134]. Interestingly, two dimers form,
presumably one with two disulfide bonds and one with only
one [134]. UmuD D20C has wild-type or greater UV-
mutagenesis activity (Figure AII-2, p. 178).
21 L UmuD L21C has wild-type or greater UV-mutagenesis
activity (Figure AII-2, p.178).
22 V UmuD V22C C24A F94C robustly forms iodine-induced
cross-links to homodimer [134]. Interestingly, two dimers
form, presumably one with two disulfide bonds and one with
only one [134].
23 Q ClpXP degradation of UmuD2 results in cleavage after this
residue [127].
24 C Mutation to Alanine in UmuD gives a slight hypermutable
phenotype when under control of T7 promoter [143]. C24A
has normal extent of glutaraldehyde cross-linking to UmuD2
[143]. Position is relatively solvent accessible; cross-links as
UmuD2 well with iodine and moderately with BMH or Cu
phenanthroline [143]. Extent of Cu phenanthroline cross-
linking as UmuD2 does not depend on protein concentration
[143]. This cleavage site position is usually an alanine in
other RecA*-dependent autocleavage enzymes, but the
bacteriophage 080 repressor also has a cysteine in the wild-
type sequence [143]. Single-cysteine at this site (wild-type
UmuD) cross-links as UmuD2 moderately well by dialyzing
out DTT [144]. UmuD C24A undergoes RecA* cleavage to
form UmuD' more efficiently than wild-type UmuD [112].
Although in "data not shown" it is suggested that UmuD
C24A does not undergo Cu phenanthroline-catalyzed
formation of UmuD2, cleavage of UmuD C24A is inhibited
by treatment with Cu phenanthroline [112]. Wild-type
UmuD2 disulfide cross-linked at C24 is unable to undergo in
vitro RecA* cleavage in the absence of reductant [ 112].
Wild-type UmuD2 is unable to cross-link to RecA*,
suggesting that RecA* is not the enzyme in the cleavage
reaction but merely a facilitator; also cross-links robustly as
UmuD2 by AIA [88]. When expressed from a low-copy
plasmid under control of the native promoter, UmuD C24A
causes UV-induced mutation frequency intermediate between
wild-type and non-cleavable UmuD (Figure AII-3, p. 179).
However, when expressed from a constitutive promoter,
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Figure AII-2
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Figure Legend: ArgE3 reversion assay was performed as described at 25 J/m 2 [317],
using bacterial strain GW8017 and plasmids pSE 101 (empty vector), pSE 115 (positive
control), pSE115 D20C, pSE 15 L21C, pSE115 F26C, pSE115 S28C, pSE115 E93C,
and pSE115 S115C.
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Figure Legend: ArgE3 reversion assay was performed as described at 25 J/m2 [317],
using bacterial strain GW8017 and plasmids pSE 101 (empty vector), pSE 115 (positive
control), pSE 115 C24A, and pSE115 S60A.
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UmuD C24A has wild-type activity (Jamie Foti, personal
communication). UmuD cross-links robustly to P3 through
amino acid C24 [330].
25 G
26 F UmuD C24A F26C F94C form iodine-induced cross-links
very poorly [134]. Interestingly, two dimers form,
presumably one with two disulfide bonds and one with only
one [134]. UmuD F26C has somewhat reduced UV-
mutagenesis activity compared to wild-type (Figure AII-2,
p. 178). Part of a secondary site for Lon proteolysis [363].
UmuD F26A P27A S28A P29A is deficient in cleavage by
recA 730 [328] and in vivo mutagenesis activity [363].
27 P P at this position is conserved among UmuD-like proteins,
but not among structural homologs [125, 366]. S at this
position blocks cleavage when expressed as full-length
UmuD [121, 367, 368]. S mutation slightly diminishes
steady-state levels when expressed as UmuD' and reduces
MMS and spontaneous mutagenesis to a similar extent (about
50%) [350]. Part of a secondary site for Lon proteolysis
[363]. UmuD F26A P27A S28A P29A is deficient in
cleavage by recA 730 [328] and in vivo mutagenesis activity
[363]. UmuD P27S is not degraded by ClpXP, and
UmuD(P27S) in the context of UmuD(P27S)UmuD' is not
degraded by Lon (the relevance of the Lon data to the wild-
type situation is unknown) [126, 323].
28 S UmuD C24A S28C F94C cross-links as a homodimer
moderately efficiently [134]. Interestingly, two dimers form,
presumably one with two disulfide bonds and one with only
one [134]. UmuD S28C has somewhat reduced UV-
mutagenesis activity compared to wild-type (Figure AII-2,
p. 178). Part of a secondary site for Lon proteolysis [363].
UmuD F26A P27A S28A P29A is deficient in cleavage by
recA 730 [328] and in vivo mutagenesis activity [363].
29 P Part of a secondary site for Lon proteolysis [363]. UmuD
F26A P27A S28A P29A is deficient in cleavage by recA 730
[328] and in vivo mutagenesis activity [363].
30 A May be involved in RecA* interaction [143]. Mutations in
the corresponding region in ,CI protein were found to lower
RecA*-mediated cleavage but not base-induced self-cleavage
[369]. Single cysteine at this position in UmuD2 is hardly
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impaired at all for UV mutagenesis or RecA* cleavage;
cross-links as UmuD2 moderately with iodine and well with
Cu phenanthroline [144]. Position is solvent-accessibile
[144]. Single-cysteine mutant cross-links as UmuD2 very
well by dialyzing out DTT [144]. UmuD' E30V is defective
in UV and MMS-induced mutagenesis, but it is not dominant
negative to chromosomal umuD + [145]. Protein levels of
UmuD' E30V are at least as high as wild-type UmuD' when
expressed constitutively, but there may be a slight defect in in
vivo formaldehyde cross-linking to UmuD'2 [145].
31 A Single cysteine at this position in UmuD2 is impaired for UV
mutagenesis but not RecA* cleavage; cross-links as UmuD 2
moderately with both iodine and Cu phenanthroline [144].
Position is solvent-accessibile [144]. Single-cysteine mutant
cross-links as UmuD2 moderately well by dialyzing out DTT
[144].
32 D Single cysteine at this position in UmuD2 is very impaired in
both UV mutagenesis and RecA* cleavage; cross-links as
UmuD2 poorly with iodine and moderately with Cu
phenanthroline [144]. Position is moderately solvent-
accessible [144]. Single-cysteine mutant cross-links as
UmuD2 moderately by dialyzing out DTT [144].
33 Y Single cysteine at this position in UmuD2 is impaired in both
UV mutagenesis and RecA* cleavage, but the RecA*
cleavage defect is much more pronounced in vitro than in
vivo [144]. Position is solvent-accessible [144]. Single
cysteine at this position cross-links as UmuD2 moderately
poorly with iodine and moderately well with Cu
phenanthroline [144]. Single-cysteine mutant cross-links as
UmuD2 moderately by dialyzing out DTT [144]. This
position may be involved in binding ClpXP [127].
34 V Mutation to Cysteine in UmuD has a defect in mutagenesis
and RecA* cleavage [143]. Single cysteine has essentially
normal extent of glutaraldehyde cross-linking to UmuD2;
forms heterodimers with UmuD' as efficiently as wild-type
UmuD [143]. Single cysteine at this position has low to
moderate solvent accessibility; cross-links robustly with
iodine or Cu phenanthroline but moderately with BMH [143].
Extent of single-cysteine Cu phenanthroline cross-linking as
UmuD2 increases slightly with protein concentration [143].
Position is not particularly solvent-accessible, and single
cysteine at this position cross-links as UmuD2 moderately
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with both iodine and Cu phenanthroline (results are not
entirely consistent with those of reference [143]; the
discrepancy may be due to higher DTT content in reaction
buffer) [144]. Single-cysteine mutant cross-links as UmuD2
moderately by dialyzing out DTT [144]. A disulfide cross-
linked single cysteine variant at this position is unable to
undergo in vitro RecA* cleavage without reductant, and
cleavage is less efficient than wild-type even with reductant
[112]. A single cysteine variant of UmuD at this position
cross-links efficiently to RecA* (and there are many resulting
cross-linked species, as opposed to other single cysteine
variants that cross-link to RecA*); also cross-links as UmuD 2
moderately well with AIA [88]. UmuD' V34C does not
cross-link robustly to UmuD' V34C2, but UmuD V34C does
cross-link to UmuD V34C 2 [134]. V34 is more solvent
accessible in UmuD' than in UmuD [134]. UmuD C24A
V34C cross-links robustly to f3 [330]. This position may be
involved in binding ClpXP [127].
35 E May be involved in RecA* interaction [143]. Mutations in
the corresponding region in ,CI protein were found to lower
RecA*-mediated cleavage but not base-induced self-cleavage
[369]. Single cysteine at this position in UmuD2 is defective
in both UV mutagenesis and RecA* cleavage [144]. Position
is solvent-accessible; single cysteine at this position cross-
links as UmuD 2 moderately poorly with iodine but better
with Cu phenanthroline [144]. Single-cysteine mutant cross-
links as UmuD2 moderately by dialyzing out DTT [144].
UmuD' E35K is defective in UV and MMS-induced
mutagenesis, but it is not dominant negative to chromosomal
umuD + [145]. Protein levels of UmuD' E35K are at least as
high as wild-type UmuD' when expressed constitutively, and
there does not appear to be a defect in in vivo formaldehyde
cross-linking to UmuD' 2 [145]. This position may be
involved in binding ClpXP [127].
36 Q Single cysteine at this position in UmuD2 is not defective in
either UV mutagenesis or RecA* cleavage [144]. Position is
moderately solvent-accessible; single cysteine at this position
cross-links as UmuD2 poorly with iodine but moderately with
Cu phenanthroline [144]. Single-cysteine mutant cross-links
as UmuD2 moderately by dialyzing out DTT [144]. This
position may be involved in binding ClpXP [127].
37 R May be involved in RecA* interaction [143]. Mutations in
the corresponding region in ,CI protein were found to lower
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RecA*-mediated cleavage but not base-induced self-cleavage
[369]. Single cysteine at this position in UmuD2 is slightly
defective in both UV mutagenesis and in vitro RecA*
cleavage, but it does not appear affected in in vivo RecA*
cleavage [144]. Position is not solvent-accessible; single
cysteine at this position cross-links as UmuD2 robustly with
both iodine and Cu phenanthroline [144]. Single-cysteine
mutant cross-links as UmuD2 very well by dialyzing out DTT
[144]. UmuD' R37C does not cross-link robustly to UmuD'
R37C 2, but UmuD R37C cross-links very robustly to UmuD
R37C2 [134]. R37 is more solvent accessible in UmuD' than
in UmuD [134]. UmuD R37C and UmuD' R37C cross-
linked together form a predominant heterodimer band and
weak bands for the UmuD R37C2 and UmuD' R37C2
homodimers [134]. Both spin-labeled UmuD R37C and
UmuD' R37C show spin-spin interactions as homodimer
despite the different cross-linking activities of UmuD R37C2
and UmuD' R37C2, suggesting that there are only modest
structural differences between UmuD2 and UmuD' 2 in this
region [134]. UmuD' R37A is deficient for proteolysis by
ClpXP, but UmuD R37A can target wild-type UmuD' for
proteolysis [127]. Both UmuD R37A and UmuD' R37A can
form homodimers [127].
38 I May be involved in RecA* interaction [143]. Mutations in
the corresponding region in XCI protein were found to lower
RecA*-mediated cleavage but not base-induced self-cleavage
[369]. Single cysteine at this position in UmuD2 is slightly
defective in both UV mutagenesis and in vitro RecA*
cleavage, but it does not appear affected in in vivo RecA*
cleavage [144]. Position is not solvent-accessible; single
cysteine at this position cross-links as UmuD2 robustly with
both iodine and Cu phenanthroline [144]. Single-cysteine
mutant cross-links as UmuD2 very well by dialyzing out DTT
[144]. A single-cysteine variant of UmuD at this position
undergoes some RecA*-induced cleavage to UmuD' in vitro
even without reductant, and addition of reductant makes
RecA*-induced cleavage slightly more efficient than wild-
type UmuD (in contrast to results from [144]) [112]. UmuD'
I38C does not cross-link robustly to UmuD' I38C 2, but
UmuD 138C cross-links very robustly to UmuD 138C 2 [134].
138 is more solvent accessible in UmuD' than in UmuD
[134]. UmuD I38C and UmuD' I38C cross-linked together
form a predominant heterodimer band and weak bands for the
UmuD I38C2 and UmuD' 138C 2 homodimers [134].
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39 D Single cysteine at this position in UmuD2 is slightly
defective in both UV mutagenesis and RecA* cleavage (more
defective in in vitro cleavage than in vivo) [144]. Position is
highly solvent-accessible; single cysteine at this position
cross-links as UmuD 2 moderately with both iodine and Cu
phenanthroline [144]. Single-cysteine mutant cross-links as
UmuD2 very well by dialyzing out DTT [144]. UmuD'
D39G is defective in UV and MMS-induced mutagenesis, but
it does augment the activity of chromosomal umuD + [145].
Protein levels of UmuD' E35K are very low compared to
wild-type UmuD' when expressed constitutively, but only in
lexA + background, and there is a severe defect in in vivo
formaldehyde cross-linking to UmuD' 2 [145]. Side chain
may be important for dimerization to UmuD'2 [145].
40 L May be involved in RecA* interaction [143]. R variant in
cleavage site mutant background (C24D/G25D) greatly
reduces ability to cleave UmuD S60A over otherwise wild-
type cleavage site mutant [149, 370]. R variant in cleavage
site mutant background cannot cleave UmuD S60A L40R
[370]. Mutations in the corresponding region in XCI protein
were found to lower RecA*-mediated cleavage but not base-
induced self-cleavage [369]. Single cysteine at this position
in UmuD2 is impaired in both UV mutagenesis and RecA*
cleavage, but the RecA* cleavage defect is much more
pronounced in vitro than in vivo [144]. Position is solvent-
accessible; single cysteine at this position cross-links as
UmuD2 poorly with iodine but moderately well with Cu
phenanthroline [144]. Single-cysteine mutant cross-links as
UmuD 2 very well by dialyzing out DTT [144]; also cross-
links robustly as UmuD2 with AIA [88]. UmuD' L40R is
severely defective in UV and MMS-induced mutagenesis,
and it is dominant negative to chromosomal umuD+ [145].
Protein levels of UmuD' L40R as high as wild-type UmuD'
when expressed constitutively, but there does is a severe
defect in in vivo formaldehyde cross-linking to UmuD' 2
[145]. Side chain may be important for dimerization to
UmuD' 2 [145]. ClpXP degradation of UmuD 2 sometimes
results in cleavage after this residue [ 127].
41 N Single cysteine at this position in UmuD 2 is defective in both
UV mutagenesis and RecA* cleavage (more defective in in
vitro cleavage than in vivo) [144]. Position has moderately
poor solvent accessibility; single cysteine at this position
cross-links as UmuD2 poorly with iodine but moderately with
Cu phenanthroline [144]. Single-cysteine mutant cross-links
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as UmuD2 moderately well by dialyzing out DTT [144]. Side
chain may be important for dimerization to UmuD'2 [145].
ClpXP degradation of UmuD2 sometimes results in cleavage
after this residue [127]. This position may be involved in
binding ClpXP [127].
42 Q Single cysteine at this position in UmuD2 is slightly
defective in UV mutagenesis and in vitro RecA* cleavage but
not in vivo RecA* cleavage [144]. Position is solvent-
accessible; single cysteine at this position cross-links as
UmuD2 poorly with both iodine and Cu phenanthroline [144].
Single-cysteine mutant cross-links as UmuD2 poorly by
dialyzing out DTT [144]. ClpXP degradation of UmuD2
sometimes results in cleavage after this residue [ 127]. This
position may be involved in binding ClpXP [127].
43 L This position may be involved in binding ClpXP [127].
44 L Single cysteine at this position has defect in glutaraldehyde
cross-linking to UmuD2 but forms heterodimers with UmuD'
as efficiently as wild-type UmuD [143]. Single cysteine at
this position has moderate solvent accessibility and cross-
linking to UmuD2 with iodine, BMH, or Cu phenanthroline
[143]. Extent of single-cysteine Cu phenanthroline cross-
linking as UmuD2 does not depend on protein concentration
[143]. Mutations in the corresponding region in XCI protein
were found to lower RecA*-mediated cleavage but not base-
induced self-cleavage [369]. Position is moderately solvent-
accessible; single cysteine at this position cross-links as
UmuD2 poorly with iodine (again, discrepancy with reference
[143] may be due to greater DTT concentration in
experiments in [144]) but moderately with Cu phenanthroline
[144]. Single-cysteine mutant cross-links as UmuD 2
moderately well by dialyzing out DTT [144]. A disulfide
cross-linked single cysteine variant of UmuD2 at this position
undergoes some in vitro RecA*-mediated cleavage in the
absence of reductant, but cleavage in the presence of
reductant is as efficient as wild-type (but produces an extra
intermediate band) [112]. A single-cysteine variant of
UmuD2 at this position cross-links poorly to RecA* [88,
112]. Side chain may be important for dimerization to
UmuD' 2 [145]. UmuD' L44C cross-links robustly to UmuD'
L44C2, but UmuD L44C does not cross-link robustly to
UmuD L44C2 [134]. L44C is more solvent accessible in
UmuD than in UmuD' [134]. This position may be involved
in binding ClpXP [127].
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This position may be involved in binding ClpXP [127].
46 Q This position may be involved in binding ClpXP [127].
47 H Side chain may be important for dimerization to UmuD'2 (by
providing a hydrogen bond to stabilize a loop) [145]. This
position may be involved in binding ClpXP [127].
48 P This position may be involved in binding ClpXP [127].
49 S UmuD' S49N-A50T is defective in UV and MMSinduced
mutagenesis, but it slightly augments mutagnesis activity of
chromosomal umuD + [145]. Protein levels of UmuD' S49N-
A50T are at least as high as wild-type UmuD' when
expressed constitutively, and there does not appear to be a
defect in in vivo formaldehyde cross-linking to UmuD'2
[145]. This position may be involved in binding ClpXP
[127].
50 A Highly conserved among UmuD-like proteins (except S.
typhimurium [371, 372] and RulA [373]. Mutations to either
T or V disrupt homodimerization of UmuD' by yeast two-
hybrid (V variant disrupted slightly more) [350]. Steady-
state levels are approximately equal to wild-type when
expressed as UmuD', although V mutation has slightly
lowered levels [350]. T variant slightly and V variant greatly
reduces both spontaneous and MMS-induced mutagenesis as
UmuD' [350]. S variant in S60A construct can be recognized
for cleavage by S. typhimurium UmuD enzyme, whereas
otherwise wild-type S60A construct cannot [149]. UmuD'
S49N-A50T is defective in UV and MMS-induced
mutagenesis, but it slightly augments mutagnesis activity of
chromosomal umuD + [145]. Protein levels of UmuD' S49N-
A50T are at least as high as wild-type UmuD' when
expressed constitutively, and there does not appear to be a
defect in in vivo formaldehyde cross-linking to UmuD'2
[145]. This position may be involved in binding ClpXP
[127].
51 T Conserved in 9 out of 10 UmuD-like proteins [350]. UmuD'
T511 has reduced steady-state levels, a pronounced decrease
in MMS-induced and spontaneous mutagenesis, and a defect
in self-association of UmuD' by yeast two-hybrid [350].
UmuD T51I in cleavage site mutant construct (C24D/G25D)
diminishes its ability to cleave otherwise wild-type cleavage
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45 1
site mutant UmuD; UmuD T51I cleavage site mutant cannot
cleave UmuD T51I S60A [370]. UmuD' T51I is defective in
UV and MMS-induced mutagenesis, but it slightly augments
mutagnesis activity of chromosomal umuD ÷ [145]. Protein
levels of UmuD' T5 1I are at least as high as wild-type
UmuD' when expressed constitutively, but there is a defect in
in vivo formaldehyde cross-linking to UmuD'2 [145]. Side
chain may be important for dimerization to UmuD'2 (by
providing a hydrogen bond to stabilize a loop) [145]. This
position may be involved in binding ClpXP [127].
52 Y UmuD' Y52Q is probably deficient in UV-induced
mutagenesis [145]. UmuD Y52W is deficient for UV-
induced mutagenesis (Figure AII-4, p. 1 88). UmuD C24A
Y52C cross-links robustly to f3 [330].
53 F
54 V
55 K
56 A
57 S Mutation to Cysteine in UmuD has a defect in mutagenesis
and RecA* cleavage [143]. Single cysteine at this position
has high solvent accessibility, low cross-linking as UmuD2
with iodine or BMH, and moderate cross-linking with Cu
pehnanthroline [143]. Extent of single-cysteine Cu
phenanthroline cross-linking as UmuD2 increases slightly
with protein concentration [143]. Single-cysteine mutant
cross-links as UmuD 2 poorly by dialyzing out DTT [144]. A
single cysteine variant of UmuD at this position cross-links
moderately to RecA*; also cross-links as UmuD2 moderately
with AIA [88]. UmuD' S57C cross-links very robustly to
UmuD' S57C 2, but UmuD S57C cross-links very poorly to
UmuD S57C2 (this would not have been predicted by the
structures of UmuD') [134]. S57C is solvent accessible in
both UmuD and UmuD' [134]. UmuD S57C seems to have
more contaminating UmuD' than other UmuD derivatives,
and when it is cross-linked as a homodimer, the only band
visible corresponds to the size of a UmuD'D heterodimer (so
it either runs fast on a gel or only cross-links to
contaminating UmuD' S57C) [134]. UmuD S57C and
UmuD' S57C cross-linked together form both a band that
corresponds to the size of the heterodimer and one that
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Figure Legend: ArgE3 reversion assay was performed as described at 25 J/m2 [317],
using bacterial strain GW8017 and plasmids pSE101 (empty vector), pSE115 (positive
control), and pSE115 Y52W.
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appears to be UmuD' S57C2 [134]. Spin-labeled UmuD
S57C and UmuD' S57C both showed a lack of spin-spin
interactions by EPR [134]. UmuD C24A S57C does not
cross-link robustly to 3 [330].
58 G
59 D
60 S Mutation to Cysteine in UmuD has a defect in mutagenesis
and RecA* cleavage [143]. Single cysteine at this position
has essentially normal extent of glutaraldehyde cross-linking
to UmuD2; forms heterodimers with UmuD' as efficiently as
wild-type UmuD; reacts well to iodoacetate (but since this is
the active site nucleophile, that does not necessarily mean it
is solvent accessible but merely reactive); cross-links as
UmuD 2 poorly with iodine or BMH but cross-links
moderately with Cu phenanthroline [ 143]. Extent of single-
cysteine Cu phenanthroline cross-linking as UmuD 2 depends
on protein concentration [143]. UmuD S60C and S60A are
both impaired for UV mutagenesis, but UmuD' S60A is
much less impaired [103]. Single-cysteine mutant cross-links
as UmuD2 moderately poorly by dialyzing out DTT [144]. A
single-cysteine variant of UmuD2 at this position cross-links
poorly to RecA* [88, 112]. Single cysteine derivative of
UmuD at this position cross-links as UmuD 2 poorly with AIA
[88]. UmuD C24A S60C does not cross-link robustly to f3
[330].
61 M Conserved among most UmuD-like proteins, except P1
HumB protein [366]. Despite a reduced steady-state level
when expressed as UmuD', failure of this variant to self-
associate by yeast two-hybrid, and a lowered spontaneous
mutagenesis frequency under the same conditions, the I
mutation does not have a lowered MMS-induced mutation
frequency [350].
62 I
63 D
64 G G64D mutation in UmuD' has about half of wild-type
UmuD"s spontaneous mutagenesis frequency, but has at least
wild-type MMS-induced mutagenesis (interestingly, the
authors stated in the discussion that this mutation resulted in
about half of wild-type MMS-induced mutagenesis, but this
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is contrary to the table of results. I am not sure which is the
type-o) [350]. G64D in UmuD' runs lower on SDS-PAGE
than wild-type [350]. Mutations in this residue in UmuD'
cause less than a 2-fold reduction in UV mutagenesis [145].
65 G R mutation nonmutable in UmuD [76, 121, 367]. R mutation
has only slight defect in spontaneous and MMS-inducted
mutagenesis when expressed as UmuD'; therefore defect in
UmuD is probably due to lack of autocleavage [350].
Position is expected to be solvent-exposed [141].
Interestingly, yeast-two hybrid experiment shows a 4-fold
increase in homodimerization signal with G65R in UmuD'
than with wild-type UmuD' [350]. G65R mutation runs
lower than wild-type on SDS-PAGE gel [350].
66 I
67 S Mutation to Cysteine in UmuD has a defect in mutagenesis,
but much less of a defect in RecA* cleavage [143]. Single
cysteine at this position has moderate solvent accessibility,
low cross-linking as UmuD2 with iodine, moderate cross-
linking with BMH, and robust cross-linking with Cu
phenanthroline [143]. Extent of single-cysteine Cu
phenanthroline cross-linking as UmuD2 does not depend on
protein concentration, but it depends on pH (cross-linking is
more efficient at pH 8.1 than pH 7.3) [143]. Single-cysteine
mutant cross-links as UmuD2 poorly by dialyzing out DTT
[144]. A single cysteine variant of UmuD at this position
cross-links moderately to RecA*; but it cross-links as UmuD2
poorly with AIA [88]. UmuD' S67C cross-links robustly to
UmuD' S67C 2 (this would not have been predicted by the
structures of UmuD'), but UmuD S67C cross-links very
poorly to UmuD S67C 2 [134]. S67C is solvent accessible in
both UmuD and UmuD' [134]. Spin-labeled UmuD S67C
and UmuD' S67C both showed spin-spin interactions by EPR
[134].
68 D
69 G
70 D
71 L
72 L
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73 I
74 V
75 D Highly conserved residue; UmuD' D75A appears to
significantly alter the structure ofUmuD' [145]. UmuD'
D75A is defective in UV and MMS-induced mutagenesis, but
it slightly augments mutagnesis activity of chromosomal
umuD+ [145]. Protein levels of UmuD' D75A are much less
than wild-type UmuD' when expressed constitutively, but
only in a lexA+ background, and there is a severe defect in
both the extent and the protein size of in vivo formaldehyde
cross-linking to UmuD'2 [145].
76 S
77 A
78 I
79 T Mutations in this residue in UmuD' cause less than a 2-fold
reduction in UV mutagenesis [145].
80 A
81 S This and surrounding positions are not well conserved in
UmuD-LexA family of proteins [143]. Mutation to Cysteine
in UmuD results in moderate deficiency in both mutagenesis
and RecA* cleavage [143]. Single cysteine at this position
has essentially normal extent of glutaraldehyde cross-linking
to UmuD2 and forms heterodimers with UmuD' as efficiently
as wild-type UmuD [143]. Single cysteine at this position
has moderate solvent accessibility, low cross-linking as
UmuD2 with iodine or BMH, but high cross-linking
propensity with Cu phenanthroline [143]. Extent of single-
cysteine Cu phenanthroline cross-linking as UmuD2 does not
depend on protein concentration [143]. Single-cysteine
mutant cross-links as UmuD2 poorly by dialyzing out DTT
[144]. Single-cysteine variant of UmuD at this position
cross-links robustly to RecA*; but cross-links as UmuD2
poorly with AIA [88]. UmuD' S81C cross-links rather
robustly to UmuD' S81 C2 (this would not have been
predicted by the structures of UmuD'), but UmuD S81C
cross-links poorly to UmuD S81C 2 [134]. S81C is more
solvent accessible in UmuD than in UmuD' [134]. Spin-
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labeled UmuD S81C and UmuD' S81C both showed a lack of
spin-spin interactions by EPR [134]. UmuD C24A S81C
does not cross-link robustly to 03 [330].
82 H Conserved in 7 out of 10 UmuD-like proteins (no reference
listed in [350], but try 34, 36, and 38). H82Y mutation in
UmuD' results in mild defect in spontaneous and MMS-
induced mutagenesis, but yeast two-hybrid suggests a loss of
ability to self-associate [350]. UmuD' H82Y is much more
defective in UV mutagenesis than MMS mutagenesis [125].
83 G
84 D
85 I This position may be involved in binding ClpXP [127].
86 V This position may be involved in binding ClpXP [127].
87 I This position may be involved in binding ClpXP [127].
88 A This position may be involved in binding ClpXP [127].
89 A Not particularly solvent accessible in UmuD; may play
important role in protein architecture [143]. Mutation to
Cysteine in UmuD results in moderate deficiency in both
mutagenesis and RecA* cleavage [143]. Single cysteine at
this position has low solvent accessibility and low cross-
linking as UmuD 2 with iodine, BMH, or Cu phenanthroline
[143]. Extent of single-cysteine Cu phenanthroline cross-
linking as UmuD 2 depends on protein concentration [143].
UmuD A89C defective in cross-linking as heterodimer with
UmuD' (but data not shown) [143]. Single-cysteine mutant
cross-links as UmuD2 poorly by dialyzing out DTT [144].
This position may be involved in binding ClpXP [127].
90 V This position may be involved in binding ClpXP [127].
91 D UmuD D91A is soluble, slightly hypercleavable, proficient
for RecA*-mediated autoproteolysis, and deficient in binding
to DinB [77]. This position may be involved in binding
ClpXP [127].
92 G G92D is nonmutable in UmuD [76, 121, 374]. This is a
particularly interesting result because both LexA and the 434
repressor have a D at this position in their wild-type forms
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[125, 367], and there is essential no defect in mutagenesis or
dimerization for G92D in UmuD' [350]. However, UmuD'
G92D runs higher than wild-type UmuD' on SDS-PAGE
[350]. This position may be involved in binding ClpXP
[127].
93 E Mutations in this residue in UmuD' cause less than a 2-fold
reduction in UV mutagenesis [145]. UmuD E93C has wild-
type UV mutagenesis activity (Figure AII-2, p. 178). This
position may be involved in binding ClpXP [127].
94 F Spin-labeled UmuD F94C shows spin-spin interactions by
EPR with position C24 [134]. Spin-labeled UmuD C24A
F94C shows no spin-spin interactions [134]. Position 94
appears buried and rigid in UmuD but solvent exposed and
flexible in UmuD' by EPR [134]. UmuD F94C cross-links as
UmuD F94C2 almost quantitatively by copper phenanthroline
(First mentioned in [134]; data shown in Chapter 4). UmuD
C24A F94C dicysteine derivatives with an additional
cysteine on the N-terminal arms cross-link as dimers with
iodine in the following order: robust cross-linking if the
addition cysteine is V22C, less if S28C, even less if D20C,
and hardly at all if F26C [134]. Interestingly, two dimers
form, presumably one with two disulfide bonds and one with
only one [134]. UmuD F94C is completely inactive for UV-
induced mutagenesis in vivo (Figure AII-5, p. 194). The
proximity of position F94 is to the intermolecular C24, not
the intramolecular one [134]. UmuD C24A F94C does not
cross-link robustly to 3 [330]. This position may be involved
in binding ClpXP [127].
95 T Mutations in this residue in UmuD' cause less than a 2-fold
reduction in UV mutagenesis [145]. This position may be
involved in binding ClpXP [127].
96 V This position may be involved in binding ClpXP [127].
97 K This position may be involved in binding ClpXP [127].
98 K This position may be involved in binding ClpXP [127].
99 L This position may be involved in binding ClpXP [127].
100 Q Not particularly solvent accessible in UmuD; may play
important role in protein architecture [143]. Mutation to
Cysteine in UmuD results in moderate deficiency in both
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Figure Legend: ArgE3 reversion assay was performed as described at 25 J/m 2 [317],
using bacterial strain GW8017 and plasmids pSE 101 (empty vector), pSE 115 (positive
control), pSE115 S60A, and pSE 115 F94C.
194
I
! !
mutagenesis and RecA* cleavage [143]. Single cysteine at
this position has low solvent accessibility and low cross-
linking as UmuD2 with iodine, BMH, or Cu phenanthroline
[143]. Extent of single-cysteine Cu phenanthroline cross-
linking as UmuD2 depends on protein concentration [143].
Single-cysteine mutant cross-links as UmuD2 poorly by
dialyzing out DTT [144]. This position may be involved in
binding ClpXP [127].
101 L Conserved in UmuD-like proteins but not in LexA-like ones
[340]. UmuD L101G R102G is deficient in UV-induced
mutagenesis, but UmuD' L101G R102 G is not particularly
deficient [340]. UmuD L101G R102G is deficient in in vivo
and in vitro RecA*-mediated cleavage, although the effect is
more dramatic in vivo, and it exacerbates cold sensitivity
relative to wild-type UmuD [340]. However, UmuD L101G
R102G interacts with RecA* just as efficiently as wild-type
UmuD [340]. UmuD' L1O1G R102G is defective in
inhibiting recombination [340]. This position may be
involved in binding ClpXP [127].
102 R Relatively conserved in UmuD-like proteins but not in LexA-
like ones [340]. UmuD L101G R102G is deficient in UV-
induced mutagenesis, but UmuD' L1O1G R102 G is not
particularly deficient, suggesting a role in RecA* cleavage
[340]. UmuD L101G R102G is deficient in in vivo and in
vitro RecA*-mediated cleavage, although the effect is more
dramatic in vivo, and it exacerbates cold sensitivity relative to
wild-type UmuD [340]. However, UmuD L101G R102G
interacts with RecA* just as efficiently as wild-type UmuD
[340]. UmuD' L101G R102G is defective in inhibiting
recombination [340]. This position may be involved in
binding ClpXP [127].
103 P This position may be involved in binding ClpXP [127].
104 T This position may be involved in binding ClpXP [127].
105 V This position may be involved in binding ClpXP [127].
106 Q This position may be involved in binding ClpXP [127].
107 L This position may be involved in binding ClpXP [127].
108 I This position may be involved in binding ClpXP [127].
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109 P Mutations in this residue in UmuD' cause less than a 2-fold
reduction in UV mutagenesis [145]. This position may be
involved in binding ClpXP [127].
110 M
111 N
112 S Mutation to Cysteine in UmuD results in slight defect in both
mutagenesis and RecA* cleavage [143]. Single cysteine at
this position has moderate solvent accessibility (but large
error bars), low cross-linking as UmuD2 with iodine, and
moderate cross-linking with BMH or Cu phenanthroline
[143]. Extent of single-cysteine Cu phenanthroline cross-
linking as UmuD2 depends slightly on protein concentration
[143]. Single-cysteine mutant cross-links as UmuD2
moderately by dialyzing out DTT [144]. A single cysteine
variant of UmuD at this position cross-links moderately to
RecA*; but cross-links as UmuD 2 poorly with AIA [88].
Both UmuD S112C and UmuD' S112C cross-link poorly as
homodimers [134]. S112C is solvent accessible in UmuD';
the error bars are very high for the same experiment UmuD
[134]. Spin-labeled UmuD S112C and UmuD' S112C both
showed a lack of spin-spin interactions by EPR [134].
UmuD C24A S112C does not cross-link robustly to 03 [330].
113 A
114 Y
115 S UmuD S115C has augmented UV mutagenesis activity
(Figure AII-2, p. 178).
116 P
117 I
118 T
119 I
120 S
121 S
122 E
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123 D
124 T
125 L
126 D Not particularly solvent accessible in UmuD; may play
important role in protein architecture [143]. Mutation to
Cysteine in UmuD results in very slight deficiency in
mutagenesis but a large defect in RecA* cleavage [143].
D126C has slight defect in glutaraldehyde cross-linking to
UmuD2 and a great defect in heterodimer formation with
UmuD' (this inability to form the UmuD'-depleting
heterodimer might account for its discrepancy in
mutagenesis/cleavage phenotype) [143]. Single cysteine at
this position has low solvent accessibility and low cross-
linking as UmuD2 with iodine, BMH, or Cu phenanthroline
[143]. Extent of single-cysteine Cu phenanthroline cross-
linking as UmuD2 depends on protein concentration [143].
Single-cysteine mutant cross-links as UmuD2 moderately by
dialyzing out DTT [144]. UmuD C24A D126 cross-links
somewhat robustly to 13 [330].
127 V
128 F
129 G Position is conserved among homologous proteins [125, 145,
366]. G129D is non-cleavable in UmuD [121]. UmuD'
G129D is severely reduced for both spontaneous and MMS-
induced mutagenesis, and it produced the strongest signal in
a yeast two-hybrid assay (over 5-fold the signal of wild-type
UmuD') [350]. UmuD' G129D is defective in UV and MMS-
induced mutagenesis, and it is strongly dominant negative to
chromosomal umuD+ [145]. UmuD' G129S is also severely
reduced in spontaneous and MMS-mutagenesis, but less so
than G129D [350]. G129S, in contrast to G129D, shows a
defect in homodimer formation to UmuD'2 [350]. UmuD'
G129D is not dominant negative in a recA 730 background
[350]; possible reasons for this discrepancy are discussed in
[145]. Protein levels of UmuD' G129D are at least as high as
wild-type UmuD' when expressed constitutively, and there is
a slight defect in formaldehyde cross-linking to UmuD'2[145].
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130 V Position is conserved in UmuD-like adaptor proteins but not
in homologous repressors (no reference listed in [350], but
try 28, 34, 36, 38 and 40). V130M in UmuD' greatly reduces
spontaneous and mildly reduces MMS-induced mutagenesis,
but the in vivo degradation of this protein is much more
efficient than wild-type, suggesting that these defects might
be due more to the number of proteins in the cell than to any
specific functional defect [350]. Similarly, a yeast two-
hybrid of UmuD' V130M shows a defect in self-association,
but that might still be due to hyperdegradation of the protein
[350].
131 V
132 I
133 H UmuD' H133C cross-links efficiently to UmuD' V135C but
not to V134C [134]. UmuD' H133C cross-links somewhat to
UmuD' A137C, UmuD' M138C, and UmuD' R139C [134].
UmuD' H133C cross-links inefficiently as a homodimer
[134]. UmuD H133C cross-links efficiently to UmuD
V135C and slightly less efficiently to UmuD M138C [134].
UmuD H133C cross-links inefficiently to UmuD V134C,
UmuD A137C, and UmuD R139C [134]. UmuD H133C is
expressed at wild-type levels but has only 17.4% of wild-type
TLS activity; UmuD' H133C is expressed almost as well as
wild-type levels but has 49.4% TLS activity in vivo [134].
Neither UmuD H133C nor UmuD' H133C cross-links
robustly to homodimers with iodine [134]. UmuD C24A
H133C does not cross-link robustly to 3 [330].
134 V UmuD' V134C cross-links inefficiently to UmuD' H133C
[134]. UmuD V134C cross-links inefficiently to UmuD
H133C [134]. UmuD V134C is expressed at 70% of wild-
type levels and has 94.6% of wild-type TLS activity; UmuD'
V134C is expressed almost as well as wild-type levels but
has 169.6% TLS activity in vivo [134]. Neither UmuD
V 134C nor UmuD' VI 34C cross-links robustly to
homodimers with iodine [134]
135 V UmuD V135D in cleavage site mutant construct
(C24D/G25D) diminishes its ability to cleave otherwise wild-
type cleavage site mutant UmuD; UmuD V135D cleavage
site mutant cannot cleave UmuD S60A V135D [370].
UmuD' V135C cross-links efficiently to UmuD' H133C
[134]. UmuD' V135C cross-links less efficiently to UmuD'
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V134C, UmuD' A137C, and UmuD' M138C [134]. UmuD'
V135C cross-links inefficiently as a homodimer or to UmuD'
R139C [134]. UmuD V135C cross-links efficiently to
UmuD H133C [134]. UmuD V135C cross-links much less
efficiently as a homodimer or to UmuD 134C, UmuD
A137C, UmuD M138C, or UmuD R139C [134]. UmuD
V135C is expressed slightly more than wild-type levels but
has only 12.1% of wild-type TLS activity; UmuD' V135C is
expressed 60% as well as wild-type levels but has 38.5%
TLS activity in vivo [134]. Neither UmuD V135C nor
UmuD' V135C cross-links robustly to homodimers with
iodine [134].
136 K UmuD K136C is expressed at 80% of wild-type levels and
has 78.5% of wild-type TLS activity; UmuD' K136C is
expressed at 40% of wild-type levels but has 195.3% TLS
activity in vivo [134]. UmuD K136C easily precipitated in
vitro (Graham Walker, personal communication).
UmuD'A136-139 had only a slight destabilization in a clp+
strain but was significantly less stable than wild-type UmuD'
in a clpX.':kan strain [323].
137 A UmuD' A137C cross-links somewhat to UmuD' H133C
[134]. UmuD A137C cross-links inefficiently to UmuD
H133C [134]. UmuD A137C is expressed almost as well as
wild-type but has only 47.3% of wild-type TLS activity;
UmuD' A137C is expressed 40% as well as wild-type levels
but has 189.5% TLS activity in vivo [134]. Neither UmuD
A137C nor UmuD' A137C cross-links robustly to
homodimers with iodine [134]. Spin-labeled UmuD A137C
and UmuD' A137C both show spin-spin interactions by EPR,
suggesting that A137 is close to the dimer interface [134].
UmuD'A137-139 is less stable than wild-type UmuD' in both
a clp+ and a clpX::kan strain [323].
138 M UmuD' M138C cross-links somewhat to UmuD' H133C
[134]. UmuD M138C cross-links relatively efficiently to
UmuD H133C [134]. UmuD M138C is expressed at slightly
above wild-type levels but has only 22.6% of wild-type TLS
activity; UmuD' M138C is expressed at 40% of wild-type
levels but has 80.5% TLS activity in vivo [134]. Neither
UmuD M138C nor UmuD' M138C cross-links robustly to
homodimers with iodine [134]. Spin-labeled UmuD M138C
and UmuD' M138C both show spin-spin interactions by EPR,
suggesting that M138 is close to the dimer interface [134].
UmuD'A138-139 behaves like wild-type in a clp+ strain but is
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more unstable than wild-type in a clpX::kan strain [323].
This residue appears to interfere with selenium-soaking into
UmuD' crystals; mutation to UmuD' M138V or UmuD'
M138T allows soaking [342]. UmuD' M138V and UmuD'
M138T have increased UV mutagenesis activity [125].
139 R UmuD' R139C cross-links somewhat to UmuD' H133C
[134]. UmuD R139C cross-links inefficiently to UmuD
H133C [134]. UmuD R139C is expressed at 30% of wild-
type levels and has 46.7% of wild-type TLS activity; UmuD'
R139C is expressed at 25% of wild-type levels but has 122%
TLS activity in vivo [134]. Neither UmuD R139C nor
UmuD' R139C cross-links robustly to homodimers with
iodine [134]. UmuD'A139 has no phenotype related to in
vivo ClpXP proteolysis [323]. UmuD C24A R139C does not
cross-link robustly to 13 [330].
140 W in this position of UmuD 2 has wild-type activity in vivo
but a slight decrease in ClpXP-mediated proteolysis for
UmuD'(+140W) (figure AII-6, p.201).
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Figure AII-6
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Figure Legend: (A) ArgE3 reversion assay was pertormed at 25 J/m-, using bacterial
strain GW8017 and plasmids pSE 101 (empty vector), pSE 115 (positive control), and
pSE115(+140W). (B) ClpXP degradation assay of UmuD(+140W) and
UmuD'(+140W). Upper bands are UmuD; lower bands are UmuD'. Lanes are: (1)
molecular weight markers (2) wild-type UmuD and UmuD', t= 0 (3) wild-type UmuD
and UmuD', t = 2 hr (4) UmuD(+140W) and wild-type UmuD', t = 0 (5) UmuD(+140W)
and wild-type UmuD', t = 2 hr (6) wild-type UmuD and UmuD'(+ 140W), t = 0 (7) wild-
type UmuD and UmuD'(+140W), t = 2 hr (8) UmuD(+ 140W) and UmuD'(+140W), t = 0
(9) UmuD(+140W) and UmuD'(+140W), t = 0. All procedures are described in [317].
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Figure 1-1: Sequence alignment of UmuD and similar proteins.
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Figure 1-1: Sequence alignment of UmuD and similar proteins. Sequence alignment of E.
coli UmuD and plasmid-bome homologs (MucA and ImpA), the similar protein LexA, and the
full-length intrinsically disordered human a-synuclein, which has some primary structural
similarity. Residues that are identical in UmuD are in dark green; residues that are similar are in
light green.
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